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ABSTRACT 
Background: Whole grain intake is associated with reduced risk of chronic diseases, 
such as cardiovascular disease and Type 2 diabetes. Unlike more commonly 
recognised whole grains, sorghum is a so-called “ancient”, gluten-free whole grain 
food that is gaining attention from food manufacturers, consumers and researchers as 
a beneficial ingredient in novel product development. Sorghum is widely cultivated 
globally due to its adaptability to semi-arid/arid conditions and high temperatures, 
and has significant potential for sustainable grain production in harsh climates. It is a 
dietary staple in some communities of Asia, Africa and Central America, however in 
countries such as the United States and Australia, sorghum is predominantly used as 
an animal feed, with only small quantities utilised for the manufacture of human 
foods. If sorghum is to be accepted as a common food, attention to food formulations 
and processing methods that produce desirable sorghum-based cereal products, 
whilst preserving the grain’s beneficial nutritional and functional attributes, is 
required.  
 
Sorghum whole grain has been shown to have lower starch and protein digestibility 
in vitro, resulting in reduced metabolisable energy and hence smaller weight gains in 
animals, and some cultivars are high in dietary fibre and rich in polyphenolic 
compounds. Based on their purported mechanisms, these attributes may contribute to 
positive effects on metabolic markers and body weight and therefore may more 
broadly influence chronic disease prevention in humans when they consume 
sorghum-based foods regularly.  However, there is a paucity of human studies to 
date. 
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Research Hypothesis and Study Aims: This thesis proposes that sorghum grain 
consumption may assist in chronic disease prevention via weight management, 
especially in populations where food is ubiquitous and obesity-related chronic 
diseases are prevalent. Research examining the effects of sorghum intake on health 
outcomes, such as weight loss and disease biomarkers, requires clinical studies. 
These studies may also expose potential protective roles of the sorghum grain as part 
of a whole diet. The key hypothesis of this thesis is that sorghum is a viable 
alternative to more commonly consumed whole grain cereals in the human diet and 
may have positive benefits on factors associated with metabolic health including 
weight management. A review of the literature described sorghum grain structure 
and composition which relate to mechanisms by which sorghum grain components 
may influence weight management and chronic disease risk; and summarised the 
evidence on effects of sorghum consumption on health outcomes related to chronic 
disease prevention. This review provided insights into the knowledge gaps and study 
imperatives that informed the experimental components of the thesis.   
 
In order to conduct human trials successfully, particularly with participants who do 
not typically consume traditional sorghum foods, suitable ready-to-eat sorghum 
grained cereal foods in the form of flaked breakfast cereal biscuits were formulated 
and tested prior to intervention trials commencing. A randomised, crossover, feeding 
study using the flaked sorghum biscuits was conducted to investigate mechanisms 
related to general metabolic markers and antioxidant status, as well as acute satiety. 
A randomised controlled trial (RCT) was then conducted with the aim to test the 
weight-loss effects of longer-term whole grain sorghum flaked biscuits consumption 
 
 iii 
incorporated into an energy-restricted diet plan. This study also examined the effects 
on key biomarkers of metabolic health, inflammation and oxidative stress. 
 
Methods:  
Gaps in the knowledge of effects of sorghum consumption on indicators of metabolic 
disease, including weight, were identified and elements of study designs were 
incorporated into the experimental components of the thesis. Whole grain flaked 
cereal biscuits were formulated on a pilot line by our industry partner (Sanitarium 
Health and Wellness) using a multistep process involving steaming, drying, rolling 
and baking. For the acute satiety study, forty subjects (20 males and 20 females) 
were tested on four occasions after a 12-hour fast. At baseline, they consumed 50 
grams (or 3 biscuits) of one of four treatment meals: white, red or brown whole grain 
sorghum flaked biscuits or a whole grain flaked wheat biscuit control. Subjective 
satiety was measured at 8 time-points over four hours and food intake at the 
subsequent meal and for the rest of the day recorded. In a subset of 20 subjects, 
plasma glucose, insulin, and four appetite-related gut peptides (GIP, GLP-1, PYY 
and ghrelin) were also measured. In the subsequent RCT investigating chronic 
sorghum consumption, sixty subjects (14 males and 46 females) were randomised to 
either a sorghum (intervention) or wheat (control) group. Both groups received 
advice on an energy-restricted diet from an Accredited Practising Dietitian and were 
provided with 45 g of cereal products to include daily in their prescribed diets for 12 
weeks. The primary outcome was weight loss. Secondary outcomes included: plasma 
glucose, HbA1c, insulin, total cholesterol, HDL-c, LDL-c, TAG, and various 
markers of inflammation and oxidative stress (IL1β, IL-6, IL-8, TNFα, hsCRP, HPX 
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and TAC), measured at 0 and 12 weeks. Subjective satiety ratings were assessed at 0, 
6 and 12 weeks.  
 
Results: A vast array of nutritional and bioactive sorghum grain components, such 
as slowly digestible starches, polyphenols including anthocyanins in red sorghum, 
unsaturated fatty acids, and dietary fibre (including resistant starch), were identified 
in the literature, with potential actions in health protective metabolic processes. 
There was a paucity of human studies that are necessary to better understand effects 
of sorghum consumption (as a whole food), especially those related to health 
outcomes and indicators of disease. These findings justified the human studies 
described. During the acute meal test study, subjects reported significantly lower 
satiety ratings after consuming wheat compared to sorghum biscuits. Incremental 
AUC of postprandial GLP-1, GIP and in males, PYY, were significantly higher 
(p=0.018, p=0.031, p=0.036 respectively) for sorghum breakfasts compared to 
wheat. Energy intake at a subsequent meal did not differ between treatments, nor did 
glucose, ghrelin and TAC responses. The red sorghum biscuit showed the greatest 
alteration in appetite hormones, suggesting that the specific combination of its 
components (such as unique anthocyanin flavonoids) requires further investigation. 
Hence, these results informed the choice of a red sorghum-based biscuit to test in the 
subsequent 3 month RCT. This trial did not identify any significant differences in 
weight loss or any clinical variables between a sorghum cereal group and a wheat 
control in an energy-restricted diet.  For both groups, the majority of clinical indices 
changed significantly over time (p<0.05) and equivalent amounts of weight were lost 
(p=0.369). These results did not concur with the initial acute satiety study and there 
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was no translation to differences in weight reduction effects for sorghum and wheat 
cereals.  
 
Conclusions: Research presented in this thesis provides human evidence for acute 
satiety effects from whole grain sorghum ingestion in the form of flaked cereal 
biscuits. However, it could not be concluded that whole grain sorghum assists 
specifically with weight management, or is superior to wheat (another whole grain 
product). Further clinical trials are necessary to establish an evidence base for weight 
loss effects from chronic sorghum consumption. In the longer term, this research 
would help to further evaluate the weight loss potential of sorghum consumption, 
especially red sorghum grown in abundance locally in Australia. Weight loss effects 
would be considered to assist in the prevention of chronic diseases, particularly those 
associated with obesity. Nevertheless, new knowledge was generated from these 
studies demonstrating the potential of sorghum consumption to enhance acute 
satiety. Sorghum is not only a gluten-free whole grain cereal, but also a promising 
ingredient in cereal foods targeting appetite control. Commercially, the results of the 
feeding trials may contribute to the development of the sorghum industry globally by 
adding to the evidence base on human health effects. This thesis also showcases the 
collaboration between food industry and science to progress sorghum, a relatively 
unknown human food in Australia, through the food product innovation pipeline with 
positive outcomes for all stakeholders including researchers, food manufacturers and 
also consumers.  
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1.1 Introduction 
Human health, food and the national economy are interlinked. The current Australian 
economy is undergoing change that reflects shifts within primary industries. With the 
decline of mining, other sectors such as manufacturing, services, education and 
agriculture have become increasingly important in stimulating economic growth. Of 
these five economic pillars, agriculture has been a consistent and important 
component, despite contributing less than 3% of gross domestic product (GDP) in 
2014
(1)
. Australia’s farmers produce enough food to feed 80 million people
(2)
, 
providing not only 93% of the domestic food supply
(3)
, but also supporting an export 
market valued at more than A$41 billion per annum or more than 13% of export 
revenue
(1; 2)
. The major commodities are grains and oilseeds, followed by meat, then 
industrial crops (sugar, cotton and wine), wool, dairy and horticulture
(1; 2)
.  
 
In fact, the demand for Australian-produced food is increasing, especially from 
Asian markets such as China, driven by their large populations and a growing middle 
class. Furthermore, frequent food contamination incidents in Asia have resulted in a 
general mistrust of food produced in that area and a growing demand for Australia’s 
“green and clean” produce. The problem was seen in China, in 2008, when melamine 
(a toxic polymer) was added to infant formulae, resulting in 6 infant deaths and 
52,000 hospitalisations
(4)
. As a consequence, the demand for Australian-made infant 
formulae, perceived to be safe, surged, stripping local supplies
(4)
.  These types of 
incidents have reinforced Australia’s reputation as a producer of the highest food 
quality, with exceptional food safety and biosecurity standards.  
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Australian agriculture faces major challenges in supplying the increasing demand for 
food in the local and Asia-Pacific region, one of which is climate change. Climate 
change has resulted in increased global temperatures and reduced rainfall, which in 
turn have impacted on the usability of land for farming through loss of biodiversity, 
dry-land salinity, acid soils, pests and weeds
(5)
.  Hence, it has become critical to 
engage in sustainable agricultural practices in order to protect farming land whilst 
meeting demands for greater food production. In turn, cultivating more 
environmentally sustainable crops, suitable to Australia’s often-harsh climate, is 
important, especially since grains are the nation’s leading commodity
(1)
.  
 
Sorghum (Sorghum bicolor (L.) Moench) is a good example of a sustainable crop 
that requires fewer nutrient inputs and significantly less water than other crops, such 
as corn
(6)
. In many countries of Africa, Asia and Central America, sorghum is widely 
cultivated due to its adaptability to semi-arid and arid conditions and high 
temperatures, and is a major contributor to the staple diets of local populations
(7)
. 
Globally it ranks fifth in cereal production and in Australia it ranks third, with the 
2014-2015 sorghum harvest producing 2.2 million tonnes of grain across 730,000 
hectares of total land area
(7; 8)
. This was a significant increase on previous years, 
predominantly in response to above-average rainfalls and a higher demand from 
China. In Australia, the primary use of sorghum has been as low-value livestock feed 
and more recently in biofuel production
(9)
,
 
while demand for use in human food 
manufacturing has been negligible. Sorghum has therefore remained both under-
utilised and less-recognised compared to other cereal crops, such as wheat.  
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The commercialisation of sorghum for human use in Australia has faced significant 
challenges, limited mainly by (a) a reluctance from farmers, in the absence of 
reliable markets, to invest in crop management necessary to improve the volume and 
consistency of production, and (b) the lack of incentives for grain processors to 
invest in market development, given the availability of alternative grains with better 
profit margins. Despite these limitations, a small number of food products have 
emerged on supermarket shelves over recent years that contain sorghum as a key or 
component ingredient, suggesting that demand for sorghum in human food 
production is increasing. For example, the Sanitarium Health and Wellbeing 
Company, a leading cereal food manufacturer with a strong ethos for healthy eating 
and wholesome foods, engaged in food innovation and launched a gluten-free 
breakfast cereal made exclusively from sorghum in 2014
(10)
. The launch of this 
product aligned with the broader expansion of the health food sector seen in 
Australia
(11)
, suggesting that the relationship between food and health is having an 
increasing impact on food innovations by food producers. These types of food 
product developments and investments are what is required to further stimulate 
consumer interest in sorghum as a human food ingredient, and encourage growers 
and food product manufacturers to participate. Furthermore, the lure of a growing 
consumer movement dedicated to "healthy living" and “naturally functional” 
foods
(11)
 and the ability of food companies to reformulate rather than to always 
innovate, often helps to overcome initial corporate resistance.   
 
To successfully launch new products in the marketplace and promote them to 
consumers, marketing and branding become critical components. However, in 
Australia, the marketing of novel food products made from ingredients with potential 
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benefits for human health, such as sorghum-based foods, must be conducted within a 
strict regulatory environment. Moreover, any food companies wishing to make a 
health claim must comply with “Standard 1.2.7 - Nutrition, Health and Related 
Claims”, regulated by Food Standards Australia New Zealand (FSANZ)
(12)
. This 
standard regulates claims appearing on food labels and in advertisements, in the form 
of nutrition content claims and health claims. These claims are voluntary statements 
made by food companies and may refer to the nutritional content of the food 
(nutrition content claims) or they may refer to a relationship between food, or a 
property of food, and a health effect (health claims). Health claims are further 
categorised as “general level health claims” (GLHC) or “high level health claims” 
(HLHC). GLHCs refer to a component or nutrient in a food and how it may affect 
health. For example, ‘Fibre helps to keep you regular’
(13)
. These types of claims 
cannot be used in association with serious diseases, such as heart disease, or 
indicators of disease, such as cholesterol. HLHCs refer to a component or nutrient in 
a food and how it may affect a serious disease or biomarker (indicator) of a serious 
disease. An example of this type of claim is: ‘This food is low in sodium (salt). A 
diet low in sodium may help reduce blood pressure’
(13)
.  Overall, health claims must 
be based on food-health relationships that have been substantiated according to 
Standard 1.2.7 and manufacturers need to provide supporting scientific evidence to 
demonstrate that their product contains the described ingredient/s
(12)
. Health claims 
related to weight control and satiety effects of foods are currently not permitted. 
HLHCs must also meet the Nutrient Profiling Scoring Criterion (NPSC), a point 
system broadly ranking the nutritional quality of a food
(12)
. For example, foods high 
in saturated fat and sugar are not allowed to carry a health claim, even if low in salt, 
because they would not meet the NPSC. 
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Scientific evidence therefore underpins the substantiation of health claims for food. 
However, not all scientific evidence is equivalent. The National Health and Medical 
Research Council (NHMRC) classifies the quality of scientific evidence according to 
a hierarchy which assigns “levels of evidence” based on the type of research question 
asked and its associated research design (Table 1.1)
(14)
. FSANZ uses these “levels of 
evidence” in its validation of health claims for food. Thus, for novel sorghum-based 
foods, substantiating potentially beneficial effects on disease risk factors will require 
rigorous scientific investigation in human studies. In addition, consistent results from 
randomised controlled trial (RCTs) are needed to build the highest level of evidence 
for practice. Specifically, investigating the long-term effects of consuming sorghum 
as part of a healthy diet is necessary in order to build on the small number of 
promising human studies, as well as other encouraging in vitro and animal research. 
 
To this end, the research presented in this thesis is a contribution to the level of 
evidence necessary to substantiate potential future health claims related to sorghum-
based foods. The results may also guide other researchers, consumers, the food 
industry, growers, health professionals, and government-based grain advocacy 
organisations on the general benefits of sorghum consumption for humans, and the 
process for research to investigate health effects from particular food ingredients. 
Findings from the body of work presented in the thesis collectively add to the 
knowledge base for sorghum as a promising whole grain cereal with the potential to 
assist in the prevention of chronic disease, particularly in developed countries such 
as Australia. The relevant thesis components are: (1) a critical review of the existing 
literature on sorghum, (2) research underpinning the innovative development of a 
sorghum-based food product, (3) a study of the mechanisms of sorghum grain action, 
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and (4) a randomised controlled trial testing the effects of chronic consumption of a 
novel sorghum based product.  
 
Moreover, this thesis represents more than just a contribution of evidence in support 
of a scientific question. It showcases the collaboration between food industry and 
science to progress the position of sorghum, a relatively unknown human food in 
Australia, through the food product innovation pipeline (Figure 1.1). In doing so, our 
knowledge is increased about many facets of sorghum - from plant biology through 
to environmental and agronomic considerations necessary for plant growth, to the 
nutritional and chemical composition of sorghum grain, and then finally the potential 
mechanisms of action that may be behind observed longer-term effects of chronic 
sorghum consumption. In addition, by developing a food product suitable for the 
modern Australian palate, the impact of grain processing and food format selection 
on clinical effects was elucidated. 
 
 
Figure 1.1 Key factors in the innovation of sorghum-based food products  
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Table 1.1 NHMRC Hierarchy of Evidence
(15)
 
 
Level 
 
Intervention 
 
Diagnostic 
Accuracy 
 
Prognosis 
 
Aetiology 
 
Screening 
Intervention 
I A systematic review of 
level II studies 
A systematic 
review of level II 
studies 
A systematic 
review of level II 
studies 
A systematic 
review of level II 
studies 
A systematic review of 
level II studies 
II A randomised 
controlled trial 
A study of test 
accuracy with an 
independent, 
blinded 
comparison with a 
valid reference 
standard, among 
consecutive 
persons with a 
defined clinical 
presentation 
A prospective 
cohort study 
A prospective 
cohort study 
A randomised 
controlled trial 
III-1 A pseudorandomised 
controlled trial (i.e. 
alternate allocation or 
some other method) 
A study of test 
accuracy with an 
independent, 
blinded 
comparison with a 
valid reference 
standard, among 
non-consecutive 
persons with a 
defined clinical 
presentation 
All or none All or none A pseudorandomised 
controlled trial (i.e. 
alternate allocation or 
some other method) 
III-2 A comparative study 
with concurrent 
controls: 
 Non-randomised 
experimental trial 
 Cohort study 
 Case-control 
study 
 Interrupted time 
series with a 
control group 
A comparison with 
reference standard 
that does not meet 
the criteria 
required for Level 
II and  
III-1 evidence 
Analysis of 
prognostic factors 
amongst persons 
in a single arm of a 
randomised 
controlled trial 
A retrospective 
cohort study 
A comparative study 
with concurrent 
controls: 
 Non-randomised, 
experimental 
trial 
 Cohort study 
 Case-control 
study 
III-3 A comparative study 
without concurrent 
controls: 
 Historical control 
study 
 Two or more 
single arm study 
 Interrupted time 
series without a 
parallel control 
group 
Diagnostic case-
control study 
A retrospective 
cohort study 
A case-control 
study 
A comparative study 
with concurrent 
controls: 
 Historical control 
study 
 Two or more 
single arm study 
IV Case series with either 
post-test or pre-
test/post-test outcomes 
Study of 
diagnostic yield 
(no reference 
standard) 
Case series, or 
cohort study of 
persons at 
different stages of 
disease 
A cross-sectional 
study or case 
series 
Case series 
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1.2 Thesis Overview and Structure  
This thesis begins with a summary of the existing evidence on whether sorghum 
consumption assists in the prevention of chronic disease (Chapter 2). Gaps in the 
literature were identified, in particular a paucity of reports on research involving 
human subjects. These observations were used to guide the development of the 
human clinical trials designed for the experimental components of the thesis. 
 
A methodological framework underpinning the research undertaken for the thesis is 
presented in Chapter 3. This includes overviews of experimental study designs and a 
discussion of the different experimental methods utilised in the clinical trials within 
the thesis, giving insights into concepts of validity, strengths and limitations. 
Importantly, reviews of specific biomarkers, both as indicators of health status and 
appetite regulation, are also provided. 
 
In order to conduct human trials testing sorghum-based foods in the Australian 
context, product development is important as such foods are not commonly 
available. Chapter 4 describes the overall processing protocols used to formulate a 
ready-to-eat sorghum grain breakfast cereal for use as a suitable test food in human 
trials. Details are provided on the nutritional, chemical and physicochemical 
properties of the end-products to enable more accurate interpretation of clinical 
effects observed in the clinical trials conducted.  
 
To examine some of the potential mechanisms of action of sorghum consumption on 
health, an acute study was conducted (Chapter 5). This trial investigated not only 
subjective satiety, but also alterations to post-prandial responses in glucose, insulin 
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and a number of appetite-regulating gut hormones. In addition, antioxidant status 
was measured. Results confirmed that sorghum-grained breakfast cereal enhances 
acute subjective satiety and increases satiety-enhancing hormone levels acutely after 
ingestion. The cereal food made from red sorghum grain, a variety rich in 
anthocyanin flavonoids, elicited the greatest overall acute satiety-enhancing 
responses.  
 
While these initial acute satiety results indicated that satiety effects might translate to 
longer-term effects on food consumption and thereby weight, this required testing on 
chronic disease biomarkers or health outcomes from a sorghum-enriched diet 
(containing red sorghum flaked biscuits) using a “gold-standard” study design, the 
randomised controlled trial. Chapter 6 presents results from this trial, demonstrating 
that equivalent amounts of weight were lost in the sorghum intervention group and 
the wheat control group, and for both groups the majority of clinical indices showed 
significant beneficial changes over time. 
 
Chapter 7 summarises the results and conclusions of the four tenets of this thesis (the 
current scientific evidence of effects, the product formulation and the two 
experimental studies), and uses these to address the central aim and hypothesis. 
Limitations of the study designs are discussed and key recommendations for future 
research are provided. 
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A major component of this chapter is the substantive content of the published article:  
Stefoska-Needham, A., Beck, E.J., Johnson, S.K.,
 
Tapsell, L.C. (2015)
 
Sorghum: An Underutilized 
Cereal Whole Grain with the Potential to Assist in the Prevention of Chronic Disease. Food Reviews 
International, 31:401-437.  
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2.1 Introduction 
Cereal whole grains are significant contributors to energy, nutrients and dietary fibre 
in the human diet and are important for health. Numerous prospective studies 
demonstrate that regular consumption of whole grains lowers the risk of heart disease 
and diabetes by 20-30%
(16; 17)
, improves blood glucose regulation
(18)
, achieves better 
weight management over time
(19; 20)
, and lowers the risk of certain types of cancer 
(21)
. A critical appraisal of the body of evidence is reflected in multiple national 
dietary guidelines that inform the community to eat more “grain foods particularly 
whole grain cereals” and to reduce consumption of refined grains
(17; 22)
. 
 
Sorghum (Sorghum bicolor (L.) Moench) is a gluten-free whole grain cereal that is 
better known to Western societies as an animal feed rather than a human food source. 
Sorghum is grown around the world
, 
and ranks fifth in global cereal production after 
maize, rice, wheat and barley
(7)
. Sorghum is widely cultivated due to its adaptability 
to semi-arid and arid conditions and high temperatures. In these regions it is a major 
contributor to the staple diets of local populations
(9)
. In countries such as Australia 
and the United States, the primary use of sorghum has been as livestock feed and 
more recently in biofuel production
(9)
. Increasingly, the nutritional and agronomic 
advantages of sorghum, combined with a growing consumer movement dedicated to 
"healthy living"
(11)
, has peaked commercial interests in developed economies on how 
to make sorghum-based food products more accessible to consumers who remain 
largely unaware of their potential health benefits.     
 
The starting point for exposing health benefits of foods is often their nutritional 
properties. In the case of sorghum, as with plant foods generally, the phytochemical 
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component is of particular interest and this reflects recent developments in the 
nutritional sciences. The type of phytochemicals, namely phenolic acids, flavonoids 
and condensed tannins, in some sorghum varieties have been purported to reduce the 
risk of certain types of cancer, cardiovascular disease, obesity and diabetes
(23)
. 
Sorghum also has decreased starch and protein digestibility in vitro, and is high in 
dietary fibre and resistant starch and this array of qualities may play a role in 
mechanisms that reduce disease risk (Table 2.1). Not least, is the fact that sorghum is 
gluten-free and is suitable for people with coeliac disease and gluten intolerances
(24)
. 
Table 2.1 Sorghum’s nutritional and functional attributes associated with metabolic 
disease effects 
 
Component/Property Proposed benefits 
Slow starch digestibility
(25; 26)
 
(slowly digestible starches; interactions with 
endosperm & polyphenolic compounds that 
reduce starch hydrolysis) 
Potential to attenuate blood glucose & insulin 
responses & increase satiety through reduction of 
glycaemic index of sorghum-based foods. This 
has relevance in appetite regulation, weight 
management & risk reduction of obesity-related 
diseases such as diabetes 
High antioxidant activity
(23)
  
(phenolic acids, monomeric polyphenolic 
flavonoids, polymeric polyphenolic condensed 
tannins) 
Potential to reduce oxidative stress that plays an 
important role in the pathogenesis of many 
chronic diseases such as diabetes, atherosclerosis, 
some cancers, aging, arthritis & neurological 
diseases  
High fibre
(27)
  
(including resistant starch, ranging  
from 2.2 g
(28)
 – 6.5 g
(29)
 / 100 g dry matter) 
Offers benefits to gut microbiome, metabolic 
disease risk & gastrointestinal health 
High unsaturated fatty acid content of 
lipid
(30; 31)
 
(oleic acid, linoleic acid, linolenic acid and 
policosanols in wax
(18)
) 
Improving dyslipidemia & thus promoting heart 
health 
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In a traditional nutrition sense, the value of sorghum grain has been considered to be 
slightly inferior compared to other cereal grains on the basis of lower protein and 
starch digestibility and consequently, reduced metabolisable energy. This 
consideration is especially relevant to many of the world’s poorest and most food-
insecure communities where sorghum is a core food. In these cases sorghum is 
combined with legumes and other cereals to increase macro- and micro- nutrient 
density of sorghum-based foods and diets
(32; 33)
, and to this end, bio-fortified 
transgenic sorghum lines have been developed
(34)
.
 
Paradoxically, these properties of 
lower digestibility and reduced available energy may prove to be better suited in 
populations where over-weight and obesity related chronic diseases, such as 
metabolic syndrome, diabetes, heart disease and cancer are major public health 
issues
(35)
. 
 
Over the past decade, key researchers have exposed the potential role of sorghum in 
human health and in disease prevention
(23; 36; 37)
. They have argued for a paradigm 
shift from perceiving sorghum as a low-value cereal grain to a health-promoting, 
environmentally sustainable food for inclusion in the global human diet. In order to 
achieve commercial adoption of this position, food innovation is required that would 
extend the range of sorghum-based products available to consumers. At the same 
time, quality human clinical trials are required to provide evidence of health effects. 
 
 
The research needs to be conducted in a food-health paradigm that considers not only 
the effects of individual grain constituents and their involvement in physiological 
processes, but also the effects of consuming sorghum-based foods within the broader 
context of whole diets. Because sorghum has been largely used as an animal feed in 
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Western societies, much of the research has been done on livestock, but a wide range 
of studies have emerged that provide the basis for moving into human clinical 
studies. To guide valid hypotheses for clinical human research, a summary of the 
existing evidence and knowledge base is required.  
 
2.2 Literature review method 
A comprehensive, narrative literature review was determined most appropriate in 
light of the complex amalgamation of research topics considered (plant anatomy, 
food chemistry, food processing, nutrition, and evidence for health effects). Search 
terms included “sorghum”, “sorghum grain”, “composition”, “nutrient”, “chemical”, 
“human”, “health”, “chronic disease”, “diet”, “benefit”, “weight”, “subject”, 
“intervention”, “clinical”, “trial”, and combinations thereof.  The following 
databases were utilised to identify relevant literature; Cochrane Library, CINAHL, 
MEDLINE, PubMed, Science Direct, Scopus and Web of Science. 
 
Aims of the review were to:  
1) describe sorghum grain structure and the specific chemical, nutritional and 
functional attributes that relate to mechanisms by which sorghum grain components 
may influence weight management and chronic disease risk;  
2) summarise the evidence reported in the scientific literature on effects of sorghum 
consumption on health outcomes related to chronic disease prevention. 
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2.3 Results 
2.2.1 Structure of the Sorghum Plant  
Sorghum is a self-pollinating, summer annual belonging to the grass family of 
Poaceae.  The sorghum plant resembles a cane-like grass, ranging in height from 
60cm to 460cm. It mostly has a single stem and produces a deep taproot under 
favourable soil conditions
(38)
. The leaves look similar to maize leaves, varying from 
7 to 24 leaves per plant depending on the cultivar (Figure 2.1). The flower head (or 
seed head) is usually a compact panicle, of approximately 25-36cm, that sits on top 
of the stalk of a mature plant and carries two types of flowers.   
 
 
Source: iStock by Getty Images (www.istockphoto.com) 
 
Figure 2.1 Field of red sorghum plants depicting maize-like leaves and compact 
panicles (grain seed heads) 
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2.2.2 Sorghum: potential as a environmentally-sustainable, commercial crop for 
human food production 
Sorghum is a dependable crop that requires fewer nutrient inputs and significantly 
less water than other crops
(6)
. Largely due to its remarkable natural diversity, 
sorghum can be grown on over 80% of the world’s agricultural land, including 
marginal land not suited to cultivation of other crops
(39)
. As global demand increases 
for more productivity from low-quality land with fewer resource inputs, sorghum is 
positioned well to meet those needs in a sustainable way. However, historically the 
utilisation of sorghum for human use in Western societies has been grossly limited 
mainly due to its reputation as a livestock feed, the lack of potential markets and the 
paucity of human dietary studies, as discussed in Chapter 1. Having said this, during 
the course of this thesis, a growing number of food products have emerged on 
supermarket shelves that contain sorghum as a component ingredient, suggesting that 
demand for sorghum for use in human food production is increasing (Figure 2.2). In 
the majority of instances, these food products have been marketed for their gluten-
free attribute rather than other potential nutritional attributes of the sorghum grain. 
 
 
Figure 2.2 Example of different sorghum-containing food products currently on 
supermarket shelves (May 2016) 
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2.2.3 Nutritional and chemical composition of the sorghum grain  
Sorghum grain is similar to maize with respect to chemical composition, with its key 
components being: starch, proteins, lipids, non-starch polysaccharides and 
phytochemicals such as phenolic compounds, phytosterols and policosanols. 
Sorghum grain also contains dietary fibre, including resistant starch, and 
micronutrients including vitamins and minerals, oil bodies, waxes and ash. 
 
The grain is spherical with a slightly flattened germ end, reaching approximately 
4mm in length
(40)
 (Figure 2.3). Like other cereal grains, the sorghum caryopsis is 
divided into three distinct anatomical parts: the pericarp (outer layer or seed coat), 
endosperm (storage tissue) and germ (embryo). Genes referred to as the R and Y 
genes control pericarp colour. The testa is a sub-coat located between the pericarp 
and endosperm, and is also controlled by genes (B1 and B2 genes)
(41)
. When both 
genes are dominant, the testa is pigmented. In general, sorghum grains are smaller 
than those of maize but have a similar starchy endosperm that is usually white and 
floury.  Most sorghum grains are partially covered by husks (glumes) that are 
removed from the grain during threshing. Consequently, there is no husk to remove 
during milling
(42)
. The pericarp is made of 3 segments - epicarp, mesocarp and 
endocarp
(43)
. The epicarp is the outermost layer and is usually covered with a thin 
waxy film. It contains most of the sorghum pigments that strongly influence the grain 
colour. The mesocarp, the middle structure, contains varying amounts of starch 
granules
(40)
, a feature unique to sorghum and pearl millet. 
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Figure 2.3 Sorghum Caryopsis  
(© Anita Stefoska-Needham adapted from Sautier and O’Deyes(44)) 
 
The endosperm is the largest part of the caryopsis, accounting for 82-87% of the 
grain weight
(43) 
in the form of mostly starch and protein. It is comprised of the 
aleurone layer, peripheral layer, and corneous and floury areas. The aleurone 
contains proteins (protein bodies, enzymes), ash (phytin bodies) and oil 
(spherosomes). The germ is comprised of the scutellum, the embryonic axis and 
embryonic disc. The germ is very rich in lipids and contains a large proportion of 
protein. The protein of the germ is mainly albumins and globulins, which are rich in 
lysine, tryptophan and other essential amino acids
(45)
. 
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The proximate nutritional composition of sorghum whole grain is similar to wheat 
whole grain; energy density is 1377 vs 1418 kJ/100 g dry weight, total carbohydrate 
74.6 vs 71.1, fat 3.3 vs 2.5 and protein 11.3 vs 13.7 g/100 g dry weight, respectively 
(Table 2.2). However, sorghum has lower starch digestibility relative to other grains 
such as maize, rice, wheat and barley, although the degree of digestibility depends on 
the method of processing
(25; 46)
. The nutritional quality of sorghum proteins is 
diminished because they are more resistant to digestion
(46)
 and have low levels of 
essential amino acids such as lysine, tryptophan and threonine
(47)
. In contrast, there 
are high levels of leucine that were previously implicated, but now not accepted, as a 
cause of niacin deficiency and consequently endemic pellagra in some sorghum-
eating populations
(48-51)
.
 
 
 
As with cereals more broadly, sorghum is a source of B-complex vitamins such as 
thiamin, riboflavin, vitamin B6, biotin, and niacin, but levels are diminished with 
grain refining processes including decortication
(52)
. The mineral composition in 
sorghum is similar to millet and is predominantly composed of potassium and 
phosphorus, with low levels of calcium
(53)
. Sorghum-based foods are a good source 
of both iron and zinc, although anti-nutrients such as phytates may diminish 
bioavailability
(54; 55)
. A complete nutrient analysis of sorghum is detailed in Table 
2.2.   
 
Sorghum grain is generally rich in health-promoting phytochemicals, especially 
polyphenols. Importantly, sorghum varieties are classified largely according to their 
total extractable phenols, in combination with grain appearance (Table 2.3). White 
sorghums have no detectable tannins or anthocyanins and have very low total 
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extractable phenol levels. Red sorghums have no tannins but have a red pericarp with 
significant levels of extractable phenols, namely anthocyanins. Brown sorghums 
have a pigmented testa and contain significant levels of tannins, with varying degrees 
of pericarp pigmentation. Black sorghums are a special variety of red sorghum that 
turns black in sunlight during maturation and they contain very high levels of 3-
deoxyanthocyanidins (3-DAs), which are located in the pericarp
(57; 58)
.  
 
The colour of the sorghum grain, the naturally occurring variations of which are 
shown in Figure 2.4, significantly influences the colour of the flour and thus the 
appearance of end food products. 
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Table 2.2 Nutritional Composition of Sorghum, Wheat and Corn 
(per 100g dry weight, edible portion)
(40; 56)
 
Proximates Sorghum,White,Whole Wheat, Durum, Whole Corn, Yellow 
  Energy (kcal / kJ) 329/1377 339/1418 365/1527 
  Protein (g) 10.62 13.68 9.42 
  Total lipid (fat) (g) 3.46 2.47 4.74 
  Carbohydrate, by difference (g) 72.09 71.13 74.26 
  Fibre (g) 6.7# 10.7* 7.3 
Lipids       
  Fatty acids, total saturated (g) 0.610 0.454 0.667 
  Fatty acids, total monounsaturated (g) 1.131 0.344 1.251 
  Fatty acids, total polyunsaturated (g) 1.558 0.978 2.163 
  Cholesterol (mg) 0 0 0 
Minerals       
  Calcium, Ca (mg) 13 34 7 
  Iron, Fe (mg) 3.36 3.52 2.71 
  Magnesium, Mg (mg) 165 144 127 
  Phosphorus, P (mg) 289 508 210 
  Potassium, K (mg) 363 431 287 
  Sodium, Na (mg) 2 2 35 
  Zinc, Zn (mg) 1.67 4.16 2.21 
  Copper, Cu (mg) 1.080 0.553 0.314 
  Manganese, Mn (mg) 1.630 3.012 0.485 
  Selenium, Se (mg) 12.2 89.4 15.5 
Vitamins       
  Vitamin C, total ascorbic acid (mg) 0 0 0 
  Thiamin, B1 (mg) 0.332 0.419 0.385 
  Riboflavin, B2 (mg) 0.096 0.121 0.201 
  Niacin, B3 (mg) 3.688 6.738 3.627 
  Pantothenic acid, B5 (mg) 1.250 0.935 0.424 
  Vitamin B6 (mg) 0.440 0.419 0.622 
  Folate, DFE (µg) 20 43 19 
  Vitamin B-12 (µg) 0 0 0 
  Vitamin A, RAE (µg) 0 0 11 
  Vitamin D (IU) 0 0 0 
  Vitamin E (alpha-tocopherol) (mg) 0.50 0.71* 0.49 
Amino Acids       
  Tryptophan (g) 0.124 0.176 0.067 
  Threonine (g) 0.346 0.366 0.354 
  Isoleucine (g) 0.433 0.533 0.337 
  Leucine (g) 1.491 0.934 1.155 
  Lysine (g) 0.229 0.303 0.265 
  Methionine (g) 0.169 0.221 0.197 
  Cystine (g) 0.127 0.286 0.170 
  Phenylalanine 0.546 0.681 0.463 
  Tyrosine (g) 0.321 0.357 0.383 
  Valine (g) 0.561 0.594 0.477 
  Arginine (g) 0.355 0.483 0.470 
  Histidine (g) 0.246 0.322 0.287 
  Alanine (g) 1.033 0.427 0.705 
  Aspartic acid (g) 0.743 0.617 0.655 
  Glutamic acid (g) 2.439 4.743 1.768 
  Glycine (g) 0.346 0.495 0.386 
  Proline (g) 0.852 1.459 0.822 
  Serine (g) 0.462 0.667 0.447 
*Whole grain wheat flour        #White sorghum (fibre in other sorghum types ranges between 8.8-11.1g / 100 g). 
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Table 2.3 Classification of sorghum according to appearance and extractable phenols 
 
 Tannins Anthocyanins Pericarp Testa 
 
White or “Food-
type” Sorghum 
 
Nil Nil Not pigmented Absent 
Red 
Sorghum 
 
Nil High Red Not pigmented 
Black Sorghum 
 
Nil Very High Black Not pigmented 
Brown Sorghum 
 
Very high High Pigmentation variable Pigmented 
 
 
 
 
 
Figure 2.4 Grain colour variation in seed heads of different sorghum cultivars 
(Image source: © Anita Stefoska-Needham) 
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2.2.4 Processing of sorghum grain to produce foods for human consumption 
Cereal-based food products, including those made from sorghum grain, require 
processing
(59)
. The aim of processing is to transform raw grains into edible food 
products that possess good sensory qualities and retain beneficial nutritional and 
functional properties
(60)
. In Western countries, cereal grains are most commonly 
utilised in the production of breads, breakfast cereals and cereal-based snack foods. 
For breads and other baked goods, grains are generally milled to produce flour, 
which in turn is subjected to treatment with water and heat
(59)
. Commercial 
breakfast cereals may be extruded, puffed, baked and flaked. Feasibly, sorghum 
grain can be treated using the same methods, in addition to being popped, in a 
similar manner to corn
(60)
. However, processing affects the chemical composition 
and physical properties of foods, either positively or negatively, thereby impacting 
on the potential health benefits that can be delivered by the end food product
(60)
. For 
example, processing may affect starch gelatinisation and digestibility and therefore 
impact on the glycaemic index (GI) of a food
(61)
, with implications for blood 
glucose regulation
(62)
. Also, the levels of phytochemicals tend to be lower in 
processed sorghum foods than in the native grains, lowering the food’s total 
antioxidant capacity and thereby sorghum’s potential to mitigate oxidative stress 
processes
(60)
. Overall, research on the effects of different processing methods on 
sorghum grain is limited, in particular in relation to the flaking of sorghum grain, 
which was the method used to manufacture a food product for testing in the 
experimental components of this thesis (full method described in Chapter 4). Only 
one study was identified in the literature
(345)
, showing that flaking sorghum 
grains reduces soluble, bound and total polyphenol content, however because this 
was not a clinical study extrapolation to the human condition is not possible. 
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Sorghum constituents isolated from the native grain may have different effects after 
processing/treatment compared to those arising from the natural, unprocessed grain. 
Moreover, the effects elicited by the whole food may be greater or different from 
the corresponding actions of the individual food constituents, through synergistic 
interactions between components within the food matrix (described by the concept 
of food synergy: Section 2.2.6)
(63)
. Thus, it is essential to examine sorghum as a 
whole food, as is, after processing. To assist with our understanding of the whole 
food effects, it is important to firstly recognise the array of sorghum components, as 
reviewed in the following section. 
 
2.2.5 Sorghum grain components with the potential for functional properties 
          Starches 
Sorghum grain is a good source of starch, containing approximately 71% of dry 
whole grain weight
(40)
. The starch is encapsulated in granules that are located 
predominantly in the endosperm (storage tissue), though uniquely some are present 
in the pericarp (outer layer of grain)
(40)
.  Sorghum starch is comprised of both 
amylose and amylopectin polysaccharides (branched polymers of glucose) with 
very low percentages of amylose present in the starch of waxy sorghum varieties 
compared to 24-33% in non-waxy sorghum starch
(37)
. Sorghum starch granules are 
densely packed and enclosed by protein bodies embedded in a protein matrix, a 
unique structural aspect of sorghum grain
(46)
. Disulphide-bond cross-linking 
involving kafarins in the protein matrix forms a protective network around the 
starch granules reducing starch digestibility
(26)
.  
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The lower starch digestibility reported for sorghum foods is not an intrinsic property 
of the sorghum starch granules themselves, but appears mainly to be a consequence 
of the interactions of the starch with the endosperm protein matrix, as well as with 
cell wall material and polyphenolic compounds, such as condensed tannins and 
flavonoids
(62; 64-67)
. These interactions impede carbohydrate-hydrolyzing enzymes, 
such as α-glucosidase and α-amylase, thereby lowering starch digestibility
(68)
. The 
presence of the protein matrix has also been associated with reduced starch 
gelatinisation during cooking resulting in partially-gelatinised sorghum starch 
granules that may resist enzymatic degradation
(46)
. Sorghum starch has amongst the 
highest gelatinisation temperatures, ranging from 66-81 °C, depending upon 
cultivars, and is higher than that of maize, wheat and barley
(37; 69)
. However, the 
extent of gelatinisation of starch granules as a result of processing cannot easily 
predict  digestibility and physiological effects such as glycaemic responses. Factors 
such as the precise ratios of amylose to amylopectin, their arrangement within the 
starch granule, further degradation of other polymer molecules and post-processing 
conditions also influence the postprandial effects of a starchy food
(70)
.  
 
Recent publications report on the in vitro starch digestibility of different sorghum 
foods, including sorghum-refined maize snack-like extrudates
(71)
, whole grain 
sorghum-refined wheat flour flat bread
(72)
 and whole grain sorghum-durum semolina 
pasta
(28)
. These in vitro studies confirm that sorghum foods can be formulated and 
processed to deliver slowly digested starch (SDS), with the potential to assist in 
improving blood glucose control, however these predicted positive results require 
rigorous testing in humans.
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 Resistant Starch and Non-Starch Polysaccharides 
Sorghum foods also contain varying amounts of resistant starch (RS) depending on 
factors such as processing, cooking, cooling, food storage, gelatinisation, and 
cultivar
(28; 29; 62; 72)
. Physiologically, RS resists hydrolysis by enzymatic digestion in 
the small intestine
(73)
 and enters the colon where it is partially or completely 
fermented to produce beneficial short-chain fatty acids (SCFA)
(74)
. Here, the RS can 
act as a prebiotic
(75; 76)
 by stimulating the proliferation of beneficial bacteria already 
in residence in the gastrointestinal tract (GIT). To date these effects have not been 
widely researched with respect to sorghum foods and sorghum-based diets.  
 
Non-starch polysaccharides (NSPs) have been associated with lower blood plasma 
cholesterol levels, reduced small intestine transit time, and improved bowel 
function
(77; 78)
. NSPs are the major component of dietary fibre in sorghum grain and 
are mainly located in the pericarp and endosperm cell walls, constituting 2-7% of the 
total weight of the grain depending upon cultivar
(27; 79)
. Sorghum NSPs are both 
cellulose and non-cellulosic consisting of arabinose, xylose, mannose, galactose, 
glucose, and uronic acid monomers
(37; 80)
. The non-cellulosic polysaccharides are 
primarily water-insoluble glucuronoarabinoxylans (GAX) along with β-glucans
(81)
, 
although naturally occurring β-glucans in sorghum are lower than that of barley and 
oats
(29; 82)
. The GAX in sorghum are very abundant and are highly substituted with 
glucoronic acid residues, and acetyl and feruloyl compounds. Sorghum contains 
other non-carbohydrate cell-wall components that form part of the dietary fibre 
fraction such as lignins, at levels up to 20% of the total cell wall contents by dry 
weight
(83)
. The total dietary fibre content of different sorghum cultivars ranges from 
7.6% in low-tannin sorghums to 9.2% in high tannin varieties
(27)
, and its level in 
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sorghum-based meals can be manipulated by cooking and fermentation
(84)
.
 
The effect 
of consumption of sorghum NSPs has not been investigated in humans.  
 
 Proteins 
Protein is the second largest constituent of sorghum grain (6-18%) after starch
(42)
. 
Sorghum endosperm proteins are found in both a matrix and as protein bodies that 
are enveloped by the matrix. Sorghum proteins are classified as albumins, globulins, 
kafirins, cross-linked kafirins and glutelins
(85)
. Of these, kafirins are the main 
protein
(86)
, comprising 50-70% of total protein content
(46)
. The kafirins are prolamin 
storage proteins with limiting levels of some amino acids, in particular lysine
(45)
, a 
disadvantage not unique among cereal grains. The kafirins differ in structure from 
the gliadin and glutenin storage proteins in wheat. They do not elicit damage to the 
mucosa of the small intestine of people with coeliac disease
(24)
, making sorghum a 
viable ingredient for gluten-free foods such as bread. However, the inability of 
sorghum kafirins to make elastic dough and the difficulty in making bread of high 
consumer acceptability presents challenges and has driven research into the 
manufacture of quality sorghum-based gluten-free food products
(72; 87)
. 
 
Sorghum kafirins are poorly digested due to the formation of cross-linking especially 
when moist cooked, resulting in protease resistance
(46)
. In vitro and animal studies 
have also shown that sorghum protein digestibility may be reduced by other protein-
protein, protein-phenol and carbohydrate-phenol complexes that have been 
identified
(80; 88-90)
. Cornu and Delpeuch
(91)
 reported that the nitrogen digestibility in 
humans on a diet of 80% sorghum decreased from 65.4% to 60.5% when the 
decorticated sorghum in the diet was replaced by whole grain sorghum, suggesting 
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that higher fibre sorghum varieties may have lower protein digestibility. Rather than 
a fibre effect per se, this more likely relates to the higher polyphenol content that 
naturally occurs in whole grain sorghum and the resultant binding of phenols to 
dietary protein
(80)
. In sorghum-consuming communities, where protein malnutrition 
is an issue, efforts to increase protein digestibility are imperative and lactic acid 
fermentation, decortication and extrusion have been shown to improve digestibility 
and consequent amino acid availability
(71; 90; 92)
. 
 
Sorghum grain also contains a broad range of bioactive peptides, recently reviewed 
by Lin et al.
(93)
 These are of current interest to researchers due to their potential 
biological role in human physiological processes including pathogenesis. The peptide 
bioactivities include antioxidant, antihypertensive, anticancer, antimicrobial, and 
opioid activities as well as immunomodulatory and cholesterol-lowering effects. The 
specific bioactive peptides isolated in sorghum include but are not limited to: 
amylase inhibitors
(94)
, proteinase inhibitors
(95)
, cationic peroxidase
(96)
, 2-kDa antiviral 
peptide
(97) 
and xylanase inhibitors
(93)
. To date, research linking cereal grains with 
potential bioactive peptide activity has been limited, however there are more 
sorghum studies appearing in the literature
(93; 98)
.
 
Overall, there is much to consider in 
translating this knowledge to human clinical trials, in particular the study populations 
of interest and the health/disease outcomes that might be researched. 
 
 Lipids 
Sorghum grain contains approximately 3-4% lipids, the majority of which are 
neutral triglycerides, rich in unsaturated fatty acids and mostly present in the 
germ
(30)
.
 
The predominant fatty acids are oleic acid (31.1–48.9%), linoleic acids 
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(27.6–50.7%), linolenic acid (1.7–3.9%), stearic acid (1.1–2.6%), palmitic acid 
(11.7–20.2%) and palmitoleic acid (0.4–0.6%)
(40; 99; 100)
. Two less common saturated 
fatty acids, octanedioic (C8:0) and azelaic acid (C9:0), have been identified in some 
sorghum varieties
(99)
. This lipid composition has generated interest in sorghum as a 
source of edible oil, representing a potentially valuable dietary source of 
monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA), with 
higher PUFA levels than MUFA
(99)
. This desirable lipid composition is conducive to 
mechanisms that lower lipid levels in humans and therefore to potentially lower risk 
factors associated with heart disease.
 
 
Based on research in hamsters, Carr et al.
(101)
 suggested that the primary cholesterol-
lowering mechanism of sorghum lipid extracts appears to be a reduction in 
cholesterol absorption with a concomitant increase in faecal sterol excretion. 
Specifically, policosanols (a mixture of long-chained primary alcohols) in the 
sorghum lipid extracts appear to inhibit endogenous cholesterol synthesis
(84)
. 
Sorghum also contains plant sterols that may reduce cholesterol absorption to 
collectively lower plasma and liver cholesterol concentrations
(101)
. These results were 
recently supported by Lee et al.
(102)
 in a hamster model of hypercholesterolemia, 
investigating the effects of whole kernel grain sorghum oil (rich in plant sterols) and 
wax (high in policosanols). The authors report that the sorghum oil played a more 
significant role in modulating cholesterol, most likely by inhibiting absorption, 
however subtle interactions by the wax may have contributed to the effect
 (102)
. 
 
The policosanols in sorghum wax (found on the surface of the grain kernel) are 
comprised of mainly docosanol (C22), tetracosanol (C24), hexacosanol (C26), 
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octacosanol (C28), triacontanol (C30), and dotriacontanol (C32)
(103)
. In sorghum, 
C28 and C30 are the most abundant policosanols
(31)
. A mixture of C28 and C30 from 
sugar cane wax has been shown to improve blood lipid levels
(104)
, however reports on 
the human effects of sorghum-derived policosanols have not been published to date. 
 
Martinez et al.
(105)
 reported an alternative mechanism for the cholesterol lowering 
effect of sorghum lipid extract from research done with hamsters. They reported that 
sorghum lipid extract acts as a “prebiotic” to improve the host cholesterol 
metabolism through effects on gut microbiota. Bifidobacteria significantly increased 
in the hamsters fed grain sorghum lipid extract and was positively associated with 
HDL plasma cholesterol levels
(105)
. In humans, this shift in bifidobacteria is 
associated with improved overall health, including reduced gut infections and 
suppression of colon cancer initiation
(106-108)
.  
 
Finally, sorghum lipids may also possess antiproliferation properties. Zbasnik et 
al.
(109)
 extracted lipids from sorghum dry distiller's grain (a by-product of the ethanol 
industry) and observed an anti-proliferative effect on human colon carcinoma cells. 
They suggested that the effect may have been a result of synergistic interactions of 
vitamin E (predominantly gamma-tocopherol), triacylglycerides, free fatty acids 
(predominantly linoleic acid), policosanols, aldehydes, and sterols (predominantly 
campesterol and stigmasterol) that were identified in the extracts
(109)
.
 
Although 
sorghum dry distiller’s grain is primarily used for animal feed, it is chemically and 
microbiologically safe as a human food ingredient, therefore further research in 
humans is relevant.  
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 Phytochemicals  
Most sorghum varieties, except white sorghums, have a high concentration of 
phytochemicals (Figure 2.5), particularly phenolic compounds, which exhibit high 
antioxidant activity and are linked to health benefits
(23; 57; 110)
.
 
In fact, bran of some 
sorghum grain varieties reportedly has the highest antioxidant activity of all cereal 
crop fractions, even higher than many fruits and vegetables
(23)
. Specifically, sorghum 
bran has up to two orders of magnitude higher antioxidant activity than oat bran and 
wheat cereal, and an order of magnitude higher than rice bran although the precise 
amount is highly dependent on the variety of sorghum (Figure 2.6).  
 
Phenolic compounds  
The phenolic compounds in some sorghum grain varieties are more abundant and 
diverse than in any other cereal grain
(57)
. Sorghum grain varieties that have a 
pigmented testa and thick pericarps have the highest levels
(111)
. The phenolic 
compounds are concentrated in the bran component of the grain (in particular the 
testa and pericarp) and can be categorised into three main groups; 1) phenolic acids 
(hydrobenzoic acids and hydrocinnamic acids), 2) monomeric polyphenolic 
flavonoids (flavanols, flavanones, flavones, flavan-4-ols and anthocyanins), and 3) 
polymeric polyphenolic condensed tannins (also known as proanthocyanidins or 
procyanidins). Refer to Figure 2.5. 
 
The phenolic compounds in sorghum grain exhibit high antioxidant activity through 
their ability to scavenge free radicals
(57)
. The degree of antioxidant activity is 
correlated to the content of phenolic compounds in a specific sorghum cultivar and
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Figure 2.5 Classification of dietary phytochemicals (adapted from Liu, 2004)
(121)
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Figure 2.6 Antioxidant activity in sorghum bran fractions (dry basis) relative to 
other cereals and common fruits measured by Oxygen Radical Absorbance Capacity 
(ORAC) and expressed as μmol Tocopherol Equivalents (TE) 
 
(Compiled from previously reported data
(23; 56)
)   
  
this in turn is influenced by its genotype and growing environment
(111)
. Levels of 
phenolic compounds and the activity of enzymes, which synthesize or catabolize 
phenols in sorghum grain, strongly influence food product properties such as flavor 
and color, and are therefore important determinants of sorghum for food use
(36)
. In 
general, sorghum processing decreases antioxidant activity mainly as a result of 
reducing levels of measurable phenolic compounds
(112-114)
. This may be as a result of 
thermal degradation or lowered extractability during the analytical procedures used 
for their measurement
(113)
. However, some processes including steeping, 
germination, fermentation
(115)
 and roasting of steamed grain
(116)
 have been reported 
to increase the level of polyphenolics. These may be related to improved 
extractability through breakdown of the food matrix, which might also result in 
higher bioavailability. 
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It has been postulated that sorghum grain phytochemicals may provide overall 
disease protection through not only antioxidative but also hypoglycaemic, and 
hypolipidaemic mechanisms
(117; 118)
. However, the extent of these health beneficial 
effects is unclear since only limited clinical research has been reported. Reduction in 
oxidative stress is implicated in these protective processes
(119)
, therefore sorghum 
polyphenolic compounds may be relevant in disrupting the cascade of 
pathophysiological changes that lead to metabolic disease. In vitro, sorghum bran 
extracts with a high phenolic content and thus high antioxidant properties were 
shown to inhibit albumin glycation, whereas wheat, rice, oat and low-phenolic 
sorghum bran extracts (such as white sorghum) did not
(120)
. Albumin glycation is the 
non-enzymatic process that results in formation of advanced glycation end-products 
(AGEs). AGEs have been associated with metabolic diseases such as diabetes and 
atherosclerosis. Human clinical investigations are warranted to further test these 
effects, especially since sorghum bran extracts have been suggested for use in food 
ingredients, food supplements or nutraceutical products.  
 
 Flavonoids  
The anthocyanin flavonoids found in pigmented sorghums, but not in white 
sorghums, are of particular interest to researchers since some are unique to sorghum 
grain and they have potent antioxidant properties
(122)
. The 3-deoxyanthocyanins (3-
DA and derivatives) are the major class of flavonoid and are located in the 
pericarp
(57; 58)
.
 
3-DAs lack the hydroxyl group in the 3-position of the C-ring and 
include the apigenidin and luteolinidin that are largely responsible for the 
pigmentation of certain sorghum grain varieties, namely red and black sorghums
(123)
. 
A recent in vitro analysis of red sorghum flour extracts showed strong free radical 
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scavenging activity as measured by an oxygen radical absorbance capacity (ORAC) 
assay and protection against LDL-oxidation, contributing to the evidence base for the 
potential of red sorghum as a valuable health-promoting food grain
(124)
.
 
However, 
understanding the bioavailability of sorghum anthocyanins for the putative health-
promoting effects in humans is a much-needed focus of future research. 
 
 
In vitro research investigating effects of specific sorghum anthocyanins is emerging. 
A study utilising the human epithelial larynx carcinoma cell line (Hep-2) by Devi et 
al.
(125)
 demonstrated that anthocyanins extracted from red sorghum bran, specifically 
luteolinidin and apigenindin, induced significant anti-proliferative activity. Powerful 
anti-proliferative effects were also observed against colon cancer cells when black, 
red, and white sorghum extracts, rich in 3-DA were tested
(126; 127)
. Yang et al.
(128)
 
proposed that these protective effects result from estrogen-induced apoptosis of the 
non-malignant colonocytes that were strongly influenced by the flavones, apigenin 
and luteolin. In breast cancer cell lines, 3-DA isolated from red sorghum bran have 
been shown to have strong anti-proliferative properties and to be cytotoxic
(129)
.
 
Sorghum chloroform extracts have particularly strong anti-inflammatory effects in 
vitro (in both cell-free and cell-mediated experimental systems) through almost 
complete suppression of lipopolysaccharide-mediated production of nitric oxide, 
tumor-necrosis factor-α, and interleukin-6. These effects are correlated to flavonoid 
concentration in the extracts
(130)
. 
 
 Tannins  
Tannin sorghums contain high molecular weight condensed tannins that are 
oligomers or polymers composed of flavan-3-ol nuclei, found in the pigmented testa 
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of the sorghum grain
(41)
. They are formed by B-type (dimeric) procyanidins 
(3,5,7,’,4’-OH), namely procyanidin B-1 as represented in Figure 2.7. Condensed 
tannins exhibit strong antioxidant activity in vitro via free radical scavenging 
activity, chelation of transition metals and inhibition of pro-oxidative enzymes. The 
antioxidant activity of sorghum tannins is higher than that of tannins extracted from 
any other crop
(122; 131; 132)
.
 
In animal studies, sorghum tannins have been shown to be 
15-30 fold more effective at quenching peroxyl radicals than simple phenolics
(133)
. 
 
Figure 2.7 Procyanidin B-1, a type of condensed tannin, isolated in sorghum 
(Image source: ©Anita Stefoska-Needham, adapted from Koleckar et al.(134)) 
 
The presence of tannins in sorghum grain may reduce the nutritive value and lower 
metabolisable energy of the grain.  Several mechanisms have been proposed to 
explain this “anti-nutritional” effect as reviewed by Awika and Rooney
(23)
. These 
include:  binding of proteins and carbohydrates into insoluble complexes that resist 
digestive enzyme breakdown
(135-138)
;
 
binding of digestive enzymes directly, 
inhibiting their enzymatic activity
(139; 140)
;
 
and inhibition of intestinal brush border 
bound amino acid transporters
(141)
, particularly by tannin sorghums with higher 
degrees of polymerization
(142)
, resulting in reduced digestive enzyme activity. These 
effects were also reflected in animal feeding trials that demonstrated the feeding 
efficiency of tannin sorghums was 5 to 10% lower than non-tannin sorghums, 
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depending on the animal species, the method of grain processing and diet type. In 
general, animals consumed more feed yet experienced the same or slightly less 
weight gain when tannin sorghum formed the basis of their diets
(139; 140; 143)
. Such 
effects in a Western diet, where food is ubiquitous, may be beneficial if these results 
are to be translatable to humans. 
 
Antioxidant tannins may be key protective components in sorghum foods for the 
mitigation of oxidative stress-induced diseases, with anti-proliferative and anti-
inflammatory effects as their key mechanisms of action. For example, brans from 
tannin sorghum varieties (naturally high in tannins, such as brown sorghum) and non-
tannin sorghum varieties (black, red and white-grained) have demonstrated significant 
anti-inflammatory potential in vitro on the basis of strong inhibition of hyaluronidase 
activity (enzymes involved in cancer metastasis, osteoarthritis and skin aging)
(129)
. 
The inhibition of the hyaluronidases correlated positively with total phenolic content 
and antioxidant capacity of the extracts, with greater effects observed in sorghum 
bran extracts than those of wheat and rice bran. In two experimental inflammatory 
systems using blood cells and a mouse-model, Burdette et al.
(144)
 also demonstrated 
that the anti-inflammatory activity of ethanolic extracts of different sorghum brans 
correlated with their phenolic content and antioxidant activity. At present, it is not 
possible to extrapolate these in vitro effects to in vivo effects after realistic 
consumption of sorghum by humans. However, the research provides mechanistic 
models for further investigation. 
 
Grimmer et al.
(145)
 demonstrated the potent anti-mutagenic activity of higher 
molecular weight compared to lower molecular weight tannins isolated in sorghum-
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derived polyphenol extracts. Gomez-Cordoves et al.
(146)
 also demonstrated that 
sorghum tannins induce anti-carcinogenic effects against human melanoma cells in 
vitro through increased melanogenic activity (a protective effect against UV 
irradiation damage to human skin) and therefore reduced formation of human 
melanoma cells. Collectively, these cell line studies demonstrate the bioactive 
potency of sorghum grain constituents, in particular the tannins, although in vivo 
studies have not occurred. 
 
2.2.6 Sorghum as a whole food: the case for “food synergy” 
All of these components represent the lifecycle and survival of the sorghum plant, 
and may in part explain the evolutionary success of sorghum, whose origins date 
back to 8000 BCE
(147)
. When the sorghum plant is eaten, as for all foods, there is an 
impact on human biological systems, including processes that lead to chronic 
disease. However, information about nutrients and bioactive components in isolation 
is incomplete in explaining the health effects of sorghum foods because food is what 
people eat, not individual constituents. Therefore, food is central to the relationship 
between nutrition and health, underpinned by the food synergy concept, which views 
food as a whole integrated system, and not merely as a collection of individual 
nutrients and other bioactive substances
(148)
. Hence, evidence from studies of whole 
food sorghum foods will provide more useful information about the sorghum-diet-
health relationship, examples of which are reviewed in the subsequent sections of 
this review. 
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2.2.7 Experimental research testing effects of sorghum consumption on human 
health  
There is extensive scientific literature identifying a diverse range of nutrients and 
bioactive components in sorghum grain, with potential actions in numerous 
biological systems in the human body. However, a key question remains: what 
happens when people actually eat sorghum? To understand this, human studies are 
needed, specifically designed to elucidate the effects of sorghum consumption on 
protective health benefits. To date, these types of human investigations are severely 
limited and there is an obvious paucity in the literature. Although numerous studies 
have been conducted with human subjects (Table 2.4), the majority have addressed 
micronutrient metabolism (such as interactions between leucine, molybdenum, and 
niacin)
(149)
, iron absorption from cereals
(54)
,
 
dietary fibre effects
(150)
, protein 
digestibility
(151)
 and oral rehydration therapies
(152)
. Overall, these studies contribute 
to the knowledge base on sorghum, however they do not address the central question 
associated with this thesis: what is sorghum’s potential to assist in chronic disease 
prevention? The next section of this review therefore summarises the limited, 
existing experimental evidence that suggests protective health effects of sorghum 
consumption (for example, studies that investigate effects on energy balance, 
glycaemic control, lipids, oxidative stress and cell-mediated responses).  
 
 Effects on energy balance 
Energy balance is pivotal in body weight regulation. Changes in body weight are 
associated with an imbalance between the energy content of food eaten and energy 
expended by the body to maintain life and to perform physical work
(153)
. Sorghum 
may be a valuable lower-energy grain alternative in Western diets where overweight 
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and obesity rates continue to rise and represent major public health burdens
(35)
. 
Sorghum’s energy value is approximately 1377 kJ/100 g however the available 
energy for human metabolism may be lower than this estimate due to the described 
low starch and protein digestibility rates. This postulation is partly based on evidence 
from numerous feeding studies that show animals (from rodents to livestock species) 
fed whole grain sorghum, in particular the slowly digested high tannin sorghum 
varieties, have reduced weight gain
(139; 140; 143; 154; 155)
. 
 
In general, dietary fibre and whole grain intakes have been associated with reduced 
risks of obesity, overweight and with lowered waist-to-hip ratio
(156; 157)
. Effects of 
dietary fibre on appetite and satiety have been proposed as major mechanisms for 
these reductions. Whole grain sorghum, with high fibre and slowly digestible 
starches, may increase satiety in humans due in part, to effects on GI of foods. It is 
believed that many communities in Africa who prefer to eat foods made from tannin 
sorghums do so because they impart stronger feelings of satiety and satiation 
compared to other cereals
(23)
. Sorghum’s satiety effects in humans have not yet been 
investigated through controlled dietary trials.  
 
Sorghum contains resistant starch (RS) and fermentation of RS in the colon is linked 
to a number of positive effects including those on the gut microbiome
(76; 158)
. Studies 
specific to energy control with sorghum intake are limited however a recent study by 
Shen et al.
(159)
, evaluated the effects of sorghum RS on changes to body weight, 
blood lipids and intestinal flora in 60 overweight and obese rats receiving treatment 
for 8 weeks. Results demonstrated that overweight rats fed a high-fat diet containing 
30% sorghum RS gained less weight than rats fed a comparator diet devoid of 
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sorghum RS (p<0.05). However, there was no significant difference in weight 
measures in the obese rats who were administered the same test diets. Thus sorghum 
RS did not overcome weight gain caused by high fat diets, but it did have an 
ameliorating effect. Statistically significant changes to the synthesis and secretion of 
serum leptin and adiponectin, two adipose-derived hormones that are involved in the 
regulation of food intake and body weight, were also reported in the sorghum RS 
groups, as were improvements to the intestinal flora (as measured by increased 
populations of Bifidobacterium and Lactobacillus and reduced populations of 
Enterobacteriaceae). This is an important study that demonstrates mechanisms by 
which sorghum RS may assist in the prevention and treatment of obesity.  The study 
also identified positive lipid changes. Triglycerides, total cholesterol and LDL-
cholesterol in both the overweight and obese rats consuming sorghum RS-enriched 
diets were significantly lower than the control groups (p<0.05). HDL-cholesterol 
levels were significantly higher in the sorghum RS groups (p<0.05).   It remains to 
be seen whether these effects can be translated to the human condition. At this stage, 
the human studies demonstrate only possible mechanisms but the positive results in 
animal models identify that whole grain sorghum may be useful in managing energy 
balance to assist with control of over-weight and obesity. 
 
 Effects on glycaemic control  
Good glycaemic control is associated with reduced post-prandial glucose peaks and 
is important in diabetes management
(160)
. Sorghum foods have demonstrated slow 
starch digestibility in vitro and in animal feeding trials, suggesting favorable effects 
on post-prandial glycaemic and insilinaemic responses in humans. Numerous animal 
feeding studies have shown that sorghum in the diet effectively improves glucose 
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metabolism compared to sorghum-free diets
(133; 161-163)
. A limitation in some of these 
studies is that the specific type of sorghum extract is not defined, thus it cannot be 
determined whether effects are linked to phenolic, fibre or macronutrient contents. 
Furthermore, whether the concentrations of sorghum extracts are physiologically 
relevant, that is, capable of eliciting these blood glucose attenuation effects in 
humans after a realistic dose, is not yet clear. 
  
A recent study by Cervantes-Pahm et al.
(164)
 reported on the use of a pig model to 
investigate the comparative nutrient and energy digestibility of a range of grains 
widely used for human consumption, including whole grain sorghum. In this study, 
the apparent ileal digestibility of sorghum starch was lower than for corn
(164)
. The 
authors attributed this to the high level of resistant starch in sorghum, which 
appeared to be fully fermented in the pig hindgut since ~100% starch disappearance 
was reported. The low apparent ileal digestibility of its starch in pigs suggests that 
sorghum may be of value for reducing the GI of human foods
(164)
. Caution in 
extrapolating these pig trials to human health is needed, since in this study raw grains 
were used, whereas in human food the grains are invariably cooked, changing the 
structure and digestion properties of the starch.  
 
Dixit et al.
(165)
 have even gone as far as to specifically recommend sorghum grain is 
regularly consumed in the modern Indian diet to assist in the reduction of Type 2 
diabetes and cardiovascular disease in this population. Despite the positive 
recommendation, only four in vivo human studies exploring these effects have been 
reported in the literature, each with limitations and inconsistencies
(166-169)
. The most 
recent of these human studies investigated the effects of consuming muffins made 
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from grain sorghum on plasma glucose and insulin levels
(169)
. In a randomised-
crossover design, 10 male subjects consumed muffins containing 50 g of total starch 
(TS) from either grain sorghum flour or whole wheat flour (although the available 
carbohydrate was not reported), with all additional ingredients the same across both 
treatments. Glucose and insulin levels were measured at baseline (15 minutes prior to 
consumption), time-point 0 (onset of consumption) and 15, 30, 45, 60, 75, 90, 120, 
and 180 minutes after consumption. Additionally, levels of rapidly digestible starch 
(RDS), SDS, RS and TS in muffins were analyzed. Results indicated that RDS, SDS 
and RS contents were significantly higher in sorghum muffins compared to wheat 
muffins (p<0.05). Plasma glucose incremental area under the curve (iAUC) reduced 
by ~26% and glucose measures at the 45 to 120 minute intervals were significantly 
lower for the sorghum muffin (p<0.05). Also, plasma insulin iAUC reduced 
significantly and insulin measures at the 15 to 90 minute intervals were significantly 
lower for the sorghum muffins (p<0.05), reducing by ~55%. Lack of information on 
the available carbohydrate in each test muffin is a limitation but this study shows the 
potential of sorghum-based foods to attenuate blood glucose and insulin responses.   
 
In a similar study, Lakshmi and Vimala
(167)
 also demonstrated that the consumption 
of whole grain sorghum meals compared with consumption of the same meals based 
on dehulled sorghum and other recipes prepared with wheat and rice (as controls), 
resulted in significantly lower glycaemic responses (P<0.05) in 6 subjects with Type 
2 diabetes mellitus
(167)
. These observations may have been in part due to the 
difference in fibre content of the meals that ranged from 2.2 g to 4.8 g in whole grain 
sorghum treatment meals and 1.8 g to 2.7 g in dehulled sorghum treatment meals. 
Also, the different cooking methods utilised in the treatment meal recipes (pan-fried, 
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boiled, fermented-steamed) may have had an effect on starch digestibility and 
therefore carbohydrate metabolism.  
 
Further glucose control studies by Mani et al.
(166)
 evaluated the GI of six traditional 
Indian meals, one of which was based on sorghum. The test meals were consumed as 
baked bread (prepared from flours of sorghum or finger millet or pearl millet) or as 
pressure-cooked meals (based on kodo millet, consumed as is or with added whole 
mung beans or with added mung bean dal). No fats were added in the preparation of 
the test meals. Testing was undertaken in 36 subjects with Type 2 diabetes mellitus. 
Glucose responses were measured one and two hours after consumption of the test 
foods (50 g available carbohydrate) and compared to a 50 g glucose load. The mean 
GI of the sorghum bread was relatively high at 77% +/-8 (SE), but not as high as the 
finger millett bread which had a GI of 104% +/-13 (SE), equivalent to the glucose 
load . The pearl millet bread had the lowest GI of all six test meals, producing a GI 
of 55% +/-13 (SE). No significant difference was observed in blood glucose level 
after each of the test foods at the 1 hour and 2 hour time-points when compared with 
the corresponding blood glucose response to the 50 g glucose load. The study 
identifies sorghum’s digestibility in this meal format (baked bread) may not be as 
slow as in vitro studies may suggest. 
 
Abdelgadir et al.
(168)
 investigated the influence of six traditional Sudanese 
carbohydrate-rich meals (prepared from wheat, sorghum, millet and maize flours) on 
glucose and insulin responses in a randomised crossover design with 10 subjects with 
Type 2 diabetes mellitus (6 males and 4 females). Millet porridge had the most 
favorable (lowest) post-prandial glucose and insulin responses followed by wheat 
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pancakes, then sorghum porridge and sorghum flat bread, whereas maize porridge 
induced higher glucose and insulin responses (as measured by mean iAUCs). 
Consideration of the method and time of preparation, particularly the duration of 
fermentation and the degree of milling, as well as the nature of starch and fibre 
content is important when interpreting these findings. That is, inadequate reporting 
of the precise physicochemical properties of the final products limits generalisability 
in food studies. Overall, the glucose and insulin response studies using sorghum in 
humans have used small sample sizes (with low statistical power), reducing the 
likelihood that a statistically significant result reflects a true effect. Hence results are 
ambiguous and the evidence base is inconclusive. 
 
 Effects on serum lipids 
Measurement of a standard lipid profile (including total cholesterol, LDL (low-
density lipoprotein) cholesterol, HDL (high-density lipoprotein) cholesterol, and 
triglycerides) is recommended in the prediction of cardiovascular risk
(170)
. 
Mechanisms for the role of sorghum grain components in cardiovascular protection 
have been investigated
(23)
, however only one study has been conducted with human 
subjects. In this study, using 10 males and 6 females, a significant reduction 
(p<0.05) in total cholesterol, triglycerides and HDL cholesterol was observed after 
daily consumption of 100 g of unrefined sorghum in the form of pancakes over 3 
weeks
(171)
. However, the content of subjects’ background diets was not adequately 
reported, making assessment of dietary confounders difficult.  
 
Most of the research identifying beneficial effects of sorghum consumption still lies 
with animal models
(133; 159; 172-174)
. Klopfenstein et al.
(175)
 concluded that sorghum 
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bran was effective in lowering serum and liver cholesterol levels in hamsters. This 
effect was repeated in another hamster model of hypercholesterolemia, when grain 
sorghum lipid extract included in the diet significantly reduced plasma non-HDL and 
liver esterified cholesterol levels while increasing HDL levels
(101)
. In all these 
studies, total cholesterol levels were reduced in animals consuming sorghum-based 
diets compared to sorghum-free control diets. In a single negative finding, Lee et 
al.
(176)
 found that while sorghum consumption increased HDL-cholesterol levels, 
total cholesterol and LDL-cholesterol levels were increased in a rat model. However, 
the lack of a control group in this research makes conclusions difficult. 
 
Sorghum tannins have not been broadly investigated in relation to their effects on 
cardiovascular disease risk factors, unlike tannins from some other foods and 
beverages such as red wine and tea. There may be an anticoagulant effect of sorghum 
tannins, yet to be tested in humans, as evidenced in cultured mullet fish that were fed 
tannin-containing sorghum distillery residues
(177)
. The sorghum residue significantly 
improved blood thinning and erythrocyte membrane integrity of the fish blood cells 
in cooler water temperatures over the winter months, enabling normal blood 
viscosity and prevention of red blood cell hemolysis induced by typical oxidation 
processes. The authors suggest that the antioxidant activity of the tannins and 
polyphenols present in the sorghum residue contributed to the prevention of red 
blood cell hemolysis. A translation to human studies has yet to be conducted but 
overall the experimental evidence suggests that sorghum grain may induce beneficial 
lipid-lowering effects.  
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Effects on oxidative stress biomarkers and plasma antioxidant capacity 
Oxidative stress is a condition in which an imbalance results between the production 
and inactivation of reactive oxygen species (ROS) and reactive nitrogen species 
(RNS) in the body that contributes to cellular dysfunction and pathogenesis of a 
variety of human diseases (including atherosclerosis, diabetes, hypertension, aging, 
Alzheimer's disease, kidney disease and cancer)
(178)
. Oxidative stress is also linked to 
metabolic syndrome (MetS)
(179)
. A randomised, controlled, crossover human study, 
involving 22 healthy adults, was conducted to assess the acute effects of consuming 
pasta containing red or white whole grain sorghum flour (30% sorghum, 70% 
semolina) on plasma total polyphenols, antioxidant capacity and oxidative stress 
markers compared to a wheat control made from 100% semolina
(180)
. Compared to 
baseline, the 2 hour post-prandial levels of plasma polyphenols, antioxidant capacity 
and superoxide dismutase (SOD) activity were significantly (P<0.001) higher 
following the red sorghum pasta (RSP) meal while the protein carbonyl level was 
significantly lower (P=0.035). Furthermore, net changes in polyphenols, antioxidant 
capacity and SOD activity were significantly (P<0.001) higher while protein 
carbonyls were significantly (P=0.035) lower following consumption of the RSP 
meal than the control meal. Pasta containing red whole grain sorghum flour, but not 
white sorghum flour, enhanced antioxidant status and improved markers of oxidative 
stress in healthy subjects. The increase in plasma polyphenols by the RSP meal may 
be attributed to its higher content of polyphenols. The potential limitations of this 
study include the short duration and use of only one postprandial blood collection. 
Furthermore, subjects in this study were healthy and their results may differ to 
people with oxidative-stress induced disease such as diabetes and obesity. Studies in 
subjects with mild to moderate oxidative-stress induced disease and who consume a 
sorghum-enriched diet daily over an extended period of time are required to further 
investigate potential effects on anti –oxidant processes from sorghum consumption.  
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Effects on cell-mediated immune responses 
Cell mediated immune responses have been linked to cancer development. 
Epidemiological evidence dating back to the early 1980s has correlated consumption 
of sorghum with reduced incidence of oesophageal cancer, warranting closer 
attention to the potential chemopreventive properties of sorghum chemical 
components. Data from various sorghum-consuming countries in Africa and Asia has 
demonstrated lower esophageal cancer incidences compared to regions where wheat 
and maize were the major cereals consumed
(181-184)
.
 
However, contamination of maize 
in these communities by the Fusarium fungi, which convert nitrates to nitrites, 
known carcinogens, has been identified as a more likely cause of increased rates with 
maize consumption. Nevertheless, such epidemiological observations have driven 
research efforts towards understanding potential cell-mediated chemopreventive 
properties of sorghum grain components and their mechanisms of action not just against 
esophageal cancer, but other cancers of the gastrointestinal tract and beyond. 
Currently research is in its infancy, with growing numbers of cancer cell line studies 
exploring anti-inflammatory, anti-mutagenic and anti-proliferative effects that are 
important in prevention of carcinogenesis. Some animal studies have also shown that 
phenolic extracts derived from sorghum, on the basis of high antioxidant activity 
particularly from red, black and tannin sorghum varieties, have been able to 
effectively induce cell arrest and suppress tumor growth in vivo
(185)
.
 
Many more in 
vitro and animal studies are required before antioxidant effects of sorghum extract, 
aimed at cancer prevention and treatment can be justified in clinical trials. The role 
of sorghum consumption in cancer prevention is more likely to be examined in 
epidemiological studies with mechanistic studies contributing to the discussion on 
the plausibility of findings. 
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Table 2.4 Human studies incorporating sorghum-based test meals 
 
 
 
Studies of vitamin metabolism 
 
Lead Author/Year Focus of investigations Subjects/Experiment Results 
 
Gopalan et al. (1960)(48) Role of amino acid imbalance 
(relative excess of leucine) in the 
pathogenesis of pellagra.  
13 healthy & pellagrin subjects. 5g dietary leucine 
administered daily & changes in urinary excretion of N-
methyl nicotinamide (NMN) measured. 
Leucine increased urinary excretion of NMN in all subjects. Isocaloric replacement 
of rice by sorghum (jowar) resulted in increased urinary NMN excretion in all 
patients.  
Deosthale et al. (1974)(186) Sorghum molybdenum (Mo) 
consumption effects on copper 
(Cu) & uric acid excretion. 
4 adult males (age not specified). Low (0.21 μg/g) & high 
(1.39 μg/g) Mo-containing grains were used in diets 
controlled for calories, protein, minerals, sulfur. 
Uric acid increased only in high Mo intakes (10-15 mg Mo/day). Urinary Cu 
excretion was sig.ly increased with increasing levels of Mo. Faecal Cu excretion 
was unchanged.    
Krishnaswamy et al. 
(1976)(187) 
Vitamin B6, leucine absorption.  6 healthy males (25-35 yrs). Metabolic interrelations between 
excess dietary leucine & vitamin B6 studied. 
Vit. B6 counteracted effects of leucine on urinary quinolinic acid excretion, in vitro 
nicotinamide nucleotide synthesis by erythrocytes; corrected abnormalities of 5-
hydroxytryptamine metabolism induced by excess leucine.  
Obizoba (1979)(188) Mineral & vitamin metabolism. 5 healthy women (19-25 yrs). Fed 4 iso-nitrogeneous mixed 
plant protein diets various blends based on whole wheat, navy 
bean & 3 sorghum flour varieties (Purdue normal, high lysine 
& Nigeria normal).  
Various effects on measured Ca, Mg, Fe, Niacin, riboflavin, folic acid levels were 
reported & related to the contents in the test diet. 
Wang et al. (1991)(189) Fibre effects on niacin status/ 
niacin utilisation. 
10 healthy adult subjects. 28 g per day of ready-to-eat cereal 
(whole-ground sorghum flour) or cereal from decorticated 
sorghum flour (bran removed, polished). Urine, stool & 
fasting blood samples collected. 
Whole grain sorghum cereal decreased fecal transit time, lowered urinary NMN 
excretions, but raised blood serum levels of NMN & nicotinamide when compared 
to polished grain sorghum cereal.  
Schmid et al. (2007)(149) Dietary intake analysis of 
mothers & their children in 
South India. 
218 mothers (> 15 yrs) & their children (< 5 yrs) in South 
India. Comparison of dietary intake of subjects with & 
without intervention to manage malnutrition. 
Mothers had sig. higher intakes of energy & protein in summer, & sig. higher 
intakes of energy, protein & Fe in rainy season. No differences in children. In 
mothers, sorghum contributed 29% energy, 33% protein, 53% iron. 
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…) 
 
 
Studies of iron (Fe) status/absorption 
 
Lead Author/Year Focus of investigations Subjects/Experiment Results 
 
Derman et al. (1980)(190) Fe absorption from maize & 
sorghum. 
21 male & female South African subjects, healthy & Fe-
deficient. Ages not specified. Study compared thin gruel, 
sorghum & wheat beers. 
Ten times as much Fe was absorbed from the traditional maize & sorghum beer as 
from gruel made from the same ingredients. 
Radhakrishnan et al. 
(1980)(191) 
Fe bioavailability.  12 healthy & 13 anemic subjects. Ages not specified. Diets 
based on high & low tannin sorghum.   
In 12 healthy subjects, Fe absorption from the low & high tannin varieties was 
similar. In 6 anemic subjects, Fe absorption from low tannin sorghum was sig. 
higher. In the other 7 anemic subjects, there was no difference observed.   
Gillooly et al. (1984)(192) Fe absorption. 
 
53 Fe-deficient Indian females (age not specified). 6 different 
experiments. Systematically examined effects on Fe 
absorption of polyphenol & phytate in sorghum. 
When amounts of both compounds were reduced to low levels by pearling, there 
was a sig. increase in Fe absorption.   
Haidar et al. (1999)(193) Fe deficiency anaemia (IDA) 
status. 
1449 pregnant & lactating subjects (15-49 yrs) in Ethiopia.  Overall status of IDA determined by hemoglobin level was 18.4 % with higher rates 
in maize, milk & sorghum staple areas.   
Hurrell et al. (2003) (54) Fe absorption. 34 males & 44 females (21-38 yrs). Measured the influence of 
phytic acid degradation on Fe absorption from cereal 
porridges. 
Phytate degradation improves Fe absorption from cereal porridges prepared with 
water but not with milk, except from high-tannin sorghum. 
 
Cholesterol control 
 
Cardiovascular effects  
Suhasini et al. (1991) (171) Effect of unrefined sorghum or 
maize on serum lipids. 
6 males & 10 females (23-26 yrs). Grp 1 ate 100g unrefined 
sorghum. Grp 2 ate 50g of unrefined maize.  
Both diets showed sig. reduction in serum total cholesterol & triglyceride levels 
with simultaneous increase in HDL cholesterol value over 3 weeks. 
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…) 
 
 
Studies of diabetes/glycaemia/oxidative stress 
 
Lead Author/Year Focus of investigations Subjects/Experiment Results 
 
Mani et al. (1993)(166) Determination of glycaemic 
index of commonly consumed 
foods in India.  
36 subjects (Type 2 DM). Glucose responses were measured 1 & 
2 hrs after consumption of test foods (50g available carbohydrate) 
& compared to a 50g glucose load. 6 foods tested, 1 based on 
sorghum. 
The mean glycaemic index of the sorghum meal was 77% +/- 8 (SE), indicating 
a relatively high glycaemic index. No sig. difference was observed in blood 
glucose level at the 1 h & 2 h time-points when compared with the 
corresponding reference.  
Lakshmi et al. (1996) (167) Glucose & insulin responses to 
sorghum-based meals. 
3 males & 3 females with Type 2 DM (45-60 yrs). Consumption 
of whole grain sorghum meals compared with the same meals 
based on dehulled sorghum & other recipes prepared with wheat 
& rice. 
The consumption of whole grain meals resulted in sig. lower glycaemic 
responses (P<0.05) in 6 subjects, in part due to differences in fibre content & 
cooking methods.  
Abdelgadir et al. (2005) (168) Glucose & insulin responses to 6 
traditional Sudanese meals from 
wheat, sorghum, millet & maize 
flours.  
Glucose & insulin responses in a randomised crossover design 
with 10 subjects with Type 2 diabetes mellitus (6 males & 4 
females). 
Millet porridge had the lowest post-prandial glucose & insulin responses 
followed by wheat pancakes, sorghum porridge & sorghum flat bread. Maize 
porridge induced higher glucose & insulin responses (as measured by mean 
iAUC).  
Poquette et al. (2013)(169) Glucose & insulin responses to 
sorghum-based meals. 
Randomised-crossover design, 10 males consumed muffins 
containing 50g of total starch from either grain sorghum flour or 
whole wheat flour. Plasma glucose & insulin measured over 3 hrs.  
Plasma glucose & insulin iAUC reduced by ~26% & 55% respectively. 
Glucose & insulin measures were sig.ly lower for the sorghum muffins 
(p<0.05) at different time points. 
Khan et al. (2014)(180) Plasma total polyphenols, 
antioxidant capacity & oxidative 
stress responses to sorghum 
pasta meal.  
Randomised-crossover design, 22 males and females consumed 
pasta containing red or white whole grain sorghum flour (30% 
sorghum, 70% semolina) or a wheat control made from 100% 
semolina. One blood collection at 2 h time-point. 
Plasma polyphenols, antioxidant capacity and superoxide dismutase (SOD) 
activity were significantly (P<0.001) higher following red sorghum pasta (RSP) 
meal & protein carbonyl level was significantly lower (P=0.035) following 
consumption of the RSP meal than the control meal (wheat). 
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…) 
 
 
Fibre studies  
 
Lead Author/Year Focus of investigations Subjects/Experiment Results 
 
 
Cornu et al. (1981)(74) Effect of fibre in sorghum on N 
digestibility.  
12 healthy Cameroonian adult males whose habitual diet is based 
on a sorghum meal (2.4-4.2 g of crude fibre / 100 g DM). Subjects 
received successive diets of 3.3, 4.8, 5.4 g of crude fibre / 100 g of 
DM. 
Increased fibre intake resulted in a sig. rise in quantity of fecal matter excreted 
(N & formic insoluble substances), but a reduction in urinary N losses.  
MacLean et al. (1983)(67)  Effect of decortication & 
extrusion on the digestibility of 
sorghum. 
9 children (7-24 mo). Sorghum provided 8% protein & 62% 
carbohydrate (kCal) in diet. Lysine was supplemented to 3% of 
protein. Casein provided 6.4% protein (kCal) in the control diet.  
N absorption from sorghum & control not different but N retention lower than 
control. Fecal weights & energy losses showed minor differences. 
Decortication & extrusion improve protein quality & digestibility of sorghum. 
Fedail et al. (1984)(134) Effect of sorghum & wheat bran 
on the colonic functions. 
10 males (22-24 yrs) healthy Sudanese subjects. Comparative 
study of normal diet, diet of 20 g/day sorghum bran, & 20 g/day 
wheat bran, for 3 wks. Wet stool wt, gut transit time, & freq. of 
bowel evac. noted. 
The mean stool weight on normal diet was 136.6 ± 43.1 g/day, on sorghum 
bran 173.3 ± 48.4 g/day, & on wheat bran 219.1 ± 98.3 g/day (p<0.001). Both 
brans produced a similar number of bowel evacuations, stool weight & transit 
time. 
Cornu et al. (1986)(174) Effects of fibre on digestibility 
of sorghum lipids.  
12 healthy Cameroonian adult males whose habitual diet is based 
on a sorghum meal (2.4-4.2 g of crude fibre / 100 g DM). Subjects 
received successive diets of 3.3 (A), 4.8 (B), 5.4 (C) g crude fibre 
/ 100 g of DM. 
Reduced lipid digestibility occurred in all diets. No difference was observed 
between A & B fibre diets but dropped with diet C. Lipid losses increased more 
rapidly than N losses with increasing fibre content. No sig. changes in 
concentrations of fecal fat.  
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…) 
 
 
Protein digestibility studies  
 
Lead Author/Year Focus of investigations Subjects/Experiment Results 
 
 
Kurien et al. (1960)(194) Metabolism of N, calcium & 
phosphorus.  
7 boys (10-11 yrs). Effect on metabolism of N, Ca & P of 
replacing 25%, 50% or 100% of rice in a poor Indian diet by 
Sorghum Vulgare was studied. Daily intake of N was constant in 
all diets. 
Protein digestibility coefficients of protein & mean daily N retention 
diminished as sorghum increased. Sorghum led to: 1) higher Ca intake, but Ca 
retention decreased 2) higher P intake, which resulted in higher P retention. 
Nicol et al. (1978)
(195)
 Utilisation of protein in cassava, 
rice & sorghum (Sativa) based 
diets 
19 Nigerian men, 13 different feeding trials, each of 6 men. Net 
protein utilisation (NPU) of diets based on rice, sorghum or 
cassava, was compared to a minimal protein diet.  Endogenous N 
excretion measured. 
The NPU of a diet based on home-pounded, winnowed sorghum flour was 
higher than that of a diet based on milled whole-meal sorghum due to the low 
digestibility of the latter diet. 
MacLean et al. (1981)(151)  Protein quality & digestibility of 
sorghum  
13 children (6-30 mo). Protein quality & digestibility of 2 high 
lysine (2.9-3.0 g/100 g protein) & 2 conventional varieties (lysine 
content 2.1-2.2 g/100 g protein) of whole grain sorghum milled 
were assessed.  
Weight loss or poor weight gain was reported. No difference by variety in N 
absorption or retention. Stool weight & energy loss 2.5-3x control values. Total 
conc. essential amino acids was low as were conc. Lys & Thr. Lys was the 
limiting amino acid. 
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…) 
 
 
Therapeutic food studies 
 
Lead Author/Year Focus of investigations Subjects/Experiment Results 
 
Weaning foods 
Dibari et al. (2013)(196) Acceptability/safety of new 
ready-to-use therapeutic foods 
(RUTF) before use. 
41 HIV/TB patients (>18 yrs) in Kenya. Cross-over RCT 
comparing soy/maize/sorghum RUTF (SMS-RUTFh) to control -
10 d measures of product intake. 
SMS-RUTFh is acceptable & can be safely clinically trialed, if close 
monitoring of vomiting & nausea is included.  
Bisimwa et al. (2012)(197) Fortified soybean-maize-
sorghum paste Vs fortified corn 
soy blend porridge in 
underweight infants.  
6 mo Congolese infants randomly assigned to lipid-based ready-
to-use complementary foods (RUCF, n=691) or fortified corn soy 
blend (UNIMIX, n=692) for 6 mo. Hemoglobin, triglyceride, & 
cholesterol noted.  
No  sig. differences in the concentrations of hemoglobin, serum triglyceride, & 
serum cholesterol were found between the 2 grps.  
Human oral rehydration solutions based on sorghum 
Mustafa et al. (1995)(198) Oral rehydration therapy for 
acute diarrhea using cereal-based 
solutions.   
96 (children (6-40 mo) in Sudan. Comparative RCT (32 rice, 34 
sorghum, 30 control). Safety & efficacy of rice or sorghum cereal-
based oral rehydration solutions (ORS) relative to std. WHO ORS 
formulation. 
Cereal-based ORS shortened the duration of diarrhea, reduced stool vol. & the 
freq. of diarrhoea & vomiting, & the mean total ORS intake. These effects were 
more marked with the sorghum-based ORS than with the rice-based ORS.  
Molla et al. (1989)(152) Food-based oral rehydration 
solution (maize, millet, wheat, 
sorghum, rice, potato).  
266 children (1-5 yrs), history of acute diarrhea for ≤ 48 h. 
Digestibility of food-based ORS was assessed by stool pH, 
glucose content before & after acid hydrolysis & osmolality. 
The mean stool output over the first 24 h in std ORT was sig. higher than food-
based ORT. Food-based ORT showed substantial reduction in stool output.   
Pelleboer et al. (1990)(199) Oral rehydration therapy for 
acute diarrhea.  
64 Nigerian children (2.5 mo–5 yrs). Comparative RCT - subjects 
consumed either the WHO recommended oral rehydration 
solution (WHO-ORS) or a solution, containing 60 g/l sorghum 
powder. 
No sig. differences in amt. of fluid used, no. of stools & duration of diarrhea. 
No sig. difference in weight gain. 7 children died, 2 (6%) in the sorghum-ORS 
grp & 5 (17%) in the WHO-ORS grp. Sorghum-ORS was well accepted & 
tolerated.  
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…) 
 
Therapeutic food studies 
 
Lead Author/Year Focus of investigations Subjects/Experiment Results 
 
Effects on immune status in people with HIV 
Motswagole et al. (2013)(200) Effects of a sorghum meal on the 
immune status of adults with 
HIV. 
132 HIV+ adults. Double-blind randomised placebo-controlled 
trial in Botswana. Micronutrient fortified sorghum meal including 
Vit. A (n=67) or control (n=65). Serum retinol, Fe, Zn, albumin, 
CD4 cell count & HIV viral load assessed over 12 mo. 
Fortified sorghum meal did not influence serum retinol, CD4 cell count & HIV 
viral load.  
Ayuba et al. (2014)(201) Effects of supplementation with 
sorghum herbal preparation 
(Jobelyn®) on immune status. 
61 HIV+ adults in Nigeria – 2 trials. 10 HIV+ patients not 
receiving antiretroviral therapy (ARVT). Patients consumed 500 
mg Jobelyn® daily for 8 wks. Control with 51 HIV+ patients 
receiving ARVT.  
Consumption of Jobelyn® contributed to improved hemoglobin levels & 
increased CD4 cell counts HIV+ patients.  
 
Consumer/sensory studies 
 
Kayitesi et al. (2010)(32) Consumer opinions of marama 
/sorghum composite porridge. 
30 males & 22 females. Descriptive sensory analysis, consumer 
testing, texture analysis, pasting & color. 
The 100% sorghum porridge & the composite porridge with full-fat flour were 
the most acceptable to consumers.  
Vazquez-Araujo (2012)(202) Consumer input for developing 
human food products made with 
sorghum. 
Adults n=34 focus grps; n=1002 national survey; n=160 conjoint 
analysis 
Heath aspects of grain products were the most appealing for consumers, 
whereas conjoint analysis showed that sensory attributes were the principal 
drivers for purchase intent.  
Muhihi et al. (2013)(203) Sensory study: sorghum ugali 
(stiff porridge). 
Overweight & obese Tanzanian adults. Pre-& post-tasting 
questionnaires were administered. A 10-point LIKERT scale used 
to rate attributes of 3 test foods. Sorghum ugali was consumed by 
23% of participants.  
All of the test foods were highly rated for smell, taste, color, appearance & 
texture. Taste was rated highest for unrefined maize ugali. Whole grain 
carbohydrates are highly acceptable.  
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2.4 Conclusions  
There is an emerging body of scientific literature on sorghum (Sorghum bicolor), an 
underutilised cereal whole grain, that may provide health benefits and contribute to 
the prevention of chronic lifestyle related diseases, particularly in regions where 
associated morbidity and mortality rates are significant public health burdens
(22)
. It 
appears that sorghum grain components may have an impact on metabolic disease 
processes through the delivery of slowly digestible starches, resistant starch, dietary 
fibre, polyphenols (including phenolic acids, flavonoids and condensed tannins), 
policosanols, unsaturated fatty acids and the food attribute of a high antioxidant 
capacity. However, the vast majority of studies available for consideration utilised 
extracts or purified compounds and were conducted in animal models.  Few studies 
in humans have been reported, and there is a need to study sorghum as a whole grain 
in whole food formats, and in the context of a healthy diet. After all, food is 
complex, comprised of a myriad of compounds that act synergistically to elicit food 
effects
(204)
, which are further impacted and altered by processing
(205)
.  
 
Substantiating potentially beneficial effects of sorghum foods on chronic lifestyle 
related disease risk factors requires human studies whereby consistent results from 
randomised controlled trials (RCTs) are reported, contributing to the highest level of 
evidence for practice
(185)
. To date there appears to be fewer than five RCTs 
investigating sorghum metabolic disease-related effects in humans, and all 
interventions are short-term and have some experimental design shortcomings. 
Future RCTs should aim to directly examine a specific effect on chronic disease 
biomarkers or health outcomes between a control and sorghum-intervention diet, for 
a minimum of 3-6 months, enabling evidence for longer-term effects to emerge
(186)
. 
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Specifically, studies should investigate lipid profiles, longer-term markers of 
glycaemic control, and body weight. While much of the research to date focuses on 
extracts and components, the impact of the whole food reflecting the synergy 
between the components needs to be considered (Chapter 3). It is also important to 
study the content of the background diet in these RCTs as background diet can 
confound results and may interfere with the ability to attribute effects to the dietary 
variable of interest
(206)
. In addition, for translation to practice, the impact of 
sorghum-based foods on chronic lifestyle related disease must be seen in the context 
of the whole diet, carefully monitored throughout trials (Chapter 3). 
 
The evidence for a relationship between the antioxidant activity of sorghum and 
health benefits of its consumption is of particular importance due to the role 
oxidative stress plays in chronic disease development. To date, several in vitro and 
animal model studies have highlighted the potential of sorghum grain components, 
such as polyphenols, to scavenge free radicals
(207-211)
.
  
Unfortunately, these studies 
are limited in their ability to attribute direct antioxidant effects of sorghum, as they 
do not account for metabolic transformations and interactions that influence 
bioavailability and biological activity of the polyphenols in the body after ingestion. 
For example, it is unclear what transformations polyphenols undergo, from the oral 
cavity, through the gastrointestinal tract and after absorption and metabolism
(212)
. 
Thus, test regimens from such in vitro and animal studies need to be repeated in 
humans with mild to moderate oxidative-stress induced disease. Disease indicators, 
such as oxidative stress and inflammatory markers, can be measured in subjects who 
consume a sorghum-enriched diet daily over an extended period of time. 
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Finally, while the development of an evidence base for a link between sorghum 
consumption and chemoprevention is in its infancy, some evidence for strong 
antioxidant and anti-inflammatory effects that may mitigate cell proliferation, 
mutagenesis and carcinogenesis has been reported. Cell-line and animal studies 
have demonstrated the potential for such cell-mediated effects, but require 
substantiation in humans. Determining whether the concentration of sorghum grain 
extracts used in these studies may be feasibly consumed through dietary intake of 
sorghum-based foods is critical. Notwithstanding, the study of food effects on 
cancer is highly complex and clinical trials are problematic for ethical reasons. Even 
so, knowledge generated through various forms of experimental research adds to a 
general understanding of how the sorghum food matrix may be beneficial. 
 
Overall, the scientific literature exposes a range of health areas in which nutritional 
effects of sorghum have been examined, such as energy balance, glycaemic control, 
lipids, gut microbiota, and cell-mediated immune responses, including antioxidant 
and anti-inflammatory effects. However, a paucity of human studies is evident. 
Therefore, researching effects of sorghum consumption on indicators of metabolic 
disease, such as weight, is warranted and elements of study designs from the reported 
literature were incorporated into the experimental components of this thesis. 
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3.1 Overview of methodological framework  
This thesis provides a scientific framework to investigate the potential effects of 
sorghum consumption on specific health outcomes in humans. Importantly, this is 
food-based research that must be considered within the context of a whole diet and 
hence “the assumption that in most cases the many substances in food have additive 
or more than additive effects on health”
(213)
. To take this further, this concept 
suggests that food effects are the fundamental unit in nutrition, rather than their food 
constituents
(148)
. Within the framework of this thesis, sorghum as a whole grain 
cereal food with inherent properties (nutrients, dietary fibre and other bioactive 
components) is considered with the knowledge that these individual components 
interact within the food matrix to demonstrate potential protective effects against 
chronic diseases in humans (Figure 3.1).  
 
This holistic approach results in nutrition science that focuses on the inter-
dependency of nutrients/components and their food matrix within a whole diet and 
the “additive” effects they have on health outcomes when consumed over longer 
periods of time. Therefore, while observed effects within this thesis are reviewed in 
the context of individual components to understand mechanisms of action, they must 
be evaluated more broadly with outcomes assigned to the whole sorghum food rather 
than isolated sorghum components. Specifically, research examining sorghum intake 
and chronic disease requires clinical studies to elucidate the potential protective roles 
of the sorghum grain as a constituent of foods within a whole diet. This thesis 
reviews the potential active ingredients within the sorghum food products based on 
existing literature identifying possible mechanisms associated with progression of 
metabolic disease, especially weight control (for example, mechanisms involving 
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slowly digestible starches and polyphenols). Body weight regulation and associated 
inflammatory and oxidative changes are particularly relevant in chronic disease 
prevention.  Studies were therefore designed to examine potential mechanisms of 
food intake regulation, acute oxidative changes, effects of chronic consumption on 
markers of metabolic disease such as body weight, serum cholesterol and a range of 
inflammatory markers (Figure 3.1). 
 
 
 
 
Figure 3.1 Conceptualisation of thesis framework 
 
Sorghum whole grain has slow in vitro starch digestibility and some varieties are 
high in dietary fibre and rich in polyphenolic compounds that may contribute to 
effects on body weight outcomes and other weight-related clinical indices when it is 
consumed regularly as part of the human diet (Chapter 2). Food intake is a key 
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regulator of body weight and so examination of satiety-enhancing mechanisms, 
which may assist in reducing energy intake is an important component of 
investigations related to weight control. This may include changes to glucose, insulin 
and appetite-related gut hormone levels in response to altered intestinal changes that 
may occur post-prandially. Initially, evaluating subjective measures (subjective 
ratings of satiety sensations) together with food intake data, informed further studies 
aiming to identify any positive outcomes from longer-term weight loss interventions, 
such as body weight change.  Collectively, the clinical investigations in this thesis 
explored the acute- and longer-term effects of sorghum consumption, adding to the 
proof of concept that eating foods made from whole grain sorghum may assist in the 
prevention of chronic disease, in part due to mechanisms associated with positive 
changes to body weight. 
 
Well-designed clinical human trials, such as meal test studies (or mechanistic human 
studies) and intervention trials (or randomised controlled trials - RCTs), are 
important in scientific nutrition research. Mechanistic studies are highly controlled, 
laboratory-based experimental investigations that aim to expose mechanisms of 
action related to a specific component in food. On the other hand, RCTs involve 
randomisation of the study sample to a treatment or a control group to measure the 
effect of the treatment, thereby providing direct evidence of exposure to the dietary 
factor of interest
(194)
.  The existing knowledge on sorghum whole grain was found to 
be reasonably comprehensive and sorghum consumption appeared to have the 
potential to assist in the prevention of chronic disease. This knowledge formed the 
basis on which hypotheses for clinical investigations within the thesis could be 
developed. Food product formulation and careful characterisation of the test 
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foodstuff ensured that any effects associated with consumption of sorghum-based 
foods would be carefully considered. An acute mechanistic meal test study provided 
the basic understanding of the types of sorghum components that might be involved 
in altering health outcomes, as well as their mechanisms of action. Finally, a RCT 
provided direct evidence for the effects of chronic sorghum consumption on health 
outcomes.  
 
3.2 Key hypothesis and study aims 
The central concept underpinning this thesis is – 
“Sorghum is a viable alternative to more commonly consumed whole grain cereals in 
the human diet and may have positive benefits on factors associated with metabolic 
health including weight management.” 
 
To test this hypothesis, research (Figure 3.1) was undertaken with the aims of: 
1. Elucidating the functional components of sorghum reported in the scientific 
literature with potential effects on human metabolic processes.  
(Chapter 2: Nutritional composition of sorghum and evidence of its effects on 
health) 
 
2. Formulating an optimised sorghum-based test product that contains the 
nutritional and chemical properties hypothesised to elicit clinical effects. 
(Chapter 4: Formulation of a ready-to-eat sorghum flaked cereal food) 
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3. Investigating effects on proposed mechanisms associated with weight control 
and inflammation such as acute satiety, related hormonal responses and 
antioxidant potential in an acute meal test study. 
(Chapter 5: Acute meal test study testing short-term effects of sorghum 
consumption, specifically targeting satiety mechanisms) 
 
4. Testing for effects of functional components of sorghum foods within a 
controlled clinical trial over a longer time-frame with body weight and 
associated disease marker changes as outcomes.  
(Chapter 6: Randomised controlled trial testing effects of chronic sorghum 
consumption, specifically targeting body weight outcomes) 
 
3.3 Measurement Issues  
Measurement of outcomes from food consumption is pivotal in this thesis. This 
considers how food “works” or impacts on both health and disease. Specifically, how 
whole grain sorghum consumption might benefit health and assist in chronic disease 
prevention is evaluated. To better understand the food/health/disease relationship it is 
important to consider the key factors of the “spectrum of life” – beginning with 
“healthy” and ending with “death”, intercepted by the appearance of disease risk 
factors and the diagnosis of disease along that continuum. This thesis focuses 
somewhere in the middle of the spectrum, to identify effects of sorghum food 
consumption on disease risk factors in the aim of evaluating its potential to assist in 
the prevention of chronic disease development in the longer term. To this end, the 
measurement of key indicators of disease risk was necessary, including measurement 
of body weight and body composition, as well as biochemical markers that expose 
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the status of different systems or processes in the body, such as the cardiovascular 
system (lipids), glycaemic regulation (glucose/insulin), inflammatory pathways and 
oxidative stress. These are linked to the progression of disease if they are not 
maintained within “healthy” reference ranges. 
 
However, food consumption is intricately associated with human behaviour. There 
are both biological cues (for example, appetite-regulating gut peptides) and non-
biological cues (environment, emotions, habits) that influence the food choices 
people make. Since satiety may be a mechanism of action driving body weight 
changes through altered energy intake, and since satiety encompasses both biological 
and behavioural drivers of food intake, it logically follows that measurement of 
specific satiety markers are also useful in studies measuring body weight outcomes. 
Beginning with behavioural aspects of food intake, the satiety markers will be 
discussed first in the next section, followed by a review of the major methodological 
issues related to the measurement of food intake in clinical trials. Finally an 
overview of the disease markers measured in this thesis will be presented.  
 
3.3.1 Measuring Satiety, Satiation and Appetite 
Satiety and satiation are processes that affect eating behaviour. Satiety is a 
feeling/sensation that influences the interval between meals or episodes of eating
(214)
.   
Satiation occurs during the course of a meal and leads to a reduction or cessation of 
eating, and determines meal size
(215)
. Collectively, satiety and satiation processes 
help to control the size of eating episodes and the frequency of eating. Investigating 
foods that have the ability to accelerate satiation, suppress hunger, extend satiety and 
reduce overall appetite are important for obesity/appetite researchers and for food 
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manufacturers designing innovative products that may assist with dietary control and 
weight management.  
 
Studies assessing satiety, satiation and appetite commonly utilise a combination of 
measures. More objective assessments include gut hormone concentrations, gastric 
distention and emptying, brain activity and, potentially most related to outcomes, 
food intake. Although more objective in nature, these assessments can only be 
regarded as biomarkers or indicators, namely, because appetite cannot be directly 
measured using a specific test and we may consume food independent of our level of 
appetite. In particular, biomarkers for satiety measurement are of interest due to their 
potential to expose putative mechanisms of action
(216)
. On the other hand, the 
subjective assessment of satiety (aiming to assess the desire-to-eat prior and in 
response to meals) is generally measured by “the magnitude or duration of changes 
in subjective ratings of appetite-related sensations”
(217)
, often using Visual Analogue 
Scales (VAS) (Section 3.3.1.3).  
 
Generally, biochemical analyses of hormone concentrations plus subjective 
measurements of appetite and food intake data are employed to evaluate satiety and 
appetite in clinical trials, particularly in laboratory-based meal test studies. This 
precise suite of assessments was selected to study sorghum’s potential satiety effects 
in the clinical trials conducted within this thesis. 
 
3.3.1.1 Biochemical Measurements of Satiety: Gut Hormones 
Gut hormones, including ghrelin, leptin, cholecystokinin (CCK), peptide-tyrosine-
tyrosine (PYY), glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide 
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(GIP), are postulated to be part of the hypothalamic-gut-axis (or gut-brain-axis) that 
appears to be important in appetite and body weight regulation. The gut-brain-axis 
modulates short-term satiety and hunger responses to regulate the delivery and transit 
of nutrients through the gastrointestinal tract, enabling efficient digestion and storage 
of energy
(218)
. Furthermore, the axis plays a role in glucose regulation, adipocyte 
function and energy expenditure, to ensure energy homeostasis after a meal
(219)
. The 
precise mechanisms by which this axis controls food intake and eating behaviour are 
complex, and therefore beyond the scope of this review. However, evidence for the 
effects of gut hormones on appetite sensations and food intake that were evaluated in 
the meal test study conducted in this thesis, are reviewed here (namely, ghrelin, 
PYY, GLP-1, GIP). Glucose and insulin are also commonly investigated in meal test 
studies and their involvement in mechanisms that regulate appetite will also be 
discussed. It should be noted that leptin and CCK were not evaluated in this thesis as 
they are not the best fit for acute appetite investigations
(220-223)
.  
 
 Ghrelin 
Ghrelin, an acylated 28-amino-acid peptide, plays an important role in the regulation 
of food intake. It is an endogenous ligand of the growth hormone secretagogue 
receptor type 1a (GHS-R1a). Ghrelin is primarily secreted by the X/A-like cells of 
the stomach
(224)
, and is also produced in low levels by the hypothalamus and by most 
peripheral tissues. As such, ghrelin may have both endocrine and paracrine effects. 
Ghrelin exists  as both acylated and desacylated forms, with acylated ghrelin being 
more active. In this thesis, acylated ghrelin was assessed. The major biological 
functions of ghrelin include the secretion of growth hormone, the stimulation of 
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appetite and food intake, the modulation of gastric acid secretion and motility, and 
the modulation of the endocrine and exocrine pancreatic secretions. 
 
Ghrelin is the only circulating orexigenic peptide that stimulates hunger and food 
intake in both animals and humans
(221; 225-227)
. Both central and peripheral 
administration of ghrelin in rats has been shown to induce food intake and reduce 
energy expenditure accounting for body weight increases
(221; 228; 229)
. In a study with 
healthy humans, intravenous infusion of ghrelin led to a 30% increase in food 
intake
(221)
, however the dose was above physiological levels. Ghrelin is secreted in a 
pulsatile manner with highest concentrations measured during the fasted state and 
before the onset of meal consumption
(227)
. After eating, ghrelin levels drop relative to 
energy intake in people of normal weight
(230)
, but not as much in obese 
individuals
(231)
. Concentrations remain low for approximately 1-1.5 hours, 
particularly following a mixed-macronutrient meal
(221; 232)
. This pulsatile secretion of 
ghrelin suggests that it may act as a signal for meal initiation and termination and has 
been directly correlated with hunger scores
(233)
, but again not in every case
(234)
.  
 
The precise mechanisms underlying ghrelin’s effects on hunger are not completely 
understood, however there is some evidence that ghrelin increases GI motility
(235)
, 
thereby increasing gastric emptying that consequently may reduce satiety. Further, 
elevated ghrelin levels have been inversely correlated with insulin levels, adding 
support to the association between high ghrelin levels and enhanced hunger
(236)
. 
However, ghrelin may be more important in long-term energy balance with reports 
showing that ghrelin levels are inversely correlated with body weight and they rise 
after weight loss
(237; 238)
. For example, in obese individuals, ghrelin is chronically 
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lowered compared to lean individuals
(231)
, and rodents fed high fat diets have been 
shown to develop ghrelin resistance
(239)
. This suggests that ghrelin is down-regulated 
in a state of excess energy, acting as a longer-term moderator of body weight 
particularly through its interaction with leptin. In this light, ghrelin is less likely to 
have a role in meal initiation in obese subjects
(240)
.  
 
The specific effects of ghrelin appear to be inconsistent and its underlying 
mechanisms of action are not fully elucidated. However, it is clear that ghrelin plays 
a role in meal initiation in lean individuals as well as longer-term weight 
management, justifying its use in satiety research. Still, when interpreting 
experimental study results, it is important to consider that the actual peaks of ghrelin 
concentrations may be related to non-physiological functions such as meal patterns 
and habitual diet, particularly in light of evidence showing that ghrelin levels may 
rise in anticipation of eating rather than actual feeding or inter-relationships with 
other hormone actions
(241)
. 
 
 PYY  
PYY is a 36 amino acid peptide that is produced and primarily released by the distal 
L cells of the gut, in particular from the ileum, colon and rectum
(242)
. It exists 
predominantly as two bioactive forms: PYY3-36 and PYY1-36. PYY3-36 is the primary 
circulating active form and is produced when PYY1-36 is cleaved by the enzyme 
dipeptidyl peptidase-4 (DPP-IV). PYY3-36 levels are low in the fasting state and rise 
after food intake, for several hours, in proportion to the amount of energy ingested 
and especially after a protein-rich or high-fat meal
(243)
. For the purposes of this 
thesis, the generic term PYY will be used. 
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PYY has been shown to have strong anorectic properties when it is peripherally 
administered in both rodents and humans
(244-247)
. In a seminal Nature paper, 
Batterham and colleagues
(248)
 demonstrated a reduction in food intake and weight 
gain in rats when they received peripheral PYY injections. They also showed in 
humans that the infusion of normal postprandial concentrations of PYY significantly 
decreases appetite sensations (measured by VAS) and reduces food intake by 33% 
over 24 hours.  
 
The postprandial elevation of PYY and thus the inhibition of feeding have been 
attributed to a gut–hypothalamic pathway. Specifically, altered neural activity 
mediated through the hypothalamus and the vagus nerve may be responsible for 
PYY’s anorectic effects
(249)
. PYY may also promote satiety through activation of the 
‘ileal brake reflex’ that occurs when dietary macronutrients, particularly fats and 
carbohydrates, arrive in the ileum exposing it to an unusually high intraluminal 
nutrient content
(250)
. This reflex acts as a negative feedback mechanism inhibiting the 
emptying of nutrients from the stomach, essentially slowing gastric emptying and 
inhibiting transit of nutrients through the duodenum and jejunum, and as such 
placing a “brake” on hunger and food intake
(251)
. Furthermore, PYY may regulate 
food intake through interactions with other hormones rather than acting alone, further 
highlighting the complexity of this regulatory system. For example, in a crossover 
study, participants ate 27% less at a buffet lunch after receiving an infusion of PYY3-
36 plus GLP-1, compared to infusions based on either PYY3-36 or GLP-1 alone, or a 
saline control
(252)
. 
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There is a growing body of human studies that support PYY’s role in reducing 
appetite and enhancing satiety. In both lean and obese subjects, blunted post-prandial 
rises in PYY have been reported, resulting in the reduction of food intake by 
approximately 25-30% at a subsequent buffet meal
(248; 249)
. In fact, there may be a 
dose-dependent decrease in food intake
(230; 246)
. When Degen et al.
(246)
 administered 
varying doses of PYY to subjects, the highest dose resulted in a 35% reduction in the 
amount of food eaten at a subsequent meal. However, the dose was not matched to 
physiological concentrations and was associated with adverse effects such as nausea, 
possibly confounding results. On the other hand, some research groups have not 
found a corresponding decrease in energy intake with exogenous PYY infusions
(247)
.  
 
Obese individuals are more likely to have lower endogenous PYY levels, with 
fasting PYY levels shown to inversely correlate with body mass index (BMI)
(249)
; but 
not in every case
(253)
. Despite these inherently lower levels, obese subjects can still 
be susceptible to the anorectic effects of PYY when it is administered intravenously, 
in contrast to the reduction of leptin sensitivity that has been seen in obese 
individuals
(249)
. Furthermore, with sustained weight loss these levels may actually 
increase in the circulation
(254)
. Interestingly, exaggerated post-prandial PYY rises 
occur following Roux-en-Y gastric bypass surgery
(255)
, suggesting that this increased 
response may have an important role in the initial weight loss noted by this surgical 
treatment for obesity
(256)
. These variations in post-prandial circulating PYY levels 
and the associated anorectic effects, have stimulated strong research interest in the 
development of PYY-based therapies for the treatment of obesity. From a therapeutic 
food perspective, isolating ingredients/foods with the ability to continually stimulate 
PYY release is particularly interesting given that repeated PYY infusions and 
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injections have been shown to reduce food intake and body weight effectively in 
rodent models
(248; 257)
.  
 
Although studies are not in complete agreement with regards to the precise effects of 
food intake on post-prandial PYY concentrations and there is some variation in 
reported levels, there is sufficient experimental evidence that demonstrates PYY’s 
appetite-suppressing properties. This variation is more likely to again reflect the 
complexity of gut hormone mechanisms and actions as they relate to appetite 
regulation and food intake. Therefore, PYY remains an important hormone to study 
in appetite research.  
 
 GLP-1 and GIP 
GLP-1 and GIP belong to the incretin gut hormones that potentiate insulin secretion 
after meal ingestion in a glucose-dependent manner. Overall, these peptides regulate 
islet hormone secretion, glucose concentrations, lipid metabolism, gut motility, 
appetite and body weight and immune function.  
 
GLP-1 is formed from the cleavage of the preproglucagon precursor
(258)
 and exists in 
the circulation as two major bioactive forms GLP-17-26 and GLP-17-27. In this thesis, 
the generic term GLP-1 will be used. GLP-1, like PYY, is secreted from the L-cells 
of the gastrointestinal tract within minutes of food intake, in response to neural 
stimulation (via the vagus nerve)
(259)
 and in proportion to energy intake, especially 
glucose ingestion
(260)
. GLP-1 effects its actions through the GLP-1 receptor.  
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The key incretin effects attributed to GLP-1 include increased insulin release, in a 
glucose-dependent manner; decreased glucagon secretion and decreased gastric 
emptying
(261)
. As such, GLP-1 has an important role in attenuating post-prandial 
glucose rises. GLP-1 is also involved in the “ileal break reflex” and has an anorectic 
effect on appetite
(262)
. Peripheral and central administration in animals has resulted in 
reduced food intake
(263)
. Similarly, in humans reduced food intake has been reported 
when GLP-1 is peripherally administrated
(264)
, both at high and normal physiological 
levels
(265)
. Therefore, GLP-1 is likely to play an important role in the regulation of 
satiety.  
 
In individuals with Type 2 diabetes, the incretin effect appears to be diminished, 
namely through decreased postprandial GLP-1 secretion
(266)
. Thus, the incretin 
properties of GLP-1 have been of particular interest to researchers in the treatment of 
Type 2 diabetes. Specifically, medications have been formulated as GLP-1 receptor 
agonists to improve glycaemic control and promote weight loss, especially because 
the glucoregulatory properties of GLP-1 remain functional in insulin resistant 
individuals
(267)
. A meta-analysis demonstrates that GLP-1 receptor agonists lead to 
weight loss in obese patients with and without Type 2 diabetes
(268)
. In this study, 
improvements to blood pressure and total cholesterol were also reported, however it 
is unclear whether these were related directly to weight loss effects rather than the 
GLP-1 receptor agonists themselves. Astrup et al.
(269)
 demonstrated sustained weight 
loss and improved metabolic disease markers over a two-year period when 
participants took a once-daily GLP-1 analogue called Liraglutide. On the other hand, 
and as may be expected, antagonists to GLP-1 have been shown to increase food 
intake and body weight
(270)
. 
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GIP is a 42 amino acid peptide that is produced predominantly in the duodenal K 
cells in the proximal small intestine. GIP effects are actioned via the GIP receptor 
(GIPR). GIP secretion, as for GLP-1, is stimulated by nutrient intake, with low 
circulating GIP levels in the fasted state that rapidly rise within minutes after food 
ingestion. The key physiological functions of GIP include: stimulation of intestinal 
glucose transport; release of insulin from pancreatic beta cells in the presence of 
glucose to facilitate nutrient storage
(271)
; and uptake of glucose by adipocytes in an 
insulin-mimetic fashion
(272)
. Specifically, GIP promotes fat deposition through 
increased lipogenesis (via stimulation of lipoprotein lipase activity), enhanced fatty 
acid synthesis and incorporation into triglycerides, and down-regulation of glucagon-
stimulated lipolysis
(272)
.   
 
Although GLP-1 is decreased in individuals with Type 2 diabetes, GIP secretion 
from entero-endocrine cells appears to be normal or slightly elevated. However, 
impaired pancreatic β-cells appear to cause the insulinotropic effects of GIP and are 
responsible for the reduced incretin effects in these individuals
(273)
.  
 
The dynamics of postprandial incretin secretion in diet-induced obesity are not 
clearly defined. GIP secretion is either increased
(274)
 or unaffected
(275)
 and GLP-1 
secretion appears to be decreased
(274)
 or unchanged in obese, non-diabetic 
individuals. Interestingly, it has been shown those mice lacking the GIPR are 
resistant to diet-induced obesity
(276)
, although it is unclear if incretin secretion is 
affected by obesity per se or the high-energy diets that contribute to obesity. 
Nevertheless, the incretins are important biomarkers to monitor in studies 
investigating weight outcomes, including appetite research. 
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 Glucose and Insulin 
Glucose is the body’s primary fuel source, exclusively for the brain, and insulin acts 
to control blood glucose levels in response to food ingested, especially 
carbohydrates. Both glucose and insulin appear to be involved in mechanisms of 
energy homeostasis, however the role of postprandial blood glucose and insulin 
levels in the regulation of short-term appetite in humans is less clear. Low blood 
glucose levels prior to eating a meal have been postulated as a cue to meal initiation 
but links to satiety remain weak
(277)
. On the other hand, higher levels of blood 
glucose have been associated with higher subjective satiety
(278)
 and thus meals that 
elicit a higher postprandial glycaemic response are expected to suppress short-term 
appetite to a greater extent than those with a slower glycaemic response. This is 
based on the glucostatic theory that links elevated blood glucose with fullness and 
low blood glucose levels with hunger
(279)
. Based on similar theories, higher insulin 
levels have also been associated with increased feelings of satiety.   
 
Conversely, the glycaemic index theory proposes that attenuated post-prandial blood 
glucose and insulin levels are related to higher subjective satiety and feelings of 
fullness, such that foods with a low glycaemic index (GI) are more effective at 
alleviating hunger
(280)
. The rationale for this can be explained by the notion that low-
GI foods are characterised by a slower rate of digestion and absorption, which in turn 
stimulate nutrient receptors in the gastrointestinal tract for a longer period of time, 
resulting in prolonged feedback (through satiety signals) to the hunger/satiety centre 
in the brain. However, neither the glucostatic nor the glycaemic index theories are 
able to describe the interrelationships between glucose, insulin and satiety with 
certainty, and there is even some suggestion that glucose and insulin may not be 
directly involved in appetite regulation. 
CHAPTER 3: Methodology 
 77 
A meta-analysis of meal test studies suggested that insulin, but not glucose, is 
associated with short-term appetite regulation in healthy, normal weight participants, 
but this relationship was not obvious in overweight and obese subjects
(281)
. The 
authors concluded that the postprandial insulin response may be an important satiety 
signal, and that central nervous system insulin resistance in overweight might explain 
the blunted effect on appetite. However, Holt et al.
(282)
 found a significant negative 
association between individual insulin and satiety AUC responses to four test foods 
(containing 50 g of available carbohydrate as ordinary and quick-cooking rice and 
high- and low-amylose puffed rice), suggesting that increased rate of starch digestion 
and corresponding higher insulin responses are associated with lessened satiety, or 
greater feelings of hunger. 
 
Interestingly, Raben et al.
(283)
 found that the consumption of a low GI raw potato 
starch meal that was high in resistant starch resulted in lower reported satiety and 
fullness compared with a highly digestible pre-gelatinised potato starch meal. 
Furthermore, the lower levels of satiety after the low GI/high resistance starch meal 
were concomitant with lower levels of GIP and GLP-1
(283)
. A more recent 
randomised crossover trial (involving 26 overweight or obese adults who received 
four diets: high GI/high carbohydrate; high GI/low carbohydrate; low GI/high 
carbohydrate; low GI/low carbohydrate at four different visits) showed that by 
reducing the GI or carbohydrate content of mixed meals, postprandial glycaemia and 
insulinaemia were also reduced over the course of a day
(284)
. However, there was no 
difference in subjective hunger and satiety ratings between the various diets, 
regardless of GI or carbohydrate content. 
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Insulin is therefore more likely to be involved in longer-term regulation of body 
weight, with fasting plasma concentrations and postprandial responses to a meal 
being correlated with body adiposity (acting via a negative feedback signal to recent 
energy intake and body fat)
(285)
. Verdich et al.
(275)
 and Flint et al.
(281)
, propose that 
insulin is more likely to be a mediator of satiety sensations in the postprandial 
period, particularly decreasing ad libitum energy intake in normal weight individuals 
but not in the overweight and obese. Despite the lack of a direct association between 
insulin or glucose and satiety effects in humans, it is important to include 
measurements of both in appetite research in view of their physiological responses to 
the ingestion of food, their role in energy homeostasis and most importantly to help 
monitor long-term changes to glycaemia and insulinaemia in chronic studies of 
weight and disease risk.  
 
3.3.1.2 Summary of gut hormone control in appetite regulation and some 
limitations 
The regulation of appetite by gut hormones is complex and influences dietary intake 
through the “sum of many parts”. It is clear that ghrelin, PYY and the incretins 
(GLP-1 and GIP) have a role to play in this intricate system and justifiably should 
continue to be monitored in appetite studies. This review has highlighted the 
variation in study results for the postprandial effects of the various gut hormones in 
different types of studies - human, animal and cell-line.  The reasons for these 
variations are complex and may be partly due to the wide array of immunoassays and 
test meals used in the studies. Furthermore, subjects’ background diet is often not 
defined; therefore, it is difficult to determine if usual eating habits have any potential 
effects on hormone secretion. Also, results from infusion studies need to be treated 
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with care when translating them to food intake and appetite sensations in humans, 
particularly where pharmacological and not physiological doses are used, as often 
these may lead to adverse reactions that can alter desire to eat and impair dietary 
intake. Furthermore, the effective translation of preclinical data into comparable 
human observations is hampered by the predominant use of young mice and rats in 
short-term preclinical studies; it is well established that there are clear differences in 
biological responses between younger and older animals. More clinical dietary 
studies that are designed to test hormonal responses after consumption of actual food 
in humans are needed to build on the promising animal and infusion studies 
conducted to date. Despite some controversy over their use as appropriate 
biomarkers of appetite
(286)
 in individuals and perhaps at a group level, the 
measurement of glucose and gut hormones can be justified to examine mechanisms 
and provide insight into potential functionality.  
 
3.3.1.3 Subjective measurements of satiety: Visual Analogue Scales 
Appetite sensations are used reliably to measure subjective desire-to-eat, prior to and 
in response to meals
(217)
. Visual Analogue Scales (VAS) are commonly used as a 
methodological tool to quantify such feelings (Table 3.1), in a controlled 
environment, immediately before and following an eating episode, and then 
chronologically at regular time points
(287)
. In general, the VAS consists of a 100 mm 
horizontal line, anchored at each end with opposing extremes of a specific scale (for 
example, "not at all hungry" and "never been more hungry"). Participants place a 
vertical mark on the line to correspond with their appetite-related sensations. These 
feelings are quantified by measuring the distance from the left end of the line to the 
mark
(216)
. Using the VAS tool in this manner results in an acceptable degree of 
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validity and reliability
(287)
. VAS have other advantages also; they are uncomplicated 
and straight-forward to use, they are reproducible in repeated protocols where the 
effect of different treatments are compared under similar conditions, and they exhibit 
a good degree of within-subject reliability
(217; 288)
. In most cases, subjects are 
untrained. Vinoy
(289)
 suggests that the use of untrained volunteers in studies using 
VAS poses a number of issues. For example, the inter-individual differences in 
gender, age, dietary restraint are likely to effect the experience of appetite and the 
VAS ratings, making it difficult to obtain significant discrimination of satiety effects 
using small samples
(289)
. In addition, some individuals may have limited 
introspection and poor awareness of their appetite sensations. 
Table 3.1 Visual Analogue Scale Questions 
Question Extreme ends of the response Factors of appetite tested 
How hungry do you feel at this 
moment? 
I am not hungry at all 
I have never been more hungry 
Hunger 
How satisfied do you feel at this 
moment? 
I am completely empty 
I cannot eat another thing 
Satisfaction 
How full do you feel at this moment? Not at all full 
Totally full 
Fullness 
How much do you think you can eat 
at this moment? 
Nothing at all 
A lot 
Prospective food intake 
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Other limitations of the VAS tool have been noted. For example, the satiety power of 
different foods may depend on very small differences in composition, such as the 
limited amounts of active ingredients found in cereal foods. Also, differences in both 
experimental designs and in the sensitivities of study participants may make 
between-study comparisons difficult.  
 
3.3.2 Measurement of Dietary Intake 
A key research benchmark in studies assessing appetite (satiation/satiety effects) is 
the measurement of dietary intake. Dietary intake, in particular energy intake, 
strongly influences body weight changes, and weight control is typically the long-
term primary outcome measure of appetite research.  Thus, it is imperative to 
quantify dietary intake in all appetite studies, both short-term and long-term, 
especially to enable the connection between short-term satiation/satiety effects (most 
likely observed in acute feeding trials) and longer-term weight control outcomes 
(usually assessed through dietary intervention trials). After all, the main goal with 
most appetite research is to reduce an individual’s dietary intake to, for example 
control obesity. In the context of research investigating diet and chronic disease 
specifically, healthy weight is a primary preventative measure, thus long-term studies 
such as RCTs are the gold-standard to confirm that decreasing appetite will result in 
decreased dietary intake and total energy that will subsequently lead to weight loss. 
For this reason, an RCT was the obvious choice for testing longer-term effects of 
sorghum consumption in this thesis. However, there are several limitations 
associated with RCTs, some of which are relevant to this thesis and are briefly 
summarised in Table 3.2.  
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Table 3.2 Summary of some limitations associated with RCTs 
 
 
Dietary intake is measured by quantification of food consumed ad libitum. To assess 
satiation, the intake of the test food (preload) alone or as part of a meal is measured, 
whereas for satiety, energy intake at a test meal is quantified within a specified 
amount of time following the consumption of the test food
(216)
. Typically, the test 
meal is offered in a buffet style or as a single meal, pre-selected by the participant 
from a menu offered by the researcher
(216)
. There are various methods for measuring 
dietary intake in the research setting, depending on the study design, including: direct 
weighing of food consumed before and after intake; dietary recall usually for the 24-
hour period preceding testing; diet history conducted by a trained professional or 
weighed food records completed by the subject. In the case of laboratory-based meal 
test studies, direct observation by the researcher is most commonly employed with 
diet histories/records or recalls assessing the pre-test intake and subject-recorded 
food records used to capture intake after testing. There are many obstacles and 
limitations that relate to obtaining an accurate record of food intake from subjects in 
dietary studies, mostly involving under-reporting and occasionally over-
reporting
(290)
. 
 
Problems/Limitation  Steps taken in this thesis to overcome 
problem 
 
Difficulty in blinding researcher to intervention/control 
treatments 
    
   Researcher not at subject interface at key 
times during testing 
 
Background diets confounding results    Diet histories of usual intake and 3-day 
food records before testing starts 
 
Control group also undergoes dietary intervention 
 
 
   Rigour in dietary recording, design and 
analysis in order to interpret results 
accurately 
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The food composition database is an important scientific tool in dietary intake 
measurement, however it presents with several limitations. Some obvious issues 
relate to: variability in the composition of foods, partial or limited coverage of food 
items and partial or limited coverage of nutrients. Currently, coverage of 
polyphenolic compounds is grossly limited in many databases. In this thesis, 
AUSNUT 2007 Database was utilised and like all food composition databases is not 
immune to some of the problems just described. Hence, to maximise the integrity of 
the research, it was an imperative that only qualified dietitians enter dietary 
information into the database enabling informed decisions when data was missing.  
 
It is clear that human appetite and eating behaviour are complex functions, with 
many intervening variables (environmental, social and cognitive factors) that may 
influence them and ultimately an individual’s intake. As described by Bornet et 
al.
(291)
, “appetite is dependent upon interactions between biology and the 
environment. The environment contains extremely potent factors which for many 
people can readily overcome biological processes operating to maintain body 
weight”. Laboratory-based meal test studies are designed to tightly control for and 
limit these intervening variables, and in doing so may actually make translatability to 
the free-living condition somewhat less realistic.  The Stunkard and Messick 
questionnaire (also referred to as the three-factor eating questionnaire or TFEQ) has 
been designed to measure dietary restraint, disinhibition and hunger
(292)
. It is used in 
dietary studies to limit confounding factors relating to emotional or cognitive 
restraint or overeating. It is used in the screening phase to help recruit a similar study 
population whereby such emotional/cognitive drivers of food intake are reduced. 
Another point to consider in satiety studies is the fact that effects of a single eating 
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episode on satiety and energy intake may not be sustainable as repeated consumption 
could lead to either habituation and waning of the effect over time or to 
strengthening the effect due to learning
(216)
. This further indicates the importance of 
longer-term intervention trials whereby subjects are eating the test food in their 
usual, natural environment, which was the aim of the RCT described in Chapter 6. 
Though meal test studies do not usually necessitate dietary standardisation prior to 
testing
(217)
, in the acute meal test study described in this thesis, the evening meal 
prior to each visit was standardised. Importantly though, it was stratified to usual 
energy intake to ensure that subjects did not feel greater than “usual hunger”, or vice 
versa. The main reason for standardisation was to limit the variability in baseline 
plasma total antioxidant capacity (affected by polyphenolic content of foods) 
between testing days. 
 
Clinical    studies   evaluating    acute    appetite   effects post consumption of a test 
food often use buffet-style meals to assess energy intake at a subsequent mealtime.  
The amount of food offered in the buffet-style meal is deliberately in excess of 
participants’ usual intake and consists of a variety of food items, varying in   
macronutrient composition. However, this introduces a potential confounder in that 
more food may be eaten in this setting than in free-living conditions as the food is 
prepared for the subjects, is in abundance (higher quantity and greater choice) and is 
free. Thus it is difficult to distinguish whether energy intake is influenced more 
strongly by individuals’ food selections rather than the actual satiety-related effects 
of the test food.  
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In summary, understanding the limitations of different methodologies is essential to 
enable the design of rigorous clinical dietary trials and to maximise the opportunity 
to observe minimally confounded outcomes. 
 
3.3.3 Measurement of Relevant Markers of Health/Disease Risk 
Metabolic Syndrome (MetS) is defined by a cluster of associated metabolic 
abnormalities, including central obesity, dyslipidaemia, hypertension, 
hyperglycaemia, and insulin resistance. These metabolic disorders present significant 
risk factors for chronic disease development, including cardiovascular disease and 
diabetes. Dietary interventions and therapies specifically aim to prevent the 
development or advancement of such diseases, hence it is important to monitor the 
progression to MetS and its individual components when evaluating the diet-health 
relationship, or specifically in this thesis, the relationship between a sorghum-
enhanced diet and health.  
 
Traditional markers of metabolic disease relate to body measurements (such as 
weight, body mass index (BMI), and waist-to-hip ratio) and serve as indicators of 
obesity and risk of chronic metabolic disorders. In addition, biomarkers (also known 
as biological indicators) are used to monitor and predict the health of a population, to 
identify individuals with particular susceptibility or resistance to health problems, 
and to evaluate therapeutic or clinical interventions. Human dietary trials 
investigating effects on health outcomes require the measurement of such 
biomarkers, of which there are many, and each reflecting activity in at least one 
biological system such as the cardiovascular, metabolic or immune system. Selection 
of appropriate biomarkers to capture changes to clinical outcomes affected by dietary 
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intake is imperative. Blood pressure, heart rate, and pulse are commonly measured to 
indicate cardiovascular functioning. Serum cholesterol and triglyceride levels 
provide information on metabolic processes and have been used to evaluate the risk 
of coronary heart disease. Glucose and insulin are common indicators of glycaemic 
regulation and insulin resistance, providing useful information on the future risk of 
developing diabetes mellitus. Examining biomarkers of oxidative stress and 
inflammation is also essential, especially because oxidative stress is a key mediator 
of increased cytokine concentrations and low-grade systemic inflammation, 
precursors in the pathophysiology of chronic diseases. Therefore, measurement of 
cytokines (interleukins, tumor necrosis factor alpha, c-reactive protein) as well as the 
overall antioxidant potential of plasma itself (total antioxidant capacity) may be 
useful indicators of health/disease risk status.  
 
A summary of the specific disease markers evaluated in the experimental studies in 
this thesis is provided in Table 3.3. Normal references ranges have been provided for 
all weight-related measures (BMI, waist circumference, percentage body fat) (Table 
3.3a) and biochemical indices such as lipids, glucose and insulin levels (Table 3.3b). 
However, benchmarks for some of the inflammatory biomarkers are not yet available 
in the literature or accepted by pathology laboratories that may conduct such 
analyses. In these cases, the desired outcome would be to observe a decline in levels 
over time, especially after a beneficial weight-loss inducing dietary intervention 
(Chapter 6).  
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Table 3.3 (a) Summary of disease markers evaluated in the experimental studies in this thesis 
 
Indication Marker/ 
Measurement 
Normal 
reference range 
In which study was 
marker evaluated? 
Primary (1
O
) or 
Secondary (2
O
) Outcome 
Obesity    
Body Weight 
 
 
Adiposity 
 
Weight 
BMI 
 
Body fat 
20-39 years 
40-59 years 
60-79 years 
 
Waist circumference 
 
18.50-24.99 kg/m
2
 
 
Females     Males 
21-33%     8-20% 
23-34%    11-22% 
24-36%    13-25% 
 
< 80 cm (Females) 
< 94 cm (Males)  
RCT 
RCT 
 
RCT 
 
 
 
 
RCT 
RCT 
1
O 
1
O 
 
2
O 
 
 
 
 
2
O 
2
O
 
Cardiovascular system     
Blood Pressure 
 
Diastolic blood pressure 
Systolic blood pressure 
<80 mmHg 
<120 mmHg
 
Acute Meal Test & RCT 
Acute Meal Test & RCT 
2
O 
&
 
2
O 
2
O 
&
 
2
O 
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Table 3.3 (b) Summary of disease markers evaluated in the experimental studies in this thesis 
 
Indication Marker/ 
Measurement 
Normal 
reference range 
In which study was 
marker evaluated? 
Primary (1
O
) or 
Secondary (2
O
) Outcome 
Metabolism         
Lipid metabolism Total cholesterol 
LDL cholesterol 
HDL cholesterol 
Triacylglycerides
 
3.6 - 5.2 mmol/L 
< 2.59 mmol/L 
0.9 - 2.0 mmol/L 
< 1.70 mmol/L 
RCT 
RCT 
RCT 
RCT 
2
O 
2
O 
2
O 
2
O 
 
Glucose metabolism 
 
 
Insulin regulation 
 
Glucose 
Glycoslyated 
haemoglobin 
 
Insulin 
 
3.6 - 5.5 mmol/L 
4 - 6 % 
 
2.6 - 10 mIU/L 
 
Acute Meal Test & RCT 
RCT 
 
Acute Meal Test & RCT 
 
2
O 
&
 
2
O 
2
O 
 
2
O 
&
 
2
O 
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Table 3.3 (c) Summary of disease markers evaluated in the experimental studies in this thesis 
 
Indication Marker/ 
Measurement 
Normal reference 
range 
In which study was 
marker evaluated? 
Primary (1
O
) or 
Secondary (2
O
) Outcome 
Inflammation/ Oxidative Stress Status    
Cytokines 
 
 
 
 
 
 
Antioxidant 
potential 
Interleukin 6 IL-6 
Interleukin 8 IL-8 
Interleukin-IB 
Tumour Necrosis Factor-α 
c-Reactive Protein 
Hydroperoxide 
 
Total antioxidant capacity 
Not defined 
Not defined 
Not defined 
Not defined 
0-5 mg/L 
0-2.3 mmol/L H2O2 
 
1.07-1.53 mmol/L 
Trolox 
RCT 
RCT 
RCT 
RCT 
RCT 
RCT 
 
Acute Meal Test & RCT 
2
O 
2
O  
2
O 
2
O 
2
O 
2
O 
 
2
O 
&
 
2
O
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3.3.3.1 Biomarkers of Inflammation and Oxidative Stress: A brief overview 
Indications of the extent of inflammation and oxidative stress caused by ROS and 
RNS are very important in the assessment of health and/or disease status. Clinical 
trials aiming to measure the outcomes of food consumption on different human 
biological systems therefore require measurement of specific oxidative stress and 
inflammation biomarkers. A “panel” of disease markers, including cytokines, c-
reactive protein and hydroperoxide, was selected to monitor changes to inflammation 
and oxidative stress status in the RCT described in this thesis, with the aim of 
enhancing the overall evaluation of the effectiveness of the intervention (Table 3.3 
(c)).  
 
 Cytokines 
Cytokines are important regulators of adipose tissue metabolism. Adipocytes (fat 
cells) within the adipose tissue synthesise a range of cytokines including tumour 
necrosis factor alpha (TNF-α) and several interleukins (IL), notably IL-1beta (IL-1β), 
IL-6 and IL-8
(293)
. In MetS, adipocyte dysfunction is frequently present and is 
associated with an increase in M1 macrophage population within the adipose tissue. 
The M1 macrophages secrete these pro-inflammatory cytokines, which in turn act 
through a number of cell signaling pathways to induce insulin resistance and 
abnormal glucose metabolism
(294)
. Through their inflammatory properties, these 
cytokines have been implicated in endothelial cell damage within blood vessels that 
leads to vascular dysfunction and atherosclerosis. Studies have shown that elevated 
levels of TNFα, IL-6, IL-8 and IL-1β are associated with MetS and increasing levels 
are associated with more severe MetS (also assessed by hypertriglyceridemia, 
hypertension, and fasting glucose levels)
(295; 296)
. Cytokines can therefore serve as 
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potential biomarkers of inflammation and progression to MetS, and in the longer-
term, progression to more serious chronic disease. In the context of this thesis, 
TNFα, IL-6, IL-8 and IL-1β were selected as biomarkers of disease-risk status after a 
3 month dietary intervention (Chapter 6), specifically monitoring the impact of 
dietary modifications and weight loss on these markers.  
 
 C-reactive protein 
C-reactive protein (CRP) is an acute-phase protein produced by the liver in response 
to inflammation. The cytokines TNFα, IL-6 and IL-1β are widely reported to induce 
synthesis of CRP by hepatocytes (liver cells)
(297)
. In relation to metabolic disease, 
CRP is secreted in the presence of atherosclerotic inflammation and is perhaps the 
most well-known cardiovascular biomarker. In fact, CRP is commonly measured in 
health screening assessments in clinical practice
(298)
. Moreover from a nutrition 
perspective, a recent meta-analysis of 17 studies found evidence that consumption of 
a healthy dietary pattern was associated with significant reductions in CRP (weighted 
mean differences:-0.75 (−1.16, −0.35), p=0.0003))
(299)
. CRP, specifically high 
sensitivity CRP (hs-CRP), was measured in this thesis based on its widespread use 
and effectiveness as a predictor of disease progression or health status in previous 
clinical studies and in practice. 
 
 Hydroperoxide 
Lipid peroxidation, mediated by free radical activity, has been implicated in several 
disease states including cancer and rheumatoid arthritis, as well as in the 
degenerative processes associated with ageing
(299)
. There is also evidence that 
circulating lipid hydroperoxides (HPX) play a pivotal role in atherogenesis
(300) 
and 
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thus coronary heart disease, the leading cause of death in Western societies such as 
Australia
(301)
. Lipid peroxidation initiates a cascade of events that lead to enhanced 
uptake of low-density lipoproteins by macrophages and formation of lipid-laden 
foam cells, one of the earliest indicators of atherosclerosis. Given the study cohort in 
the RCT (Chapter 6) was overweight and mildly obese, and presumably under 
greater oxidative stress, plasma HPX was also measured as a biomarker. It was 
anticipated that HPX would provide insights into the effectiveness of the dietary 
intervention (and more specifically its constituent antioxidant food components) to 
reduce the extent of lipid peroxidation and more broadly alleviate overall oxidative 
stress.  
 
 Total Antioxidant Capacity 
The concept of “total antioxidant capacity” (TAC) originated in chemistry but in 
recent times it has been applied to medicine, biology and nutrition as an indicator of 
antioxidant status both in vitro and in vivo. Researchers in the food and nutritional 
sciences have been interested in evaluating TAC of foods (such as fruits, vegetables, 
grains and wine)
(302)
, as well as measuring the TAC of plasma in human studies as an 
indicator of antioxidant status
(180)
. Plasma TAC considers the cumulative action of all 
the antioxidants present in plasma, thus providing an integrated parameter rather than 
the simple sum of measurable antioxidants
(303)
. Hence, the capacity of known and 
unknown antioxidants and their synergistic interaction is assessed. Studies have 
explored acute effects of eating foods with high TAC on plasma TAC, such as high 
tomato consumption
(304)
, while other studies have evaluated nutritional interventions 
containing foods with a high TAC on disease risk and prevention
(305)
. For example, 
Pitsavos et al.
(305)
 demonstrated that adherence to Mediterranean dietary practices 
CHAPTER 3: Methodology 
 93 
was positively associated with plasma TAC levels and negatively associated with 
oxidation of the atherogenic LDL-cholesterol. In the present thesis, TAC of the test 
foods was measured, as was plasma TAC in both the acute meal test study and the 
longer-term RCT (measured at baseline and after 3 months). However, there is some 
criticism that the TAC assay excludes enzymatic activity from the total measure of 
antioxidant activity, precluding meaningful application to in vivo conditions(302).  
 
 
3.4 Overview of thesis research design 
In view of the opportunities to develop new sorghum products for human 
consumption, this thesis begins by asking the questions: what are the nutritional 
properties of sorghum and what do we know about the effects of consumption on 
humans? The first part of the thesis involved review of the literature to describe 
sorghum grain structure and the specific chemical, nutritional and functional 
attributes that relate to mechanisms by which sorghum grain components may 
influence weight management and chronic disease risk. In addition, the evidence 
reported in the scientific literature on effects of sorghum consumption on health 
outcomes related to chronic disease prevention. Next, a sorghum based food product 
was developed with a food manufacturer and two experimental studies were 
conducted to examine effects of consumption on relevant chronic disease indicators. 
Overall, these thesis components integrate to arrive at a position on sorghum’s 
potential as an underutilised whole grain cereal to assist in chronic disease 
prevention in humans.  
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The experimental work in this chapter was undertaken in collaboration with Sanitarium (the Industry 
Partner of the ARC Linkage Grant LP100200125) and the use of their pilot processing facility to 
formulate the biscuits. All biscuit analyses were completed at the Department of Food Science and 
Technology, Curtin University, Western Australia, and were led by Associate Professor Stuart 
Johnson. The candidate attended Curtin University in 2012 and was trained in analysis techniques 
detailed in this Chapter and engaged in all decisions around methods and foods/ingredients requiring 
testing. Scanning Electron Microscopy and interpretation of micrographs was performed by the 
candidate at the University of Wollongong. 
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4.1 Introduction 
Healthy dietary patterns are positively associated with indicators of health and 
wellbeing
(17)
 and contain specific foods and food components to which potent 
positive effects on disease markers may be attributed. Though food has been used 
historically to improve the health of people, modern food and nutrition research has 
focused on improving and innovating food itself, through a greater understanding of 
the links between food components, the whole diet and health. This approach has 
facilitated improvements in the quality (or functionality) of food products, enhancing 
their potential to benefit health and reduce the risk of disease when they are 
consumed regularly. Today such foods are commonly referred to as “functional 
foods”. 
 
Global food mega-trends, particularly in the developed countries, indicate a strong 
and growing consumer interest in “naturally functional” food products, including 
those that promote greater feelings of fullness and satiety
(11; 306)
. Food companies 
have responded by investing in innovative product development and reformulations 
that have resulted in novel satiety-enhancing food products. Diets containing foods 
with optimised satiety attributes could be beneficial for appetite regulation and 
longer-term weight management
(306)
 and may have the potential to assist in the 
prevention of obesity-related chronic diseases. It has been shown that plant-based 
diets rich in whole grains, with naturally higher fibre content and lower energy value, 
promote satiety
(307)
.  This thesis focuses on sorghum as a specific example of foods 
that may assist in driving satiety or decreasing energy intake, and may be particularly 
beneficial in populations where excess weight is a key driver of metabolic disease.  
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4.2 The opportunity for sorghum-based foods with satiety attributes  
Food choice at breakfast represents an important opportunity to increase satiety in 
the morning and reduce energy intake at lunch and during the rest of the day
(308)
. 
Consequently, developing breakfast products from whole grain cereals with inherent 
satiety-enhancing functional properties is a growing area of interest for researchers 
and food companies alike. Sorghum, with its reputation for being satiating
(23)
, may 
be a viable high-value ingredient for such food applications. Food manufacturers are 
also interested in sorghum for its gluten-free attribute. Traditionally, sorghum has 
been used in a variety of foods particularly in Africa, India and Central America, 
including breads, porridges, steamed and boiled products, beverages and snack foods 
(such as popped sorghum)
(60; 309)
.  
 
In more recent years in Western cultures, sorghum’s light color (characteristic of 
some cultivars), neutral flavour and pleasing texture has made it suitable for use in 
non-traditional food products including breakfast cereals, baking mixes for bread, 
gluten-free bread, cakes/brownies, pancakes, bars and gluten-free beer
(310)
. A US 
consumer survey
(202)
 identified several drivers for purchase intent of sorghum grain 
products including: local origin (domestically-grown grain), inherent health benefits 
(for example, antioxidants), and appealing sensory characteristics (such as crunchy 
texture in breakfast cereals). To date, most of the sorghum-based products that have 
been launched are marketed for their gluten-free attribute rather than the more 
broadly applicable health effects of sorghum grain. 
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4.3 Developing an optimised sorghum-based breakfast cereal  
In this thesis, a ready-to-eat (RTE) sorghum-based breakfast cereal was formulated 
as whole grain flaked cereal biscuits, mainly because this food format is well 
accepted by consumers as a breakfast cereal option based on sales data of an 
equivalent wheat-based product already on the market. A gluten-free alternative to 
traditional wheat flaked biscuits has been long sought after, particularly by 
individuals with a wheat or gluten intolerance such as coeliac disease. Of additional 
value to sorghum’s inherent gluten-free attribute would be any potential appetite and 
weight regulating functionality. Before testing for these potential effects in humans, 
it is important to confirm that the sorghum flaked cereal biscuits actually contain the 
implicated chemical and nutritional components and that processing has not 
negatively altered their physicochemical properties. 
 
For the meal test study (Chapter 5), the flaked cereal biscuits were derived from 
three different sorghum cultivars (red-, white- and brown-grained sorghums) and a 
single wheat control biscuit (Figure 4.1). Wheat was chosen as the suitable food 
control because it has a different polyphenolic profile to red sorghum but has similar 
nutritional attributes and, from a behavioural perspective, wheat cereal products are 
readily interchangeable with sorghum breakfast cereal products. For the RCT 
(Chapter 6), the same red sorghum and wheat control biscuits were tested. Great 
effort was made to formulate a similar control biscuit (not disparate in appearance 
and taste) in order to minimise confounding effects that might emerge if the control 
was markedly different to the other treatment biscuits. 
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Figure 4.1 (a) Red sorghum flaked breakfast biscuits 
 
 
 
 
 
Figure 4.1 (b) Brown sorghum flaked breakfast biscuits 
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Figure 4.1 (c) White sorghum flaked breakfast biscuits 
 
 
 
 
 
 
Figure 4.1 (d) Wheat (control) flaked breakfast biscuits 
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4.3.1 Processing Methods  
White sorghum grain (variety Liberty - a commercial hybrid) and red sorghum grain 
(variety Alpha - an in-bred line), were grown and supplied by Lochabar Enterprises 
Pty Ltd (Tara, QLD, Australia) using organic conditions specifically for human food 
use. Brown sorghum grain, variety IS8237C (an in-bred line), was supplied by the 
Queensland Government Department of Agriculture, Fisheries and Forestry and 
grown at the Hermitage Research Station (Warwick, QLD, Australia). Non cultivar-
specific Australian Prime White (APW) hard wheat, grown in central New South 
Wales, Australia and siloed at ambient temperature was supplied by Sanitarium 
Health and Wellbeing (Cooranbong, NSW, Australia). The bleach test of Waniska, 
Hugo and Rooney
(311)
 was used to determine the presence or absence of tannins in 
the grains of different sorghum varieties used for the manufacture of the breakfast 
cereals.  The white and red sorghum gave no blackened grains, indicating the 
absence of tannins. However blackened grains were observed for the brown sorghum 
indicating the presence of tannins in this variety. 
 
The test biscuits were prepared according to the following recipe: 2.5 L of water was 
added to 25 kg of whole sorghum grains and the mixture steamed for 30 minutes in a 
rotating pressure vessel. A small amount of malt extract was added (precise 
quantities not available due to a confidential formula). The cooked grains were then 
air dried to approximately 24% moisture before being passed through a flaking mill, 
reducing their thickness to approximately 0.1 mm. This differs from the “shredded 
wheat” process, in that the flakes were not cut into strips at any stage. These moist 
flakes were then pressed into a biscuit shape by hand and baked for 25 minutes at 
130 °C, drying the biscuits to approximately 7% moisture (weight basis). Prepared 
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biscuits were labeled in non-descript packaging with coding such that both the 
researcher at the participant interface and the subjects were blinded to the test foods. 
 
4.3.2 Analyses of biscuit contents  
To enable proximate and dietary fibre analysis, the test biscuits were ground to a fine 
particle size using a Grindomix GM200 mill (Retsch, Haan, Germany). All analyses 
were done in duplicate using standard methods (AOAC, 2008) and expressed as 
g/100g as is. Moisture content was determined by loss of mass on drying by AC 
945.15. Protein content was determined by Kjeldahl nitrogen determination (nitrogen 
conversion = 6.25) by AOAC 991.20. Fat content was determined by Soxhlet 
extraction according to AOAC 2003.05. Ash content was determined after 
combustions at 550 °C as described in AOAC 923.03. Total dietary fibre was 
determined by enzymatic-gravimetric analysis according to AOAC 991.43. The 
available carbohydrate of the samples was calculated by difference and the energy 
content calculated using Atwater factors according to the Australian Food Standards 
Code
(312)
.  
 
To determine polyphenolic content and antioxidant capacity, the flaked breakfast 
biscuits were ground in a bench-top blender to pass 100% though a 500 µm sieve. 
Free and bound phenolic extraction was performed in duplicate, as described by 
Adom and Liu
(117)
. Extraction of free phenolic compounds was performed by shaking 
1g of ground sample with 2 mL of 75% acetone for 10 minutes and centrifuging at 
20 °C for 10 minutes at 4000 x g to recover the supernatant. The pellet was re-
extracted twice more in the same manner and the supernatants pooled and made up to 
a final volume of 10 mL with 75% acetone. The extracts were stored at -20 °C in the 
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dark until analysis. Bound phenolic compounds were extracted from the residue after 
the extraction of free phenolics. Twenty-five millilitres of 2M sodium hydroxide was 
added to each residue and digestion was performed for 1h at room temperature under 
nitrogen gas whilst shaking. Concentrated HCl was used to lower the pH to 2 and 
then the mixture was extracted twice with 10 mL hexane for 10 minutes with 
shaking, followed by centrifugation for 10 minutes at 4000 x g at 20 °C. After each 
extraction the hexane upper layer was discarded. The lower aqueous phase was 
extracted five times with 15mL ethyl acetate by shaking for 10 minutes, followed by 
centrifugation for 10 minutes at 4000 x g and 20 °C. The pooled ethyl acetate 
fractions were evaporated to dryness at 30 °C using vacuum rotary evaporation. The 
phenolic residue was re-dissolved in 10 mL of 75% acetone and stored at -20 °C in 
the dark until analysis.  
 
The phenolic content of extracts was measured using a method by Singleton and 
Rossi
(313)
 (adapted from Adom and Liu
(117)
). Duplicate 50µL samples of the extracts 
of free or bound phenolics were diluted with 650 µL ultrapure water. Fifty 
microliters of Folin-Ciocalteu reagent was then added followed by 500µL of 7% 
solution sodium carbonate in water. The sample was mixed by vortex and incubated 
at room temperature for 90 min. The sample absorbance was measured at 750 nm 
against a 75% acetone blank. Known amounts of gallic acid (0 – 250 µg/mL) were 
used to prepare a calibration curve. The phenolic content was expressed as gallic acid 
equivalents (mg of GAE/g as is).  
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In associated investigations (to be reported elsewhere)
1
, liquid chromatography-mass 
spectrometry (LC-MS) was used in the identification and characterisation of the 
different phenolic compounds of both the unprocessed whole grains and the final 
flaked breakfast cereals. 
 
Determination of antioxidant capacity was based on the method reported by Awika et 
al.
(314)
, whereby duplicate 150 µL samples of the extracts of free and bound 
phenolics and standards of 0 – 150 µg/L Trolox in absolute ethanol were reacted 
with 2850µL of 60 mM 2,2-diphenyl-1-picrylhydrazyl (DPPH) solution in methanol 
for 8 h at room temperature in the dark whilst shaking. The absorbance at 515nm was 
measured against a blank (150µL absolute ethanol +2850 µL of DPPH solution). A 
Trolox standard curve was generated to calculate the antioxidant capacity of the 
samples expressed as Trolox equivalents (µmol TE/g as is). 
 
An enzymatic colorimetric method (K-TSTA 04/2009 kit; Megazyme International 
Ireland Ltd, Wicklow, Ireland) was used to determine total starch content (in 
duplicate) of the flaked breakfast cereals as g/100g as is. In vitro starch digestibility 
was determined by a method using rapid glucometry
(315)
 after manual grinding 
through a 1mm sieve. At time intervals of 0, 10, 20, 45, 60, 90 and 120 minutes from 
addition of pancreatin mixture in the in vitro simulation of digestion, duplicate 
glucose readings were made using an AccuCheck® Performa® glucometer (Roche 
Diagnostics Aust. Pty. Ltd, Castle Hill, Australia) and corrected against a reagent 
blank.  
                                                        
1 Price, W., Kang, J., Fang, Z., Stefoska-Needham, A., Tapsell, L.C., Johnson, S.K. Nutritional and phytochemical properties 
of flaked sorghum breakfast cereals. Food Research International (In draft). 
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Equation (1) was used to calculate digested starch D (g per 100g dry starch) at each 
time point. 
 (1) 
  
Where GG is glucometer reading (mM/L), V is volume of digesta (mL), MG is 
molecular weight of glucose (MG=180), W is weight of sample (g), S is starch content 
of sample (g per 100g dry starch), M is moisture content of sample (g per 100 g 
sample), and c is stoichiometric constant for starch from glucose contents (c=0.9). 
Rapidly digestible starch RDS (g/100g dry starch) was calculated as GG = G20 - 
G0.  Slowly digested starch SDS (g/100g dry starch) was calculated as GG = G120 - 
G20  and resistant starch RS (g/100g dry starch) was calculated as GG = 100 - RDS 
(g/100g dry starch) – SDS (g/100g dry starch).  
 
Additional physicochemical profiling was enabled with scanning electron 
microscopy (SEM), particularly showing characteristics of the starch granules in the 
different biscuits.  
 
4.4 Results and Discussion  
Optimised flaked breakfast biscuits were successfully formulated by Sanitarium 
Health and Wellbeing on a pilot line in their manufacturing plant at Cooranbong, 
NSW, Australia. Analyses of proximate and dietary fibre composition and energy 
content (on as is basis per 100g) identified modest differences between the control 
and different sorghum varieties (Table 4.1). The wheat control had the lowest levels 
of total energy, fat and available carbohydrate compared to the sorghum biscuits. 
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Total dietary fibre content of the wheat biscuit was similar to the brown sorghum 
biscuit but significantly higher than the red and white sorghum biscuits (p<0.05). 
 
Table 4.1 Proximate and dietary fibre composition and energy content of flaked 
breakfast cereals 
1,2,3
 
1Means (n=2) ± standard deviation 
2Values within a column with the same superscript letter denotes no significant difference (p>0.05) 
3Statistcal comparison not possible as some replicates identical 
 
The wheat biscuit also contained the highest level of protein compared to all three 
sorghum biscuits (P<0.05). Free and bound polyphenolic (PP) content (mg GAE/g as 
is) and antioxidant capacities (µmol TE/g as is) of the test foods were also 
determined (Table 4.2). As expected, red and brown sorghum biscuits had the 
highest PP levels, on account of the high anthocyanin and tannin contents previously 
reported for these varieties
(23)
, and lower levels of total PP were reported for white 
sorghum and wheat biscuits.  Preliminary results from the LC-MS analyses 
(unpublished data) identified different types and amounts of free, bound and total 
phenolic compounds in both the unprocessed whole grains and the flaked sorghum 
biscuits. The types of phenolics acids identified were: protocatechuic acid, caffeic 
acid and ferulic acid. The flavonoids eridictyol, quercetin, luteolin, naringenin and 
apigenin, were also identified in the samples, as were luteolinidin and apigeninidin, 
two types of 3-deoxyanthocyanidins unique to sorghum.  
Flaked cereal 
biscuit type 
Moisture 
(g/100g as 
is) 
Protein  
(g/100g as is) 
Fat  
(g/100g as is) 
Ash  
(g/100g as is)3 
Total 
dietary 
fibre  
(g/100g as is) 
Total 
available 
carbohydrates 
(g/100g as is) 
Energy 
content 
(kJ/100g as is) 
Wheat control 6.6±0.0 13.7±0.2d 1.7±0.0a 1.6±0.0 9.6±0.1b 66.9±0.1a 1508±1a 
White sorghum 6.6±0.0 10.7±0.0b 2.9±0.0b 1.6±0.0 7.3±0.4a 71.0±0.4b 1553±4c 
Red sorghum 6.6±0.0 9.4±0.1a 2.9±0.1b 1.6±0.0 7.7±0.0a 71.9±0.1b 1550±0c 
Brown 
sorghum 
6.1±0.0 11.7±0.1c 2.9±0.1b 2.1±0.0 9.9±0.2b 67.4±0.3a 1530±1b 
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Table 4.2 Free, bound and total phenolic content and antioxidant capacity of flaked 
breakfast cereals
1,2
 
Flaked cereal 
biscuit type 
Free PP 
(mg GAE/g as is) 
Bound PP 
(mg GAE/g as is) 
Total PP 
(mg GAE/g as is) 
Free AC 
(µmolTE/g as is) 
Bound AC 
(µmolTE/g as is) 
Total AC 
(µmolTE/g as is) 
Wheat control 0.71±0.01a 0.67±0.22a 1.37±0.21a 2.64±0.01a 2.67±0.01a 5.31±0.01a 
White 
sorghum 
0.65±0.04a 0.82±0.04a 1.46±0.07a 3.39±0.18a 2.08±0.01a 5.46±0.20a 
Red sorghum 1.27±0.01b 1.00±0.11ab 2.27±0.12b 11.25±0.57b 9.16±0.62b 20.40±1.18b 
Brown 
sorghum 
1.46±0.04c 1.51±0.06b 2.99±0.01c 16.36±0.23c 14.69±0.55c 31.05±0.79c 
1Means (n=2) ± standard deviation 
2Values within a column with the same superscript letter denotes no significant difference (p>0.05) 
PP, polyphenolic; AC, antioxidant capacity; GAE, gallic acid equivalents; TE, Trolox equivalents 
 
Data for the in vitro starch characterisation of the biscuits only showed significant 
differences in RS, with higher levels occurring in brown sorghum biscuits compared 
to the wheat control (p=0.044) (Table 4.3). Levels of SDS and RDS did not differ 
between biscuits. 
Table 4.3 Starch properties of flaked breakfast cereals
1,2
 
Flaked cereal 
biscuit type 
Rapidly  digested 
starch 
(g/100g dry starch) 
Slowly 
digested 
starch 
(g/100g dry starch) 
Resistant 
starch 
(g/100g dry starch) 
Wheat 31.9±1.6a 47.9±4.2a 20.2±3.9a 
White 
sorghum 
30.2±1.6a 46.5±3.2a 23.3±3.5ab 
Red sorghum 31.9±4.2a 46.9±7.7a 21.2±3.6ab 
Brown 
sorghum 
29.3±3.2a 43.2±1.6a 27.6±2.6b 
1Means (n=2) ± standard deviation 
2Values within a column with the same superscript letter denotes no significant difference (p>0.05) 
 
 
SEM show a consistent degree of starch gelatinisation within all breakfast biscuits 
(Figure 4.2), further supporting the results of the starch profiling studies which 
identified minimal differences in starch properties between biscuits (Table 4.3). 
Minimal differences in the degree of gelatinised starch between biscuits are a 
positive result since this has implications for the post-prandial clinical effects and 
may have confounded results if significant differences existed.  
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 (a)  (b)  
(c)  
Figure 4.2 Scanning electron micrographs (15kV) of (a) white sorghum flaked 
biscuit (b) red sorghum flaked biscuit (c) brown sorghum flaked biscuit depicting 
gelatinised starch granules. 
 
 
 
4.5 Conclusions 
This study confirmed that the flaked cereal biscuits retained the chemical and 
nutritional properties inherent to native sorghum whole grains, particularly with 
respect to polyphenolic content (key differences emerging between cultivars, as 
expected) and similar levels of SDS. These results validate the utilisation of the 
formulated sorghum breakfast biscuits as suitable test foods in the clinical dietary 
trials described in this thesis. They also support the use of this breakfast cereal 
format for the formulation of novel sorghum-based cereal foods. Consideration of the 
effects of processing on the biscuits’ functional, nutritional and chemical attributes 
was imperative to enable more rigorous interpretation of clinical results from the 
dietary trials conducted in this thesis and represents a key strength of the overall 
research strategy.   
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Discussion relating to meal test study design exploring sorghum’s potential satiety-enhancing effects: 
Stefoska-Needham, A., Beck, E., Tapsell, L. (2014) Acute effects of consuming sorghum-based 
breakfast meals on objective and subjective measures of satiety. Cereal Foods World. 59, No.6 
(Suppl):A29, 2014. (Oral presentation at AACCI Annual Meeting 2014, Rhode Island, U.S.). 
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5.1 Introduction 
Whole grain consumption is postulated to decrease chronic disease risk, largely due 
to beneficial effects on body weight regulation
(316)
. Studies of whole grain 
constituents, including slowly digestible starches (SDS), dietary fibre and 
phytochemicals, implicate their effects on energy balance, glycaemic control, lipids 
and inflammation. Sorghum grain constituents have also been shown to produce such 
effects (Chapter 2). 
 
Recent studies demonstrate that sorghum foods can be formulated and processed to 
deliver SDS
(72)
. Sorghum foods with both higher levels of SDS and dietary fibre 
content have the greatest potential to assist in improving blood glucose control and 
possibly to influence appetite-related gut hormones such as ghrelin, GLP-1, GIP and 
PYY. Influences on gut hormone profiles may be a key mechanism of satiety-
enhancing action. GLP-1 and GIP are incretin gut hormones that potentiate insulin 
secretion after meal ingestion in a glucose-dependent manner. They are secreted 
within minutes of food intake and are associated with increased satiety
(317)
. PYY has 
been shown to have strong anorectic properties in both lean and obese subjects
(245)
, 
reducing appetite and food intake by approximately 25-30% at a subsequent 
meal
(248)
. Ghrelin, an orexigenic hormone, decreases immediately after ingestion of 
food and stimulates hunger and food intake
(221)
. Understanding how sorghum grain 
intake acts acutely, for example affecting these key satiety hormones, may help to 
justify and formulate hypotheses for the effects of chronic sorghum consumption in 
longer-term weight reduction intervention trials.  In addition, consideration can be 
given to any observed effects in relation to known effects of individual components 
within sorghum, such as polyphenols, starches and fibre.  
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5.2 Study Aims and Hypothesis 
The aim of this double-blinded, randomised, crossover feeding study was to test the 
effects of eating three different RTE whole grain sorghum flaked breakfast biscuits 
on appetite responses in healthy subjects. The biscuits were derived from white, red 
or brown whole grain sorghum, or wheat (control), all high in SDS levels but 
differing in polyphenolic content and dietary fibre levels (Chapter 4). It was 
hypothesised that the consumption of sorghum-based breakfast cereal foods would 
reduce appetite compared to a wheat control. Specifically, sorghum-based products 
would: (1) increase acute subjective satiety; (2) alter responses of appetite-regulating 
hormones (plasma ghrelin, GIP, GLP-1, PYY and insulin) and plasma glucose; and 
(3) reduce food intake at a subsequent meal and during the remainder of the test day. 
It was postulated that mechanisms involving polyphenolic, starch and dietary fibre 
components will synergistically drive satiety changes. A secondary aim was to 
review any differences in satiety outcomes between the sorghum varieties to better 
inform which components may drive any benefits of sorghum consumption when 
consumed as whole cereal foods.  
 
5.3 Materials and Methods 
5.3.1 Subjects 
Healthy subjects, 20 males and 20 females, aged 18-50 years (BMI range from 20–
31 kg/m
2
) were sought within the local community through paid media 
advertisements and institutional emails. Subjects with serious illness including 
diabetes, with known food allergies, restrictive eaters (identified using the TFEQ 
described in Chapter 3) and those who were smokers, were excluded. Pregnant, 
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breastfeeding and post-menopausal participants were also excluded. Height, weight, 
waist circumference and percentage body fat (Tanita Scales Model no.TBF-662) 
were recorded. A diet history (DH) and three-day weighed food records were 
collected from subjects prior to the start of the testing phase in order to design an ad-
libitum meal within the subjects’ taste preferences and based on familiar foods. 
Twenty-four hour dietary recalls were collected for the day prior to each study visit 
(Figure 5.1). 
 
 
Figure 5.1 Participant engagement before randomisation into study and prior to first 
testing visit 
 
 
5.3.2 Test Protocols 
Subjects consumed four different breakfast cereal meals on four separate occasions 
after a 12-hour overnight fast with a minimum of three days between visits. Subjects 
consumed a standardised frozen meal for dinner the evening before testing, stratified 
Participant calls 
Dietary Hotline to 
register interest 
Call back from Researcher –  
telephone screening  
Attend screening interview 
(includes DH, 3FEQ, 
baseline anthropometry) 
Recruit into study, 
randomise 
 
3-day weighed food 
record completed prior to 
first visit  
 
Evening prior to 
first testing visit: 
standardised dinner 
meal consumed then 
12h fast 
TESTING VISIT at 
clinical trials unit 
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to subjects’ usual energy intake. Subjects were advised to refrain from vigorous 
physical activity and alcohol consumption in the 24-hour period prior to testing. 
Female subjects were tested within the same phase of their menstrual cycle
(318)
. The 
study was approved by the University of Wollongong Human Research Ethics 
Committee (application number HE12/410) and was prospectively registered with 
the Australian New Zealand Clinical Trials Registry (ACTRN12614000640606). See 
Figure 5.2. 
 
5.3.3 Test Foods 
The flaked whole grain biscuits were made from three different sorghum cultivars 
(red, white and brown grained) and a single wheat control, as per the protocol 
discussed in Chapter 4. Each test breakfast meal consisted of 3 biscuits (50 g total) 
served with 200 mL water. An additional 400 ml water was provided to participants 
during the course of the four-hour testing period. Analyses of proximate, dietary 
fibre, energy and polyphenolic contents of the test biscuits were completed in 
accordance with methods detailed in Chapter 4. Results of these analyses are also 
reported in Chapter 4, together with scanning electron microscopy studies.  
 
At each study visit, participants were also instructed to complete a product 
evaluation form shortly after eating the test biscuits (Appendix 2). This comprised 
both open-ended questions and also 100mm VAS lines. Specifically, questions 
related to organoleptic properties of the biscuits and asked about subjects’ 
perceptions of taste, texture, and crunch. 
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Figure 5.2 Overview of protocol for acute meal test study 
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5.3.4 Appetite Markers and Measures 
On arrival to the clinical trials unit, subjects had anthropometric measurements and 
baseline blood pressure measured. A cannula was inserted and initial fasting blood 
samples were collected. The subject then ate one of the four test breakfast meals 
within a 10-min period. Fifteen minutes from commencement of the test breakfast 
meal, the next blood sample was taken. Further samples were then collected at 30, 
60, 90, 120, 180 and 240 min. All biochemical analyses were performed by an 
accredited Pathology Laboratory, according to standard protocols for the respective 
assays. Glucose analysis was performed by the glucose hexokinase method (Roche 
Diagnostics, Australia). Analyses of insulin, active ghrelin, PYY and GIP were 
performed using a multiplexed Merck Millipore Human Metabolic Hormone Panel. 
Active GLP-1 was assayed using an Epitope Diagnostic Elisa kit. Plasma total 
antioxidant capacity (TAC) was measured using a method adapted for a Cobas Mira 
(Roche Diagnostics, Australia). Plasma was incubated with met-myoglobin and 2,2'-
azino-bis (3-ethylbenzothiazoline-6-sulphonic acid). After incubation, hydrogen 
peroxide was added and the sample incubated again. Absorbance was measured 
spectrophotometrically to determine TAC.  
 
At each of the eight time-points for blood collection, subjects completed a four-
question visual analogue scale (VAS) related to appetite
(217)
. The questions were: 
How hungry do you feel at this moment? How satisfied do you feel at this moment? 
How full do you feel at this moment? How much do you think you can eat at this 
moment? The VAS consisted of a 100 mm horizontal line, anchored at each end with 
opposing extremes of the scale (for example, "not at all hungry" and "never been 
more hungry"). The study participants were instructed to place a vertical mark on the 
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line to correspond with their feelings. The subjective sensation was quantified by 
measuring the distance in millimetres from the left end of the line to the mark. Four 
hours after completion of the breakfast, a buffet lunch was served, consisting of a 
variety of sandwiches (cut into bite-size pieces), a cold pasta salad, dried fruit, 
yoghurt and water (totaling approximately 7500 kJ and containing 50% 
carbohydrate, 20% protein and 30% fat) (Figure 5.3). All the foods were made to 
standardised recipes and were weighed before the meal was consumed and at 
completion to enable calculation of the amount of food eaten. 
 
Figure 5.3 Buffet (ad-libitum) lunch 
 
 
5.3.5 Statistical Analysis 
Sample size was calculated based on previous appetite studies measuring satiety-
related biochemical markers and VAS scores. Flint et al.
(217)
 suggested that 18 
subjects should identify statistically significant changes using a paired design and a 
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study power of 0.8 if VAS ratings vary by at least 5 mm. However, Beck et al.
(308)
 
concluded that a sample size of 37 would be required for results to reach statistical 
significance in a paired design with a power of 0.8 (alpha 0.05). Specifically for 
detection of biochemical differences, a sample size of 14, with seven subjects of each 
gender, was suggested as being sufficient to see significant results
(220)
. In 
consideration of these studies and the fact that sorghum has not been previously 
tested, a target sample size of 36-40 subjects of equal genders was set to undergo 
subjective satiety assessment through VAS, and a subset of 18-20 subjects to 
undergo biochemical analysis. Results for VAS scores, biochemical analyses and 
second-meal dietary intake were entered into SPSS for windows, Version 21.0 (SPSS 
Inc., Chicago, IL, USA). Differences in VAS responses between the breakfasts were 
identified using repeated measures analysis of variance (RMANOVA) with post-hoc 
Bonferroni adjustments. The area under the curve was assessed using trapezoidal 
methods for all biochemical data with values corrected for baseline and inclusive of 
all incremental area below the curve, as well as the area below the fasting 
concentration (net incremental AUC or net iAUC as previously described
(319)
. 
Differences in net iAUC for glucose, insulin, ghrelin, GLP-1, GIP and PYY between 
the breakfasts were identified using RMANOVA with post-hoc Bonferroni 
adjustments. For meal intake values, RMANOVA of kilojoules consumed was 
performed. Data was analysed for individual and combined sexes as past studies 
have identified some gender-related differences in satiety markers
(220)
. Regression 
analysis relationships were explored between biochemical, subjective and meal 
intake data and 24 h dietary recalls. A p<0.05 was considered statistically significant. 
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5.4 Results 
5.4.1 Subjects 
A total of 81 potential subjects expressed interest in the study, of which 65 were 
contacted to undergo further preliminary screening via telephone. From this group, 
43 people were eligible for further assessment and attended an interview to 
determine final eligibility. A total of 40 subjects were then randomised into the 
study. All subjects attended the required four study visits, resulting in a 100% 
participant retention rate. Twenty male and twenty female subjects were aged 21-50 
years (average ages were 27.7 and 31 years, respectively). Further subject 
characteristics are summarised in Table 5.1.  
 
Table 5.1 Subject characteristics at baseline (mean ± standard deviation) 
 
 
 
 
 
 
 
5.4.2 Test Food Analysis  
Test foods in the form of flaked cereal biscuits were consumed by subjects with no 
adverse reactions. Responses to the product evaluation questionnaire did not identify 
differences in subjects’ perceptions about taste, texture and crunch between the 
different sorghum biscuits and the wheat control (data not presented), suggesting that 
 Male (n=20) Female (n=20) 
Age (years) 27.7 (±6.921) 31.0 (±8.891) 
Age range (years) 21-43 21-50 
Weight (kg) 80.50 (±8.094) 63.84 (±7.814) 
Height (m) 1.84 (±0.073) 1.67 (±0.053) 
BMI (kg/m
2
) 23.78 (±2.025) 22.94 (±3.00) 
Waist circumference (cm) 83.05 (±5.196) 75.85 (±8.53) 
Body fat (%) 16.81 (±3.15) 28.35 (±5.287) 
Blood glucose (mmol/L) 4.71 (±0.303) 4.80 (±0.371) 
Blood insulin (mmol/L) 254.60 (±47.350) 289.50 (±89.022) 
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they were equally acceptable to the study sample. Analyses of proximate and dietary 
fibre composition and energy content, as well as the free and bound polyphenolic 
(PP) content (mg GAE/g as is) and antioxidant capacities (µmolTE/g as is) of the 
test foods, were reported in Chapter 4, and confirm that the formulated RTE biscuits 
were suitable test foods for this trial. Specifically, analyses of proximate and dietary 
fibre composition and energy content (on as is basis per 100g) identified modest 
differences between the control and different sorghum varieties (Table 4.1), with the 
wheat control containing the highest soluble fibre levels (4%), followed by brown 
sorghum (2.3%), red sorghum (1.5%) and finally white sorghum (1.2%). Free and 
bound polyphenolic (PP) content (mg GAE/g as is) and antioxidant capacities 
(µmolTE/g as is) of the test foods were also determined (Table 4.2). As expected, red 
and brown sorghum biscuits had the highest PP levels, due to the high anthocyanin 
and tannin contents previously reported for these varieties
(23)
, and lower levels of 
total PP were reported for white sorghum and wheat biscuits. Assessment of starch 
properties showed no difference in the amount of total starch, RDS and SDS between 
biscuits (Table 4.3). RS was highest in the brown sorghum biscuit compared to all 
other biscuits (p<0.05).  
 
5.4.3 Baseline Measurements  
Dietary recalls for the 24-hour period prior to each visit averaged 8867 kJ (4871 kJ – 
15 780 kJ). Average intake for females was 7587 kJ and for males 9949 kJ. As 
expected, regression analysis indicated some contribution of total energy intake 
consumed in the previous 24 h to the prediction of total lunch time ad-libitum intake 
(R
2
 = 0.281, p<0.001), as well as intake during the remainder of the day (R
2
 = 0.153, 
p<0.001). No relationship was identified between the 24 h recalls and baseline 
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measurements of individual VAS questions, fasting glucose, insulin, ghrelin, GIP, 
GLP-1, PYY and TAC levels. There was some correlation between polyphenolic 
content of the standardised dinner meal consumed the evening prior to testing and 
baseline plasma TAC levels, adding support to the decision to standardise this meal 
in this study design (Table 5.2).  
Table 5.2 Correlation between polyphenol content of standardised dinner meal and 
baseline plasma TAC 
  
Correlations Male (n=8) Female (n=8) 
Pearson Correlation (r) 0.863 0.451 
Significance (2-tailed) 0.006 0.088 
Effect size (Cohen’s*) Large Medium 
*Due to the small sample size, Cohen’s values were applied to determine effect size. 
 
 
5.4.4 Subjective Satiety 
The measurement of appetite sensations using VAS showed the treatment effect was 
significant in all four questions (p<0.001, RMANOVA of means for all questions) 
(Table 5.3).  Pairwise comparisons using Bonferroni adjustments indicated 
differences primarily between the control (wheat biscuit) and all three sorghum 
biscuits (red, brown and white) for all four questions (p<0.05 for all three 
comparisons in each question). No differences between sorghum biscuits were 
identified using Bonferroni adjustments for multiple comparisons. Overall, means of 
VAS responses showed significantly greater hunger and lower satiety ratings after 
consumption of wheat biscuits compared to all three sorghum treatments over the 4 h 
testing period (also shown in Figure 5.4). 
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Table 5.3 Mean VAS ratings (mm) for all 4 questions after intake of different 
breakfast cereal biscuits
1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Values within a column with different superscript letters denotes significant differences (p<0.001).  
Values with the same superscript letter denote no significant difference (p>0.05). 
 
 
 
Figure 5.4 RMANOVA of mean satiety ratings(mm) for all 4 questions  
(Q1, Q2, Q3, Q4) after intake of different breakfast cereal biscuits  
at different time points over 4h
1,2 
1Q1, Q4: Increasing values on y-axis associated with greater hunger/lower satiety sensations 
2Q2, Q3: Increasing values on y-axis associated with greater satiety/lower hunger sensations 
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5.4.5 Biochemical Indices  
Between meal differences in iAUC postprandial responses of glucose, insulin and 
various gut hormones are shown in Table 5.4. RMANOVA of insulin iAUC data 
(corrected for baseline) indicated a significant difference between responses over the 
4 h testing period (p=0.016). Post-hoc comparisons using Bonferroni adjustments 
showed differences of statistical significance between the red sorghum biscuit and 
the wheat control (p=0.032), with a greater insulin response after the red biscuit 
treatment.  
 
Similar analysis of iAUC responses for the incretin gut hormones, GIP and GLP-1, 
also showed significant differences over 4 h (p=0.031 and p=0.018 respectively), 
identified using RMANOVA. Post-hoc comparisons using Bonferroni adjustments 
showed significant differences in GIP responses for the overall 4 h period only 
between red sorghum and the wheat control (p=0.028) (Figure 5.5d). 
 
Although overall, between-treatment variations in GLP-1 responses were statistically 
different (p=0.018), Bonferroni post hoc comparisons only showed a trend towards a 
higher response after red sorghum biscuit intake compared to control (p=0.127), with 
no differences between the control and the other two sorghum varieties (p>0.05) 
(Figure 5.5c).  
 
Overall, differences in PYY iAUC responses between treatments during the 4 h 
testing period did not reach statistical significance (p=0.197), although the greatest 
release of PYY was after the consumption of red sorghum biscuit (Figure 5.5e). 
When gender-specific data was reviewed using Bonferroni adjustments, the PYY 
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concentrations were significantly higher in males after red sorghum intake compared 
to wheat (p=0.036). No significant between-treatment differences were found in 
glucose and ghrelin responses during the testing period (Figure 5.5a and 5.5f). 
RMANOVA of TAC iAUC did not identify differences between treatments (data not 
presented). No significant correlations between biochemical indices and flaked 
biscuit properties were identified (data not presented). 
 
5.4.6 Energy intake at ad-libitum lunch meal and for the rest of the day 
No significant differences in lunch energy intakes were detected (p=0.955) for the 
group or individual genders between test diets (data not presented). Similarly, when 
analysing total energy content from the rest of the day, or that intake combined with 
the ad-libitum buffet lunch, no significant differences were detected (data not 
presented). 
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Table 5.4 Postprandial responses of glucose, insulin and various gut hormones over 4h (expressed as mean net iAUC ±  standard deviation) 
  Wheat control White sorghum Red sorghum Brown sorghum p-value 
(RMANOVA) 
Glucose Δmmol/L.min 67.03 ± 84.03 47.17 ± 85.94 55.30 ± 90.28 47.68 ± 85.94 0.841 
Insulin Δ pg/ml.min 53524.93 ± 31550.26 52787.32 ± 29370.34 69282.49 ± 40375.97 64218.02 ± 35412.16 0.016* 
Ghrelin Δ pg/ml.min 2229.28 ± 4861.99 4690.35 ± 5561.33 4224.62 ± 4504.79 846.86 ± 7357.46 0.361 
GIP Δ pg/ml.min 7200.08 ± 3891.26  7892.01 ± 3796.86 10155.30 ± 3860.78 8853.11 ± 3722.51 0.031* 
GLP-1 Δ pM.min -30.69 ± 211.62  82.57 ± 124.70 104.19 ± 107.98 72.71 ± 113.74 0.018* 
PYY Δ pg/ml.min 1025.66 ± 4035.30  2489.46 ± 5093.02 3610.03 ± 2739.10 2387.58 ± 3043.18 0.197 
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Figure 5.5 Changes in mean plasma concentrations of  
(a) glucose, (b) insulin, (c) GLP-1 over time 
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Figure 5.5 Changes in mean plasma concentrations of  
(d) GIP, (e) PYY and (f) ghrelin over time 
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5.5 Discussion 
The VAS ratings for subjective appetite/hunger showed that sorghum flaked 
breakfast biscuits significantly decreased hunger and increased satiety sensations 
compared to wheat, and in particular the red sorghum showed variations in appetite 
hormones associated with satiety. Although this did not translate to differences in 
intake at the subsequent ad-libitum meal, the presence of wide standard deviations in 
the food intake data indicated there may have been a lack of power to detect 
differences at this level. Nevertheless, the subjective satiety results align with 
traditional experiences of some African communities who report feelings of satiety 
after eating sorghum foods
(23)
.  
 
Enhanced satiety has been attributed to SDS in sorghum grain and their role in 
lowering glycaemic index (GI) of sorghum foods
(169)
, particularly those made from 
polyphenol-rich sorghum varieties
(62)
. In our study, it seems SDS in isolation did not 
play a role in satiety-enhancing mechanisms between treatments, because SDS levels 
were high in all the flaked biscuits (Chapter 4)
(320)
. RS has been shown to increase 
satiety
(73)
, however in the present study the higher RS levels in the brown sorghum 
biscuits compared to wheat did not coincide with greater satiety responses post-
prandially. Hence, we must turn to other non-starch components present within the 
food matrix of the sorghum biscuits, such as dietary fibre and polyphenolic 
compounds concentrated in the bran component of the grain, to explain the observed 
differences in satiety effects in this study. 
 
In general, foods rich in fibre may promote satiety due to bulking
(283)
, relatively low 
energy density
(321)
 and increased viscosity of intestinal contents, delaying gastric 
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emptying and slowing absorption of macronutrients
(322)
. Fibre may also affect 
secretion of gut peptides, independent of glycaemic responses, which may act as 
satiety-enhancing factors
(321)
. The total dietary fibre in the sorghum biscuits was 
relatively high, ranging from 7.3-9.9%, and similar to the control food, wheat (9.2%). 
The soluble fibre, often associated with acute satiety, was highest in the wheat so it is 
also difficult to specifically ascribe effects on satiety from sorghum to the fibre in 
these food products. The absolute differences in total and soluble fibre between the 
wheat biscuit and the red biscuit, for example, was modest at 0.95 g and 0.14 g per 
serve, respectively. These doses of fibre are possibly too small to drive 
experimentally discernable differences in satiety outcomes. Future dose response 
studies, with specific manipulation of the fibre types (soluble and insoluble) found in 
sorghum, would be useful to more precisely investigate the role of fibre in satiety-
enhancing mechanisms of sorghum-based foods.  
 
Dietary polyphenols have also been implicated in appetite regulation mechanisms, 
mainly through the inhibition of α-amylase and α-glucosidase, the key enzymes 
responsible for digestion of dietary carbohydrates to glucose
(66)
. The sorghum 
biscuits were confirmed to have higher levels of total and free polyphenolic 
components compared to the wheat biscuit, however no correlations between 
polyphenolic contents and clinical measures were identified. It is interesting that the 
red sorghum showed the greatest alteration in appetite hormones, but this did not 
translate to differences in the subjective appetite responses in comparison to the other 
sorghums, only to the wheat control. This indicates that the specific combination of 
components in the red sorghum biscuit requires further investigation. Mechanisms 
invoked by polyphenolic components and dietary fibre, for example, may not be 
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discernable in appetitive and digestive responses over four hours
(323)
. Hence, review 
of hormones over greater periods of time in a study with chronic ingestion, and with 
different sorghums varieties, would be useful. This would also help to identify 
potential differences in hormone release for acute versus chronic sorghum 
consumption. 
 
Of note, plasma glucose responses were not altered. Despite similar glucose 
responses, satiety ratings differed significantly between sorghum and wheat biscuits, 
supporting the case for insulin (and not glucose) being a more likely mediator of 
satiety sensations in the postprandial period in normal weight individuals
(275; 281)
. 
Flint et al.
(281)
 showed in a meta-analysis that insulin response was significantly and 
inversely related to post-prandial hunger in normal-weight subjects, particularly 
decreasing ad libitum energy intake at a second meal. In the present study, 
consumption of red sorghum biscuits produced the highest insulin response, as well 
as the lowest ratings of hunger. Interestingly though, insulin was lower after the 
white sorghum biscuit compared to the red sorghum biscuit but resulted in the same 
subjective satiety ratings, so this again does not explain the entire mechanism.  
 
Postprandial GLP-1 and GIP responses were also higher for all sorghum biscuits 
compared to the wheat. GLP-1 in particular has an important role in attenuating post-
prandial glucose rises and is involved in the ileal break reflex, having an anorectic 
effect on appetite
(262)
, with some studies showing reduced food intake when it is 
peripherally administrated
(264)
. However, positive changes in GLP-1 and GIP in both 
sexes, and PYY levels in men, did not translate to decreased food intake at a second 
meal in the present study.   
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The key limitation in interpreting results from the present study was the inability to 
detect significant differences in food intake data at the ad libitum meal and for the 
rest of day. A larger sample size may have enabled these differences to emerge and 
to corroborate the significant subjective satiety ratings (VAS scores) and also the 
biochemical indices (insulin, GIP, GLP-1, PYY). Importantly, such a small breakfast 
as the test meal, followed by 4 hours of fasting, may have increased hunger to an 
extent that blunted any subtle differences in food intake. Factors that relate to non-
biological drivers of appetite and food intake such as environment, social and 
cognitive influences are also relevant to consider in the present study. For example, 
the amount of food offered in the ad-libitum lunch was deliberately in excess of 
participants’ usual intake and consisted of a variety of appealing food items that may 
have led to more food being eaten simply because the food was in abundance and 
pre-prepared. Differences in fibre content between biscuits, although modest, limited 
the ability of researchers to confidently ascribe effects to specific grain components 
such as polyphenolics. While controlling for fibre content may more clearly elucidate 
mechanisms in future work, the present study defined results within a standard serve 
size, relevant to consumers.  
 
 
5.6 Conclusions 
In conclusion, exploration of the use of sorghum whole grain as an ingredient in the 
formulation of foods targeted for weight control through appetite regulation is 
justified in future research. In the present study, whole grain sorghum-based flaked 
cereal biscuits (red-, white- and brown- grained) were formulated and were shown to 
increase short-term subjective satiety ratings compared to a wheat biscuit control. 
Differences in polyphenolic contents between the red, white and brown sorghum 
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flaked biscuits appear to play a role in satiety-enhancing mechanisms, although their 
precise actions are not clear. Actions of SDS and dietary fibre may contribute to 
these effects, reflecting the benefits of the whole cereal food delivering synergistic 
effects of individual grain components into the body. Additional mechanisms 
involving interactions between insulin and the incretin hormones, GLP-1 and GIP, as 
well as PYY, may be contributory factors to enhanced satiety effects of sorghum 
flaked biscuits. Choice of a test food based on red sorghum is justifiable in 
randomised controlled trials that aim to directly examine effects of sorghum intake 
on chronic disease biomarkers or health outcomes. Chapter 6 describes a 3-month 
intervention trial examining these outcomes.  
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CHAPTER 6: 
Examining the longer-term effects of chronic sorghum 
consumption: a randomised controlled trial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The majority of this chapter is the substantive content of the article: 
Stefoska-Needham, A., Beck, E.J., Johnson, S.K., Batterham, M., Grant, R., Ashton, R.,
 
Tapsell, L.C. 
(2016)
 
A diet enriched with red sorghum flaked biscuits, compared to a diet containing white wheat 
flaked biscuits, does not enhance the effectiveness of an energy-restricted meal plan in overweight 
and mildly obese adults. Journal of the American College of Nutrition. (Accepted for publication) 
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6.1 Introduction  
The acute satiety study described in Chapter 5 showed that flaked biscuits made from 
red sorghum grain, a variety rich in anthocyanin flavonoids, elicited the greatest 
overall acute satiety-enhancing responses. Neither the dietary fibre nor the starch 
contents of the biscuits could explain the responses, but overall differences in 
polyphenol contents, or a synergy between polyphenols, dietary fibre and SDS, may 
have played a role. While these initial acute satiety results were promising, longer-
term effects on chronic disease biomarkers or health outcomes from a sorghum-
enriched diet required investigation using a “gold-standard” RCT design. To 
maintain the integrity of the methodological framework used to explore the key 
hypothesis, the equivalent flaked breakfast biscuits were used in this RCT, with the 
obvious choice of red sorghum as the treatment on account of its superior acute 
satiety effects. The RCT results are important to provide the level of evidence 
necessary to guide clinical practice, inform science-based food messages (such as 
those found in Dietary Guidelines and health claims) and to support commercial 
investments by food industry and hence product development. 
 
6.2 Study Aims and Hypothesis 
This study was a 3 month randomised controlled dietary intervention trial, aiming to 
test effects of whole grain red sorghum included in an energy-restricted meal plan. 
The primary outcome was difference in weight loss between the control and 
intervention groups. Secondary outcomes included a variety of biochemical measures 
linked with change in body weight and disease markers, such as glucose, insulin, 
cholesterol and various anti-inflammatory/oxidative stress markers, as well as 
subjective satiety measures. Overall, overweight individuals following a 
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nutritionally-balanced, energy-restricted diet including sorghum whole grain foods 
would be expected to lose more weight than if they followed the same diet without 
sorghum-based foods, driven by reduced energy intake as a result of satiety actions 
of sorghum grain. Specifically, it was hypothesised that: (1) subjects receiving foods 
made from whole grain sorghum would lose more weight than the subjects receiving 
control foods (wheat-based); (2) weight loss would be accompanied by changes in 
metabolic disease risk factors, which may be anticipated given the higher 
polyphenolic content of sorghum. 
 
6.3 Materials and Methods 
6.3.1 Subjects and Recruitment 
This study was a 3 month, double-blinded, parallel, randomised controlled trial with 
a total of 60 subjects, 46 females and 14 males. There were two arms to the study: 
sorghum intervention and wheat control, with both groups receiving advice on an 
energy-restricted diet from an Accredited Practising Dietitian. All subjects were 
provided with cereal products, in the form of flaked breakfast biscuits, to include in 
their diets (Figure 6.1). The target sample size of 30 subjects per group was based on 
previous human intervention studies incorporating cereal/high fibre foods into hypo-
caloric diets
(324-326)
. Difference in weight loss between groups was used as the 
primary outcome measure to establish power for the study. To observe a two-
kilogram weight difference between groups, at a power of 80% and to be 
significantly different at level of α 0.05, 26 subjects would be required per group. 
Therefore, setting the recruitment target at 30 subjects per group would account for 
an approximate dropout rate of 15%.  
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Figure 6.1 Overview of protocol for RCT
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Eligible subjects (aged 18–65 years, BMI range from 25–35 kg/m
2
) were sought 
through paid media advertisements and institutional emails. Subjects with serious 
illness including diabetes, with known food allergies, and those taking appetite-
altering medications were excluded from the study. Restrictive eaters (identified 
using the TFEQ described in Chapter 3) and subjects who were smokers, were 
pregnant, breastfeeding and post-menopausal were also excluded. All procedures 
were approved by the University of Wollongong, Human Research Ethics 
Committee (approval number HE14/100). The trial was also prospectively registered 
with the Australian New Zealand Clinical Trials Registry (#12614000640606). 
Figure 6.1 provides an overview of the study protocol. 
 
A total of 115 potential subjects expressed interest in the study of which 103 were 
contacted to undergo further preliminary screening via telephone (Figure 6.2). From 
this group, 80 people were eligible for further assessment in the form of a detailed 
screening questionnaire. This led to sixty-one people attending an interview to 
determine final eligibility with sixty subjects randomised into the two study groups 
by a researcher independent of the subject interface, stratified by sex, block 
randomised using STATA Version 12 and using the RALLOC command (StataCorp, 
2011, College Station, Texas, USA). The researcher/dietitian (myself) and all 
subjects at the subject interface were blinded to the randomisation. The subjects 
attended the clinical research trials unit (CRTU) at the University of Wollongong, 
Australia, on five occasions. The first visit included collection of background dietary 
data using a validated diet history interview
(327)
 and instruction on the completion of 
a 3-day weighed food record. The subsequent visit included collection of fasting 
blood samples (baseline) and dietary education. Two follow-up dietary visits 
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occurred at the 1-month and 2-month time-points, with collection of fasting blood 
samples at 3 months (final visit). All the subjects had their height, weight, percentage 
body fat (Tanita Scales Model no.TBF-662) and waist circumference recorded at 
each visit to the CRTU. Visual analogue scales (VAS) related to appetite
(215) 
and 
food records were all completed at baseline, half-way through the study (at the 6-
week point) and within the final week of the study. The Baecke Physical Activity 
Questionnaire
(328)
 was completed at baseline and at the completion of the study. 
 
 
Figure 6.2 Flow of participants through the trial 
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For the appetite VAS, the subjects recorded their appetite responses on individual 
forms at six different time- points throughout the day: immediately before each of 
the three main meals and 2 h after each of these meals but before their subsequent 
snack. The VAS consisted of a 100 mm horizontal line, anchored at each end with 
opposing responses (for example, "not at all hungry" and "never been more hungry"). 
The study participants were instructed to place a vertical mark on the line to 
correspond with their feelings and the subjective sensation was quantified by 
measuring the distance in millimeters from the left end of the line to the mark. All 
nutritional analysis was performed using FoodWorks 2007, version 5 (Xyris 
Software, Brisbane, QLD, Australia) with nutrient contents of study foods added as 
required. 
 
 
6.3.2 Dietary Intervention 
For each subject, a basal metabolic energy requirement was calculated using the 
Mifflin-St Jeor equation where a BMI equal to 25 kg/m
2
 was included
(329)
. A low 
activity factor (1.3) was chosen to estimate energy requirements (given the 
overweight sample with limited usual physical activity) and then this level was 
reduced by 20% to drive weight loss. Intervention diets were designed to control for 
all macronutrients with the only variation being the trial cereal products given, as 
described in Table 6.1. The sorghum intervention group received sorghum-based 
cereal biscuits and the wheat control group received wheat-based cereal biscuits, 
matched by serve size (3 biscuits) and therefore overall mass (45 g per day). 
CHAPTER 6:  Examining the longer-term effects of chronic sorghum consumption: a RCT 
 138 
 
 
 
Table 6.1 Dietary prescription (totaling 5, 500kJ) for a typical participant 
 
Food Group Portion or serve size Number of serves / day 
 
Control or intervention products 
 
1 flaked cereal biscuit equivalent to 15g 
 
3 (2 biscuits at breakfast and 1 at afternoon tea) 
 
Breads/cereal/starchy vegetables 
 
1 slice bread or 1/2 cup cooked pasta or 1/3 cup 
cooked rice or 1 small potato  
4 
 
 
Other vegetables 1/2 cup cooked or 1 cup raw 2.5 cooked or 5 raw 
 
Fruit 
 
 
1 piece fresh or 3/4 cup canned and drained 
 
2 
 
Milk / alternatives 
 
 
150ml light or 200ml skim, 100g low-fat yoghurt 
 
2-3 
 
 
Meat / alternatives 
 
30g meat or 50g fish or 20g low fat cheese  
 
3-4 
 
Fats 
 
1 tsp oil or margarine or 1 tbsp avocado 
 
3-4 
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6.3.3 Test food products 
Test foods were manufactured in the form of RTE flaked cereal biscuits, as for the 
acute test study (method detailed in Chapter 4). The sorghum flaked cereal biscuits 
were processed from the same red sorghum grain, variety Alpha, grown and supplied 
by Lochabar Enterprises Pty Ltd (Tara, QLD, Australia). The wheat flaked cereal 
biscuits were made from non-cultivar-specific Australian Prime White (APW) wheat 
(grown in central New South Wales, Australia) and was again supplied by 
Sanitarium Health and Wellbeing (Cooranbong, NSW, Australia). The subjects were 
instructed to eat two cereal biscuits (30g) at breakfast and one biscuit (15g) at 
afternoon tea daily. The proximate, dietary fibre and energy content (on as is basis 
per 100g) (Table 6.2), polyphenolic (PP) content (mg GAE/g as is) (Table 6.3) and 
starch properties (per 100g as is) (Table 6.4) between the sorghum and wheat 
biscuits were reported and were analysed according to the methods described in 
Chapter 4.  
 
Analyses identified modest differences between the control and red sorghum biscuits 
with respect to energy, macronutrients and dietary fibre (Table 6.2). Notably, both 
total and soluble fibre levels were higher in the wheat control compared to the 
sorghum biscuits, however the actual difference between biscuits was modest at 0.86 
g and 0.13 g per 45 g test serve, respectively. Individual macronutrient levels were 
not controlled for because this study was designed to test whole foods as consumed 
in real-life settings, hence the serve size rather than specific components were 
matched. As expected, red sorghum biscuits had higher PP levels compared to the 
control (Table 6.3), most likely due to high anthocyanin contents characteristic of 
this sorghum variety
(330)
. Assessment of starch properties showed no difference in the 
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amount of total starch, rapidly digestible starch (RDS) and slowly SDS between 
biscuits, and in particular the levels of SDS in each serve classified as high (Table 
6.4).  
 
 
Table 6.2 Proximate and dietary fibre composition and energy content of flaked 
breakfast cereals
1,2,3,4,5 
 
1Means (n=2) ± standard deviation 
2Values within a column with the same superscript letter denotes no significant difference (p>0.05) 
3Statistical comparison not possible as some replicates identical 
4Analysis provided by manufacturer – standard deviations not available and statistical comparison not possible 
5Available carbohydrate calculated by difference 
 
 
 
 
Table 6.3 Free, bound and total phenolic content and antioxidant capacity of flaked 
breakfast cereals
1,2 
 
Flaked 
breakfast 
cereal type 
Free PP 
(mg GAE/g as is) 
Bound PP 
(mg GAE/g as is) 
Total PP 
(mg GAE/g as is) 
Free AC 
(µmolTE/g as is) 
Bound AC 
(µmolTE/g as is) 
Total 
antioxidant 
capacity 
(µmolTE/g as is) 
Wheat 
(control) 
0.71±0.01a 0.67±0.22a 1.37±0.21a 2.64±0.01a 2.67±0.01a 5.31±0.01a 
Sorghum (red) 1.27±0.01b 1.00±0.11a 2.27±0.12b 11.25±0.57b 9.16±0.62b 20.40±1.18b 
1Means (n=2) ± standard deviation 
2Values within a column with the same superscript letter denotes no significant difference (p>0.05) 
PP, polyphenolic; AC, antioxidant capacity; GAE, gallic acid equivalents; TE, Trolox equivalents 
 
 
  
Flaked 
breakfast 
cereal type 
Moisture 
(g/100g as 
is) 
Protein  
(g/100g as 
is) 
Fat  
(g/100g as is) 
Ash3 
(g/100g as 
is) 
Total 
dietary 
fibre 
(g/100g as is) 
Soluble 
Fibre4 
(g/100g as is) 
Total available 
carbohydrates5  
(g/100g as is) 
Energy 
content 
(kJ/100g 
as is) 
Wheat 
(control) 
6.6±0.0 13.7±0.2b 1.7±0.0a 1.6±0.0 9.6±0.1b 4,0 66.9±0.1a 1508±1a 
Sorghum 
(red) 
6.6±0.0 9.4±0.1a 2.9±0.1b 1.6±0.0 7.7±0.0a 1.5 71.9±0.1b 1550±0b 
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Table 6.4 Starch properties of flaked breakfast cereals
1,2,3
 
 
Flaked breakfast 
cereal type 
Total starch3 
(g/100g as is) 
Rapidly digested starch 
(g/100g dry starch) 
Slowly digested starch 
(g/100g dry starch) 
Resistant starch 
(g/100g dry starch) 
Wheat control 54.2 ± 0.2a 31.9±1.6a 47.9±4.2a 20.2±3.9a 
Sorghum (red) 57.7 ± 2.3a 31.9±4.2a 46.9±7.7a 21.2±3.6a 
1Means (n=2) ± standard deviation 
2Values within a column with the same superscript letter denotes no significant difference (p>0.05) 
3Total starch was determined using a Megazyme K-TSTA 09/14 Total Starch Kit (Bray, Ireland) which excludes low molecular 
weight starch hydrolysis/breakdown products that may have resulted during the manufacturing process  
 
 
 
6.3.4 Clinical Indices 
Fasting blood samples were collected at 0 and 3 months into clot gel tubes, 
centrifuged and stored at -80° Celsius until analysis could be completed according to 
standard protocols for glucose, insulin, total cholesterol, high-density lipoprotein 
(HDL-c), low-density lipoprotein (LDL-c), triacylglycerides (TAG) and high-
sensitivity c-reactive peptide (hsCRP) at Sydney Adventist Hospital Pathology 
(Wahroonga, NSW, Australia). Glycosylated haemoglobin (HbA1c) was performed 
by Southern Pathology (Wollongong, NSW, Australia) after samples were collected 
into tubes containing potassium EDTA and stored at 4° Celsius until analysis was 
conducted. Additional markers for inflammation and oxidative stress, Interleukin 1 
(IL1), Interleukin 6 (IL-6), Interleukin 8 (IL-8), hydroperoxide (HPX), tumour 
necrosis factor alpha (TNFα) and total antioxidant capacity (TAC) were performed 
by the Australasian Research Institute, (Sydney Adventist Hospital, Wahroonga, 
NSW, Australia) according to established protocols. 
 
6.3.5 Statistical Analysis 
Data for all anthropometry, blood analysis, VAS measurements and dietary intake 
were entered into SPSS for windows, version 21.0 (IBM SPSS 21.0, IBM 
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Corporation, Armonk, NY, USA). Repeated measures ANOVA (RMANOVA) using 
the general linear model with group (control, sorghum) as the between subjects 
factor, was used to identify primary changes in each parameter over time and also 
differences between the groups. Post hoc analysis using Bonferroni adjustments was 
reviewed to detect specific differences between the control and intervention groups. 
Regression analysis was used to identify correlations between group anthropometric 
and biochemical indices.  
 
 
6.6 Results 
6.6.1 Baseline Data 
There were twenty-six subjects in the sorghum intervention group (after four subjects 
withdrew) and thirty subjects in the control group. Reasons provided for their 
withdrawal were: relocation, commencement of a contraindicated medication and the 
lack of motivation to adhere to an energy-restricted meal plan. For the final analysis, 
fifty-six subjects were included, although numbers in each calculation varied because 
some subjects did not complete all forms (food records or VAS). There were no 
significant differences between group anthropometric, dietary and metabolic 
measures at baseline (Table 6.5), except for a slightly lower protein intake in the 
sorghum group. Baseline energy intakes seemed low, suggesting under-reporting by 
some subjects. Consequently at subsequent study visits, dietitians specifically 
addressed potential under-reporting with subjects when reviewing their individual 
food records. The subjects were mildly obese but overall they did not exhibit 
impaired glucose tolerance or insulin resistance
(15)
, nor were they 
hyperlipidaemic
(331)
 or hypertensive
(332)
.  
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Table 6.5 Baseline characteristics of study subjects (means and standard deviations) 
VARIABLE 
 CONTROL  SORGHUM  DIFFERENCE 
 
Mean SD 
 
Mean SD 
 
p-value 
Age (years)  48.6 11.4  48.1 10.3  0.859 
Weight (kg)  86.1 9.8  87.1 12.9  0.732 
BMI (kg/m2)  31.6 2.8 
 
31.2 3.5 
 
0.632 
Waist (cm)  105.3 9.5  102.5 12.0  0.311 
Fat (%)  40.3 5.8  38.7 6.3  0.309 
Fasting Blood glucose (mmol/L)  5.2 0.4  5.3 0.6  0.297 
Fasting Insulin (mIU/L)  12.5 5.7  12.3 6.9  0.893 
HbA1c (%)  5.3 0.3  5.2 0.4  0.554 
Total Cholesterol (mmol/L)  5.6 1.0  5.3 1.0  0.173 
LDL-c (mmol/L)  3.5 0.9  3.2 0.8  0.193 
HDL-c (mmol/L)  1.4 0.4  1.5 0.3  0.533 
TAG (mmol/L)  1.6 0.8  1.3 0.7  0.155 
IL1 (pg/ml)  0.9 1.0  0.9 0.9  0.841 
Il-6 (pg/ml)  1.5 1.6  0.8 0.7  0.052 
Il-8 (pg/ml)  6.2 2.8  5.2 1.8  0.096 
TNFα (pg/ml)  2.9 1.3  3.2 1.2  0.483 
hsCRP (mg/L)  2.7 2.6  2.4 2.1  0.662 
TAC (mmol/L Trolox)  1.2 0.2  1.3 0.2  0.476 
HPX (mmol/L H2O2)  2.5 0.5  2.4 0.6  0.495 
Diastolic BP (mm Hg)  82.3 9.6  80.4 7.4  0.407 
Systolic BP (mm Hg)  126.2 16.9  122.3 14.4  0.349 
 
6.6.2 Dietary Intervention 
The flaked cereal biscuits were consumed by subjects with no adverse reactions and 
dietary compliance was relatively high at approximately 85%, as determined by a 
manual count of uneaten biscuits upon study completion. Food record analysis 
indicated no significant difference between the groups for protein, carbohydrate and 
fat intakes at any of the time-points once the study commenced. Review of the 
overall dietary composition of baseline diets compared with the 3 month end-point 
showed a significant decrease in percentage energy from fat (p<0.001), as well as 
saturated fat (p<0.001). Percentage energy from protein and carbohydrate was not 
altered over time (Table 6.6).  
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Compliance with a weight reduction meal plan was identified by overall weight loss 
and energy reduction reported in the food records. Total energy intake was 
significantly lower at the mid-point (mean 7136kJ (SD 2164 kJ)) and the end-point 
(mean 6880 (SD 1815) kJ) (p<0.001) of the trial compared with the baseline (mean 
8742 (SD 2656) kJ), using RMANOVA with treatment as the between-group effect 
and time as the within-subject variant. The lack of an interaction effect over time 
(p=0.671) suggests that there were no differences between groups in energy intake 
over time. There were no significant differences in activity scores between the 
groups at any time-point, indicating that changes in physical activity were not a 
factor in influencing overall results.  
 
 
6.6.3 Clinical Indices 
The majority of the anthropometric and biochemical indices changed over 3 months; 
however, there were no significant differences between the groups for any of the 
measured clinical parameters over this time (Table 6.7). The average weight loss for 
the study sample was significant at 5.3 kg (p<0·001) (or 6.1% of baseline body 
weight) over the 3 month intervention. The mean weight changes ranged from a 2.1 
kg gain to a 14.7 kg loss, however weight loss was not significantly different 
between the groups (p=0·369). Waist measurements and percentage body fat 
decreased significantly compared to baseline (p<0.001). Regression analysis 
indicated that weight loss significantly predicted waist change (p<0·001) and 
percentage body fat (p<0·001). As expected, these predictions were strong (R
2 
0.389 
and R
2
 0.615). Fasting blood glucose (p<0·001) and fasting insulin levels decreased 
over 3 months (p<0·001) but HbA1c did not change. No between group differences
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Table 6.6 Energy and macronutrient intakes reported by subjects at baseline, mid-point and 3 months, with p-values for repeated measures 
ANOVA between control and sorghum groups (mean values and standard deviations) 
 
 
BASELINE  MID-POINT 3 MONTHS  P-VALUES 
 
CONTROL SORGHUM  CONTROL SORGHUM  CONTROL SORGHUM  
 
VARIABLE Mean SD Mean SD  Mean SD Mean SD  Mean SD Mean SD  Group Time Interaction 
Energy (kJ) 9274.0 2696.2 7897.3 2429.8  6993.0 2244.8 7363.9 2076.2  6752.8 2090.6 7082.0 1297.1  0.110 <0.001* 0.671 
Protein (g) 106.6 33.2 89.5 30.8  88.9 35.0 95.4 32.6  81.7 26.2 89.6 24.7  0.049* 0.008* 0.909 
% E Protein 20.0 5.2 19.5 4.1  22.4 6.5 21.9 4.0  20.7 3.4 21.5 4.1  0.56 0.059 
 
CHO (g) 234.6 84.5 190.6 60.7  187.8 74.4 181.4 43.5  177.9 56.8 183.2 40.9  0.144 0.040* 0.306 
% E CHO 39.9 5.1 39.1 7.09  42.6 8.3 40.0 5.2  42.6 6.3 41.5 6.0  0.811 0.161 
 
Total Fat (g) 85.1 25.7 77.2 31.5  54.9 23.5 61.9 26.0  57.1 23.8 57.6 15.3  <0.001* 0.381 0.979 
% E Total Fat 34.0 5.2 35.5 5.3  28.5 5.4 30.4 4.9  30.8 7.0 30.1 5.2  0.435 <0.001* 
 
SFA (g) 34.3 12.4 29.8 14.3  18.4 7.4 22.9 10.9  20.3 8.6 20.4 5.8  0.161 <0.001* 0.976 
% E SFA 13.7 3.2 13.6 3.3  9.7 2.0 11.3 2.8  11.0 3.0 10.7 2.2  0.090 <0.001* 
 
PUFA (g) 12.7 5.3 12.9 6.6  9.7 5.8 9.3 5.0  9.1 4.7 9.5 4.2  0.829 0.003* 0.946 
% E PUFA 5.1 1.7 6.1 2.8  4.9 2.0 4.5 1.5  4.9 1.9 4.9 1.6  0.234 0.081 
 
MUFA (g) 31.6 10.8 28.8 14.2  20.3 10.5 23.0 11.0  21.3 6.5 21.5 6.5  0.486 <0.001* 0.970 
% E MUFA 12.6 2.8 13.1 3.2  10.4 3.2 11.2 2.6  11.3 4.0 11.3 2.8  0.789 0.005* 
 
Total Fibre (g) 26.3 9.0 25.6 9.5  24.4 9.1 24.9 7.2  24.1 9.2 27.2 10.2  0.432 0.626 0.660 
E – energy; CHO – carbohydrate. 
* Significant values (p<0.05) were measured using repeated measures ANOVA. 
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Table 6.7 Changes in anthropometric and biochemical indices over time between control and sorghum groups (means and standard deviations) 
 
 
ALL GROUPS  CONTROL  SORGHUM  
P-VALUES 
CLINICAL Baseline data Mean change  Baseline data Mean change  Baseline data Mean change  
INDICES Mean  SD Mean  SD   Mean  SD Mean  SD  Mean  SD Mean SD   Group Time Interaction 
Weight (kg) 86.6  11.6 -5.3 3.7  86.1  9.8 -5.4 3.6  87.1  13.6 -5.2 4.0  0.369 <0.001* 0.772 
BMI (kg/m2) 31.3  3.1 -1.9 1.4  31.6  2.6 -1.9 1.3  31.1  3.4 -1.9 1.4  0.754 <0.001* 0.601 
Waist (cm) 104.2  10.9 -10.9 5.4  105.3  9.5 -11.8 5.6  102.9  12.5 -9.9 5.2  0.209 <0.001* 0.594 
Body fat (%) 39.4  6.0 -2.1 2.3  40.3  5.8 -2.1 2.3  38.3  6.9 -2.3 2.5  0.876 <0.001* 0.194 
Glucose (mmol/L) 5.26  0.50 -0.13 0.4  5.18  0.36 -0.11 0.3  5.35  0.62 -0.15 0.4  0.705 0.009* 0.162 
Insulin (mIU/L) 12.32  5.78 -2.86 3.3  12.55  5.8 -3.17 3.0  12.06  5.86 -2.53 3.7  0.481 0.000* 0.905 
HbA1c (mmol/L) 33.95  4.2 0.10 3.1  33.97  3.89 0.20 3.2  33.92  4.60 0.00 2.9  0.843 0.843 0.896 
HbA1c (%) 5.26  0.37 0.00 0.3  5.26  0.34 0.00 0.3  5.25  0.41 0.00 0.2  0.926 0.926 0.912 
Total cholesterol 
(mmol/L) 
5.47  0.99 -0.40 0.7 
 
5.64 0.98 -0.50 0.7 
 
5.28  0.99 -0.30 0.6 
 
0.139 <0.001* 0.384 
HDL-c (mmol/L) 1.42  0.38 -0.07 0.2  1.40  0.40 -0.10 0.2  1.45  0.37 -0.10 0.2  0.674 0.008* 0.454 
LDL-c (mmol/L) 3.39  0.85 -0.15 0.5  3.52  0.90 -0.20 0.6  3.24  0.79 -0.10 0.4  0.225 0.05 0.379 
TAG (mmol/L) 1.46  0.76 -0.40 0.6  1.59 0.81 -0.50 0.7  1.30  0.67 -0.30 0.5  0.393 <0.001* 0.174 
IL1β(pg/ml) 0.93  0.97 -0.15 0.4  0.92 1.03 -0.10 0.4  0.94  0.92 -0.20 0.3  0.565 0.004* 0.943 
Il-6 (pg/ml) 1.19  1.29 -0.22 0.3  1.48  1.59 -0.20 0.4  0.86  0.73 -0.20 0.3  0.752 <0.001* 0.071 
IL-8 (pg/ml) 5.73  2.46 -0.49 1.1  6.20  2.84 -0.40 1.2  5.19  1.86 -0.60 0.9  0.621 0.001* 0.075 
hsCRP (mg/L) 2.52  2.41 -0.28 1.8  2.65  2.64 -0.30 2.1  2.37  2.15 -0.20 1.3  0.059 0.207 0.728 
TNFα (pg/ml) 3.06  1.23 -0.76 0.8  2.95  1.27 -0.60 0.7  3.19  1.18 -0.90 0.8  0.110 <0.001* 0.748 
HPX (mmol/L H2O2) 86.6  11.6 -5.3 3.7 
 86.1  9.8 -5.4 3.6  87.1  13.6 -5.2 4.0  0.296 0.174 0.150 
TAC (mmol/L Trolox) 1.26  0.18 -0.06 0.1  1.24  0.15 -0.10 0.1  1.29  0.20 -0.10 0.1  0.759 <0.001* 0.247 
c – cholesterol; TAG –  triacylglycerides; HbA1c – glycosylated haemoglobin; IL1 – Interleukin 1; Il-6 – Interleukin 6; IL-8 – Interleukin 8; hsCRP – high sensitivity c-reactive protein; TNFα – tumour necrosis 
factor alpha; TAC – total antioxidant capacity.                                                      * Significant values were measured using repeated measures ANOVA
CHAPTER 6:  Examining the longer-term effects of chronic sorghum consumption: a RCT 
 147 
were identified for any of these clinical indices (Table 6.7). The inflammatory 
cytokines IL1β, Il-6 and Il-8, decreased significantly compared to baseline 
(p<0.001), as did TNFα (p<0·001). TAC levels also decreased significantly 
compared to baseline (p<0.001). There were no significant changes over time in 
hsCRP and HPX levels. The reduction in total cholesterol was not significantly 
different between the groups, with mean decreases of 0.3 mmol/L (SD 0.6 mmol/L) 
for the sorghum group and 0.5 mmol/L (SD 0.7 mmol/L) for the control. There was a 
significant decrease in total cholesterol over 3 months for all subjects (p<0.001), as 
well as significant decreases in HDL-c (p<0.001), LDL-c (p<0.05) and TAG 
(p<0.001) levels over this time.  
 
6.6.4 Subjective Satiety 
VAS results were reviewed for the six daily time-points at 0, 6 and 12 weeks to 
compare any differences that may have existed between the control and test groups 
(RMANOVA). No significant differences were identified, demonstrating that all 
individuals reported similar feelings of hunger/fullness at the same test points (data 
not shown). 
 
6.7 Discussion 
As a consequence of this dietary intervention, a reduction in energy intake was 
achieved in the overweight study sample. The reduced energy intake in both groups 
was an effective driver of weight loss over the 3 month period. Regardless of the diet 
subjects followed, they lost weight and experienced beneficial changes in waist 
circumference, fasting glucose, fasting insulin, lipids and inflammatory markers. If 
maintained over time, the mean weight loss of 6.1% and reduced waist 
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circumference (10.9 cm (SD 5.4 cm)) for the study sample, could decrease risk of 
insulin resistance, impaired glucose tolerance and dyslipidaemias
(333)
, as well as 
lower the incidence of developing type 2 diabetes
(334)
.  
 
The present study failed to confirm differentiating effects of sorghum grain 
consumption on weight loss in an energy-restricted diet over 12 weeks where only 
the test foods were different. This design is necessary, however, for rigorous testing 
of individual foods where other dietary confounders are cancelled out.  Despite the 
previous acute satiety study showing promising results (Chapter 5)
(335)
, the present 
study showed that differences in meal satiety do not necessarily translate to weight 
reduction differences in the long term. Bearing in mind that the energy restriction of 
the total diet was the same for both groups, subjects receiving foods made from 
sorghum included in the dietary advice, did not lose more weight than the subjects 
receiving control foods and similar overall dietary advice. Thus, the meal-based 
satiety mechanisms postulated to involve sorghum polyphenols did not have an 
enhancing effect on body weight changes over 3 months, nor on overall reduction in 
metabolic disease risk factors.  
 
Previous research conducted by our group has also shown that where both the 
control and intervention diets focus on healthy eating patterns and control for energy 
intakes, a difference in weight loss is not seen
(315)
. Ostensibly this is because weight 
loss is dependent on control of energy intake and hence the percentage energy 
reduction in both arms was matched. Typically also, no differences are seen when 
structured dietary advice to both the control and intervention groups is provided
(336; 
337)
, as was the case in the present study. However, differences in other risk factor 
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variables (affected by dietary attributes other than total energy, such as dietary 
fat
(338; 339)
) have been observed. Given our assumption that a higher polyphenol 
intake from sorghum may have had similar effects, the study design was appropriate, 
but we may now need to look to other potential synergistic components of the diet, 
or a higher dose to pursue our hypothesis further.  
 
The lack of differences between groups in changes in lipid levels was not consistent 
with another study investigating the effects of consuming sorghum foods on serum 
lipid levels
(171)
. In this study, a significant reduction (p<0.05) in total cholesterol, 
TAG and HDL-c was observed in 10 males and 6 females after daily consumption of 
100 g of unrefined sorghum in the form of pancakes over 3 weeks. However, this 
study used a small sample size (with low statistical power), reducing the likelihood 
that a statistically significant result reflects a true effect. Further, the content of 
subjects’ background diets was not adequately reported, making assessment of 
dietary confounders and final conclusions difficult. Overall, these results are 
ambiguous hence more human evidence for lipid effects in relation to sorghum 
consumption is warranted, and may be more relevant where weight loss inducing 
diets are not prescribed so as to discern lipid lowering effects independent of weight 
loss. 
 
A further strength of the present study was that the polyphenolic composition of the 
test foods was profiled. From a physiological perspective, consideration was given to 
the results of a recent randomised, controlled, crossover human study, involving 22 
healthy adults, assessing the acute effects of consuming pasta containing red or white 
whole grain sorghum flour (30% sorghum, 70% semolina) on plasma total 
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polyphenols, TAC and oxidative stress markers compared to a wheat control made 
from 100% semolina
(180)
. Pasta containing red whole grain sorghum flour (RSP), but 
not white sorghum flour, enhanced antioxidant status and improved markers of 
oxidative stress in healthy subjects (p<0.001). The increase in plasma polyphenols by 
the RSP meal was attributed to its higher content of polyphenols. In the present 
study, despite significant differences in the levels of polyphenols and TAC between 
the test food products, differences in the levels of inflammatory biomarkers and 
plasma TAC between the sorghum intervention and wheat control groups were not 
detectable (Table 6.3). The reasons are not clear as to why the TAC levels 
unexpectedly decreased over time even though the inflammatory markers showed 
significant improvement. While standard protocols were followed and precautions 
taken, possible oxidation of blood samples during preparation or storage, cannot be 
ruled out
(302)
. Furthermore it may be that the effects of ingesting sorghum grain 
components are short-lived and subtle, hence the positive outcomes observed in 
acute studies may not translate to whole of diet studies conducted over a number of 
months. 
 
The lack of differences in subjective satiety scores was perhaps expected. VAS are 
validated for use in highly controlled situations
(217)
, such as acute meal test studies. 
The inclusion of satiety-related VAS was justified to enable a possible link between 
reported ratings in this study and those of the previous acute satiety study
(335)
 
(Chapter 5), though realistically, the small differences from month to month in the 
present study were unlikely to be captured accurately by the subjects using the VAS 
tool. An alternative appetite questionnaire, validated for use in free-living 
conditions
(340)
, may have been more informative. 
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Separating out the effects of individual components within a food, in this case the 
flaked cereal biscuit matrix, is difficult within a human intervention trial. To this end, 
a key strength of the present study is the comprehensive characterisation of the 
physicochemical properties of the test foods used in the intervention diets, enabling 
the link between clinical effects and components within the food. In the previous 
acute study
(335)
, determination of polyphenolic compounds, dietary fibre, profiling of 
starch contents and proximate analyses of the RTE sorghum flaked biscuits, guided 
the hypothesis that the polyphenolic compounds in particular played a role in 
observed acute satiety effects that would drive weight loss in the present RCT. 
Overall, the lack of positive results should not infer that sorghum is not a beneficial 
ingredient in cereal foods, as subjects consumed the foods successfully, lost weight, 
decreased their serum cholesterol and showed other positive outcomes related to 
metabolic health. The whole grain sorghum product was as effective as the whole 
grain wheat product in the present study. Sorghum, like other whole grain cereals, 
delivers beneficial, health-promoting components and properties (such as 
antioxidants, dietary fibre, SDS and valuable energy) when it is consumed as part of 
a healthy food within a healthy diet. 
 
As with most human dietary intervention trials, there are a number of confounding 
variables in the present study that require some consideration. Firstly, the trial was 
only a 3 month intervention and this period of time may not be long enough to detect 
differences between the subjects’ compliance with an energy restricted diet and the 
actual effects of the dietary intervention. It has been shown that subjects who 
reported greater compliance with a weight loss protocol lost more weight regardless 
of the dietary intervention
(341)
, suggesting that strategies to increase adherence may 
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be more important than the actual composition of the diet. Validated “measures of 
adherence” to enhance compliance to dietary advice in the context of clinical 
interventions would therefore be useful in future studies
(342)
. 
 
Secondly, the present study included similar test food products for both the 
intervention group and the control group, which only varied in the source of grain 
(sorghum versus wheat). The effect of individual grain components within the cereal 
biscuits, even if positive, are likely to be relatively small and hence showing a 
statistical difference between the groups would be difficult, especially over 3 
months. Significant differences between the treatment and control groups may have 
been detected if the whole wheat control biscuits were lower in dietary fibre and 
higher in RDS compared to the sorghum biscuits. Further, instructing subjects to eat 
food products at both breakfast and at afternoon tea as part of the compliance criteria 
for the dietary intervention protocols, may have actually increased overall energy 
consumption at times when the subjects might otherwise have chosen not to eat or to 
eat less in either arm of the study.  
 
Thirdly, it is difficult to control the dietary intake of human subjects. Although food 
records and discussions with subjects during study interviews indicated high 
compliance with consumption of test products, the subjects were less compliant with 
the energy restriction as evidenced by the lower-than-predicted weight loss. All four 
subjects that withdrew from the study were from the intervention group, which could 
infer the greatest difficulty with compliance, but this is less likely given the reasons 
provided for their withdrawal. Lastly, large standard deviations existed within all the 
analysed datasets, limiting the ability to detect significant results. The large standard 
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deviations indicated that individual fluctuations are more varied than any overall 
effect of sorghum intake.  
 
6.8 Conclusions 
In summary, although the groups experienced significant weight loss and general 
improvement in all clinical measures such as fasting glucose, insulin, cholesterol and 
key inflammatory biomarkers, no effects appeared specifically related to sorghum 
consumption. Overall, there were no discernable differences between an energy-
restricted diet containing a wheat-based cereal food and that containing a sorghum-
based cereal food.  With a longer intervention and greater exposure to the test foods, 
some differences might have been detected, as subtle effects of components in the 
cereal foods would become more prominent. Nevertheless, the consumption of 
sorghum flaked breakfast cereal biscuits in the context of an energy-restricted diet is 
not deleterious in overweight and mildly obese individuals, and in fact represents a 
viable gluten-free alternative to wheat in food products.  
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A component of this chapter is contained within the article:  
Stefoska-Needham, A. (2016) Progressing the position of sorghum, a potentially sustainable cereal 
crop, through the food product innovation pipeline: an Australian perspective. Agroecology and 
Sustainable Food Systems. (Under Review) 
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7.1 Summary of Findings 
“Food is not just food. Food is a many splendoured thing” 
Anita Stefoska-Needham…Inspired by Kaisa Poutanen (Dietary Fiber Conference, Paris, 2015) 
 
Food represents a complex set of compounds. In nature these compounds act 
synergistically and serve a biological purpose in the original organism (plant or 
animal)
(63)
. Even more complex, is the understanding of a food’s capacity to 
contribute to beneficial effects in the human body. The complexity of dealing with 
food was demonstrated in this thesis, which presented a case study of the effects of a 
novel food on health.  This case study investigated the potential of whole grain 
sorghum as an ingredient in whole foods to assist in the prevention of chronic 
disease, particularly by examining hypotheses relating to body weight regulation as a 
key strategy for management of metabolic disease. Specifically, it was hypothesised 
that sorghum was a viable alternative to existing whole grain cereals and may have 
positive benefits on markers of metabolic health including weight management. In a 
broad sense, by focusing on a single food ingredient – the sorghum grain – this thesis 
asks whether sorghum might have a more significant place in the diets of 
Australians.  
 
The research undertaken for this thesis could be seen as a particular form of case 
study on how research on new foods for human consumption might take place.  After 
positioning sorghum as a nutritious food, the research focused on the effects of a 
novel food product developed in partnership with a food manufacturer (Sanitarium 
Health and Wellbeing) and facilitated through the Australian Research Council 
Industry Linkages program.   The examination of sorghum’s potential to assist in the 
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prevention of chronic disease exposed a number of the complexities which scientific 
research needs to address in dealing with food effects on health. Findings from this 
thesis add to the knowledge base for sorghum as a viable human food, particularly 
within the Australian context where interest from food companies, researchers, 
farmers and consumers is just beginning to grow. The thesis considers an important, 
albeit gradual, transition for sorghum as a low-value livestock feed to a value-adding 
human food ingredient. With the backdrop of a changing Australian economy (where 
the agricultural sector is becoming a more significant economic stimulator), and a 
growing priority for sustainable agriculture in the face of climate change
(5)
, sorghum 
appears as an appealing and appropriate choice of crop. After all, sorghum is 
relatively cheap to produce, with remarkable adaptability, enabling it to survive in 
harsh climates common to many regions of Australia.  
 
An examination of the existing scientific research on sorghum provided a picture of 
the state of the evidence base for sorghum consumption assisting in the prevention of 
chronic disease. It also exposed a myriad of nutrients and bioactive compounds in 
sorghum grain with potential actions in metabolic processes. The sorghum grain 
components included slowly digestible starches, non-starch polysaccharides, 
proteins, fats and a vast array of phytochemical compounds, including phenolic acids 
and flavonoids. Studies of these components implicated effects on energy balance, 
glycaemic control, lipids, gut microbiota, and cell-mediated immune responses, 
including antioxidant and anti-inflammatory processes. Put together, it also appeared 
likely that, as a result of food synergy, the whole food is likely to be more potent 
than its individual components
(148)
. For this reason, whole sorghum-based foods were 
used to test the effects of sorghum intake. The critique of effects of bioactive 
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components within sorghum gained from the literature review guided the direction 
and formulation of valid hypotheses for subsequent human studies reported in the 
thesis, and informed the development of an optimised sorghum-based food product 
for testing. This was a necessary and innovative step in the thesis, and reflected the 
absence of existing sorghum-based foods in the Australian diet.  
 
The food product innovation transformed sorghum from its raw grains into a whole 
food product (flaked cereal breakfast biscuits), appealing to the Australian palate. To 
link the potential actions of food components within the sorghum flaked biscuits with  
effects, it was necessary to comprehensively characterise the physicochemical 
properties of the test foods and this was a major strength of this thesis. Aside from 
typical analyses such as proximate determinations, evaluation of 
polyphenolic/antioxidant compounds and starch properties was also made. Full 
details on the processing of the sorghum grain were considered including unique 
information from scanning electron microscopy, which intimated details on the status 
of starch granules in the final test foods (mainly with respect to gelatinisation). 
Collectively, this data assisted with ascribing clinical effects to particular 
components within the sorghum food matrix.  This information also guided specific 
recommendations made to the food manufacturer around future formulations of 
flaked sorghum biscuits. In particular, consideration was given to lowering the input 
and final moisture levels in order to minimise starch gelatinisation, to further 
increase the content of slowly digestible starches and to potentially lower the 
glycaemic index of the final product. Importantly, this information also provided 
evidence for potential mechanisms of action that may contribute to outcomes in the 
subsequent trial testing the longer-term effects of chronic sorghum consumption.  
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This thesis contributed to the evidence that whole grain sorghum enhances acute 
satiety and is likely to be equivalent to wheat when consumed as an ingredient in 
whole foods. Meal test results showed an increase in anorexigenic hormones (GLP-1 
and GIP in both sexes and PYY in males) over four hours after sorghum whole grain 
was ingested in the form of flaked breakfast biscuits, especially after red sorghum 
intake. Likewise, subjective satiety was increased acutely after sorghum biscuits 
were consumed compared to wheat biscuits. Interactions between polyphenols, 
dietary fibre and SDS within the food matrix may have contributed to the observed 
elevated satiety effects of sorghum flaked biscuit consumption (compared to wheat), 
although the involvement of other nutrients and bioactive components may also be 
relevant. These may include additional effects from gut hormone stimulation. While 
differences in polyphenol content may be relevant, no individual component was 
definitively implicated in the mechanistic pathways, supporting the food synergy 
concept whereby “many substances in food have additive or more than additive 
effects” on health outcomes
(343)
.  
 
As part of an energy-reduced diet, sorghum produced significant weight loss and the 
majority of clinical measures (fasting glucose, insulin, serum cholesterol and key 
inflammatory biomarkers) improved over 3 months during the dietary intervention 
trial. However, these effects were not significantly different to an energy-reduced 
wheat control diet. Overall, it was not possible to conclude that whole grain sorghum 
assisted specifically with weight management, or was superior to wheat (another 
whole grain product). However, the lack of differentiating results between chronic 
consumption of sorghum and wheat should not infer that sorghum is an inferior 
ingredient in cereal food products, especially since subjects consumed the sorghum-
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based foods successfully and experienced beneficial effects. What is evident from 
this research is that a whole grain sorghum product appears as effective as a whole 
grain wheat product in the context of an energy-restricted diet.  
 
Sorghum, like other whole grain cereals, delivers beneficial, health-promoting 
components and properties when it is consumed as part of a healthy food within a 
healthy diet, and it represents an excellent gluten-free whole grain alternative to 
wheat. This knowledge assists with future marketing of sorghum as a food with 
potential health benefits, to consumers. Today more people are motivated by the idea 
that healthy eating encompasses wholesome foods and drinks, which are minimally 
processed, to fuel the body and provide long-lasting energy
(11)
. Weight management 
is often an underlying driver for consumer food choice, particularly in Western 
societies where rates of overweight and obesity are prevalent. Foods that are able to 
assist in appetite control are of particular interest to both consumers and food 
companies alike. Equally appealing is the use of alternative and/or novel ingredients 
that are naturally functional, the so-called “ancient grains” being a good example
(11)
. 
Market researchers predict that the “healthy living” movement will continue
(11)
, 
resulting in more consumers prioritising their personal health and demanding 
naturally healthy, minimally processed whole food product innovations, which could 
include products from sorghum. 
 
Following this demand will be interest from the food industry to make health claims 
about these novel “healthy” food innovations, and thereby an increased demand for 
science to substantiate these claims is expected. For now, specific health claims 
about weight regulation, appetite and satiation/satiety enhancement are not permitted 
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in Australia under the FSANZ regulations
(12)
, though this may change with more 
scientific evidence demonstrating appetite-regulating effects of different foods. This 
would firstly require the development of guidance documents on satiety-related 
health claims, similar to those produced by Health Canada
(216)
. Should this become 
available, the results from the research in this thesis would make a contribution to the 
required evidence base. 
 
7.2 Limitations and considerations for further research 
As with all research, the major limitations of this thesis relates to the breadth and 
depth of analysis that is made available through the study designs. Nevertheless, the 
choices made were consistent with convention.  Food-based research has historically 
used mechanistic studies to explain health effects of food consumption, though this 
has often proven futile for supporting claims on health outcomes mainly because the 
human body is complex and the pathways that lead to improved health or disease 
development are multifaceted. Adding to this intricacy is the complexity of food 
itself and the myriad of interactions between food components and body processes. 
A good example of this complexity comes from the acute study in this thesis, 
whereby insulin response was lower after the white sorghum biscuit compared to the 
red sorghum biscuit but resulted in the same subjective satiety ratings.  If greater 
insulin responses are indeed associated with enhanced acute satiety effects
(281)
, then 
why did the subjects not perceive greater feelings of satiety? Similarly, although the 
satiety related hormones GLP-1 and GIP were elevated after red sorghum 
consumption, the release of the hunger hormone ghrelin was not different between 
treatments despite differences in subjective satiety sensations. There is no clear 
answer to fully explain these results, although human behaviour may be the most 
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powerful determinant of people’s food choices. We all experience eating food in 
response to non-biological cues such as emotions, hedonic hunger (eating to obtain 
pleasure in the absence of an energy deficit), environmental influences, and habits.  
For example, if satiating/satiety effects could override other factors on eating, then 
the sorghum group may have eaten less, but this was not the case. More 
consideration should therefore be given to assessing human behaviour in these types 
of studies.  
 
Given the complex nature of food effects, translating scientific research into practical 
food and nutrition advice on disease prevention is difficult. Nevertheless, 
mechanistic studies of food components add to our knowledge about nutrition and 
contribute to inferences about important causal pathways. In this vein, the acute meal 
test study in this thesis identified important satiety-enhancing actions occurring 
within the sorghum grain (ascribed potentially to SDS, polyphenols, dietary fibre), as 
well as highlighted potential physiological processes involving gut hormones. The 
subsequent trial then served as a platform to test whether these effects could be seen 
over a longer time frame and within the context of a whole diet, which after all, more 
closely resembles the natural context of human eating behaviour. However these 
studies were conducted with a single food – and while well-characterised to define 
the ingredient, it is difficult to ascertain how an ingredient will translate into another 
food.  
 
The RCT design (Chapter 6) was the necessary choice for conducting this 
“translational” nutrition research because its internal validity for comparing an 
intervention to a control is considered to be the “gold standard” and results from 
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RCTs are usually reliable for causal inferences. However, where both the control and 
intervention diets focus on healthy eating patterns and control for energy intakes, as 
was the case in the RCT in this thesis, it seems that a difference in weight loss is not 
likely to be seen
(336)
. This is because weight loss is dependent on control of energy 
intake and the percentage energy reduction was matched in both arms in the present 
RCT. Usually though, differences in other risk factor variables (not affected by total 
energy) can be observed, as seen in other studies of similar design
(339)
. It was 
postulated that a difference in serum cholesterol, glucose, insulin and inflammatory 
markers may be detected between groups (partly due to differences in bioactive 
components such as polyphenolic compounds), but this was not the case. Possibly, 
the amount of sorghum grain in the serve size of the test cereal food products was 
inadequate to elicit differences in satiety and metabolic markers over 3 months. 
Although it is not novel to consider that serve size/dose is important in food studies, 
it is an important factor especially in cereal food studies because clinical effects may 
be dependent on small components within the food matrix.  
 
The RCT results raise the important question about whether the strategy to match the 
percentage energy restriction in both the control and intervention arms is actually a 
limitation. An alternative option is to design studies with additional study arms, 
whereby subjects consume their usual diet without energy restriction and eat the test 
foods of interest daily. To demonstrate this using the RCT in this thesis as an 
example, there would be four study groups: 1) usual diet + sorghum; 2) usual diet + 
wheat; 3) energy-restricted diet + sorghum; 4) energy-restricted diet + wheat. 
Effectively, this suggests two controls and two intervention groups; a control for 
overall dietary composition (including total energy) and eating behaviour and a 
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control for the test food being studied (cereal). It should be acknowledged that this 
might be prohibitive from a practical point of view as costs are increased with more 
subjects and subject recruitment becomes a challenge when volunteers are not 
promised a weight loss intervention. Nevertheless, an alternative strategy such as this 
may be worthwhile to increase opportunities of detecting differences in weight loss 
or biomarkers between groups. Greater study power achieved through a larger 
sample size and/or conducted for a longer time-frame may have allowed differences 
between groups to emerge, though this presents with other challenges typical of 
RCTs including confounding and compliance issues (Chapter 6). 
 
Although energy restriction is pivotal to weight loss, and weight loss is a key 
preventative strategy for disease prevention, it does not reflect the overall quality of 
an individual’s dietary intake. In fact, energy restriction could compromise nutrient 
intake and lead to an unbalanced diet. Aside from the energy-restricted dietary 
prescription provided to subjects in the RCT (based on the Dietary Guidelines of 
Australia), diet quality was not formally monitored. Grafenaeur et al.
(344)
 state that 
the emphasis on diet quality in a weight-loss context recognises the interrelationships 
between foods and food components, and considers the relationship between the 
dietary pattern and overall health. Upon reflection, this is a key component of the 
research framework of this thesis and to this end, a formal assessment of diet quality 
using a validated tool, for example the Food Choices Score (FCS)
(344)
, would have 
provided useful information about the types of food choices individuals made and 
how those selections influenced their eating behaviour, rather than using adherence 
to total energy reduction as the sole gauge of dietary intake and in the end, body 
weight outcomes.  
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7.3 Key recommendations for future studies 
Specifically in relation to sorghum, ongoing investigation is warranted on the use of 
sorghum whole grain as an ingredient in the formulation of foods targeted for weight 
control through appetite regulation, in both a research and commercial context. The 
outcomes of this thesis identify the following key points and raise important 
recommendations and questions for prospective studies using sorghum foods. 
 
1. Part of the effects of sorghum consumption on acute satiety appears to relate 
to stimulation of gut hormones such as GLP-1, GIP and PYY. These effects 
were demonstrated over 4 hours, hence future research should use this time 
frame as the minimum testing period. However, review of hormones over 
greater periods of time in a study with chronic ingestion, and with different 
sorghums varieties, would be useful, especially since mechanisms involving 
polyphenolic components and dietary fibre appear to be quite subtle. These 
hormones would be best reviewed during meal test studies pre- and post- 
long-term interventions, given that a single fasting level taken at a particular 
point in time over 3 months is not likely to be representative. Although, 
plasma glucose responses were not altered in the acute study (probably due to 
similar starch properties between treatment foods), specific testing of the 
flaked biscuits’ GI and insulin index would have provided additional 
mechanistic information. This may have also helped to better understand the 
increased insulin response observed after red sorghum biscuit intake. 
Numerous studies suggest that insulin plays a greater role in acute satiety 
than glucose
(281)
, however ideally reduced insulin responses may be more 
valuable in diabetes prevention. Controlling for fibre content may more 
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clearly elucidate mechanisms and future dose response studies with 
manipulation of the sorghum fibre types would be useful to more precisely 
investigate the role of fibre in satiety-enhancing mechanisms of sorghum-
based foods. 
 
2. Studies should aim to determine whether differences in satiety would persist 
with chronic sorghum intake – and in turn whether these differences would 
influence long-term food intake and thence weight management. Specifically, 
evidence from future RCTs (aiming to directly examine effects on health 
outcomes between a control and sorghum-intervention diet) are needed to 
better understand the health-promoting potential of sorghum consumption – 
as this remains ambiguous in this thesis. However, food-based RCTs present 
with substantial design challenges, particularly when examining weight loss 
outcomes. Developing research strategies to test weight loss outcomes in 
free-living individuals where energy intake is not controlled but scientific 
rigour is preserved, should be a key focus in this endeavor. Additionally, a 
focus on diet quality in a weight-loss intervention trial and more broadly in 
research aiming to link food and health (such as sorghum consumption and 
health), would be advantageous as improved diet quality exposes individuals 
to health promoting food components such as dietary fibre and antioxidant 
compounds and these factors can be better evaluated and considered in the 
overall study outcomes.  
 
3. More-commonly consumed food formats should be tested in future studies of 
sorghum grain consumption, including bread, pasta, porridge and other 
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breakfast cereal options. Invariably, foods are processed from cereals using 
different methods that impact on both sensory and nutritional aspects of the 
food. The acute satiety study in this thesis may have been improved with at 
least an additional test food included in the crossover design, one based on an 
alternative food format such as porridge. This would have assisted with 
evaluating the influence of processing on the sorghum grain and subsequently 
the impact on biomarkers. Various chemical and physical reactions are 
initiated during food processing that may alter the properties of the sorghum 
grain and food matrix, impacting on the fate of the food once ingested. It is 
imperative in future sorghum-based studies to broadly define the post-
processing physicochemical properties of the test foods in order to make 
plausible links between observed clinical effects and potential mechanisms of 
action at the food level. 
   
7.4 Concluding Remarks 
Sorghum is an excellent crop suitable for sustainable agriculture, particularly in 
Australia which is experiencing negative impacts of climate change and global 
warming
(5)
. This research suggests that commercial investment in sorghum food 
product development is warranted. Further, with consumer trends indicating a 
growing demand for naturally functional, minimally processed and satiety-enhancing 
foods
(11)
, whole grain sorghum represents a novel ingredient in food formulations, 
especially those targeted for appetite control. ‘Value-adders’ would benefit not only 
from sorghum’s gluten-free attribute, but its source of nutrients, slowly digestible 
starches, dietary fibre, antioxidant compounds, and its application (especially red 
sorghum) as a natural food colour. Not only do the findings from this thesis provide 
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new knowledge that may improve health outcomes for consumers of sorghum-based 
products in the longer term, but they also contribute to developing and growing the 
sorghum industry globally. Multinational corporations and smaller entrepeneurial 
food companies now need to invest in launching sorghum-based product formats that 
have the potential to become popular within these markets.  
 
 
7.5 Post-Script 
By the completion of this PhD thesis, a sorghum-based food product was launched 
successfully in the market by the food manufacturer associated with this research; a 
business decision that was supported by scientific developments from this body of 
work. This joint innovation project reflects the value of collaboration between food 
industry and academic research to explore a food’s potential through rigorous 
science.  
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APPENDIX 1 
Appetite-Related Visual Analogue Scales (VAS) 
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QUESTIONS ON APPETITE AND DESIRE FOR FOOD 
 
 
INSTRUCTIONS: 
Make a vertical mark      on each line that best matches how you are feeling at this moment. 
 
For Example: 
 
I am not                 ________________________________________________ I have never been 
hungry at all                             more hungry 
 
 
 
       
How hungry do you feel at this moment? 
 
 
I am not                 ________________________________________________ I have never been 
hungry at all                             more hungry 
 
 
 
 
    How satisfied do you feel at this moment? 
 
 
I am completely     ________________________________________________           I cannot eat 
empty                                 another bite 
 
 
 
 
    How full do you feel at this moment? 
 
 
Not at all full           ________________________________________________              Totally full 
 
 
 
 
   How much do you think you can eat at this moment? 
 
 
Nothing at all          ________________________________________________                      A lot 
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APPENDIX 2 
Product Evaluation Questionnaire: Flaked Cereal Biscuits 
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ABOUT YOUR BREAKFAST CEREAL 
 
Instructions 
 
For questions that appear like this, draw a vertical mark (|) on each line that 
best matches how you feel about the breakfast cereal you have eaten 
 
Dislike very much    ________________________________________________    Like very much 
 
 
1. How much did you like or dislike the taste of the breakfast cereal? 
 
I disliked the       ________________________________________________          I liked the  
taste a lot        taste a lot 
 
 
 
 
2. How would you describe the taste of the breakfast cereal you have eaten? 
(please tick the boxes which correspond to your selection) 
 
Sour  
  
Bitter   
  
Sweet  
  
Salty  
  
Other (please specify):  
 
 
 
3. How much did you like or dislike the texture of the breakfast cereal? 
 
I disliked the       ________________________________________________         I liked the  
texture a lot                    texture a lot 
 
 
 
 
4. How much did you like or dislike the crunchiness of the breakfast cereal? 
 
I disliked the       ________________________________________________         I liked the  
crunchiness a lot                                crunchiness a lot 
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5. How satisfying/filling was the breakfast cereal after you had eaten it? 
 
Not very filling        ________________________________________________   Very filling 
 
 
 
6. Do you usually add any additional food items such as fruit, sugar, yoghurt 
or honey (apart from milk) to your breakfast cereal?      
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________ 
 
 
 
7. If you were allowed to add additional food items such as fruit, sugar, 
yoghurt or honey to the breakfast cereal you have eaten, how likely would 
you be to eat this cereal (please circle one): 
 
Be more likely to eat the cereal 
 
Be equally likely to eat the cereal 
 
Be less likely to eat the cereal 
 
 
 
 
8. If you were able to buy this breakfast cereal from a grocery shop and it was 
priced similarly to other breakfast cereals, how likely would you be to buy 
it? (Please tick one)  
 
Definitely Would Buy  
  
Probably Would Buy   
  
Unsure  
  
Probably Wouldn’t Buy  
  
Definitely Wouldn’t Buy   
 
 
